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ABSTRACT 
The experience of fatigue has been a common problem among community populations 
for decades. The symptom of fatigue is also a frequent health complaint in primary care 
practices. Fatigue patients have been shown to be significantly high users of health care 
resources, particularly when compared to non-fatigued patient populations. To date, an 
understanding of the presence and the impact of the symptom of fatigue within the context of the 
Canadian health care system has been understudied.  
 The objective of this research was to determine the number of patients who were suffering 
from the symptom of fatigue within a primary care setting and to explore the determinants of 
their health care utilization patterns. Furthermore, these patterns of health care use were 
compared to a non-fatigue symptom patient population, who were also from a primary care setting. 
The data were extracted from a longitudinal electronic medical record database, which captures 
details of primary care encounters throughout Southwestern Ontario.   
 The fatigue symptom patients were found to experience a large complex of co-occurring 
morbidity and a markedly high level of referral following their visit with the symptom of fatigue. 
As well, the fatigue symptom patients were found to have an increased number of subsequent 
visits to their primary care provider and an increased number of investigations during a one year 
follow-up period, when compared to the non-fatigue symptom group. 
 These findings begin to create an understanding of fatigue symptom patients, their 
complex of morbidity, and their subsequent health care use patterns. This information will help 
to improve the management of fatigue symptom patients in Canadian primary care practices and 
in the Canadian health care system more broadly.  
 
KEYWORDS: Fatigue, Primary Care, Prevalence, Health Care Utilization  
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CHAPTER ONE – INTRODUCTION 
 The first chapter of this thesis will give a brief introduction to the magnitude, 
measurement and management of the symptom of fatigue. This will begin to establish the 
background and contextual basis for the main focus of this research, which are the health care 
utilization patterns of fatigue symptom patients in primary care.  
 
1.1. An Introduction to the Problem of Fatigue  
 Symptoms of ill health are a common part of daily life for most people 1, 2. More 
specifically, the symptom of fatigue is a common experience in general populations throughout 
the developed world. Community-based surveys conducted in the United States and in Europe 
have indicated that as many as 50% of community populations reported experiencing fatigue if 
asked 3, 4, and national population surveys have estimated that 20% to 30% of adults reported 
experiencing significant fatigue at any given time 3, 5. However, the prevalence of the symptom 
of fatigue among the Canadian population continues to be unknown and understudied. The 
Statistics Canada 2005 Canadian Community Health Survey, which is a cross-sectional survey 
that covers approximately 98% of the Canadian population aged twelve years of age and older, 
found that almost a million Canadians, predominantly female and middle-aged, have received a 
diagnosis of chronic fatigue syndrome (CFS) or fibromyalgia 6. This is likely a substantial 
underrepresentation of the prevalence of fatigue symptoms among Canadians, as a small 
minority (5% to 10%) of individuals who experience fatigue actually receive a diagnosis of CFS 
or fibromyalgia from their health care provider 7, 8. Fatigue symptoms have been found to be 
present in at least 20% of patients who visit a primary care provider each year 9. Not only is 
fatigue a common complaint in community and primary care settings, but it also represents a 
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multifaceted and trying issue for many individuals. Previous literature has highlighted the 
importance of epidemiological research as a resource for understanding this multidimensional 
problem.  
 
1.2. The Measurement of Fatigue  
 In health care, fatigue can be interpreted, presented, and measured in a number of ways, 
including as a subjective symptom, a physiological measurement, or as a chronic syndrome. 
Firstly, fatigue can be defined as a subjective self-reported feeling; this is what people generally 
report when they seek medical treatment 8, 10. Fatigue can be described by an individual as 
feeling tired, being exhausted, feeling weak in a specific part of the body, lacking energy or 
experiencing “everything as an effort” 11. However, these experiences are often difficult to 
quantify or objectively measure for health care professionals. Secondly, physiological 
measurements of fatigue can be achieved through objective observations of muscle   
performance 12 or the time-dependent decrease in the ability to perform physical coordination or 
mental tasks 13. Finally, many studies in the existing fatigue literature have focused on the 
subgroup of patients who have received the diagnosis of chronic fatigue syndrome. CFS is a 
distinct clinical entity from idiopathic fatigue in that it is characterized by fatigue that persists for 
longer than six months (therefore is classified as chronic fatigue) and that is also associated with 
impaired memory or concentration, sore throat, tender lymph nodes, headaches, non-restorative 
sleep, and postexertional malaise 14. Another condition that tends to be related to fatigue 
presentation is fibromyalgia. This condition presents with fatigue that is associated with chronic 
pain and stiffness of the body, particularly the neck, shoulders, low back, and hips 14. The current 
study will include patients who have presented to their primary care provider with a wide range 
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of fatigue experiences, encompassing the entire spectrum of fatigue. As stated by Lewis & 
Wessely (1992), fatigue is best viewed on a continuum 15.   
 
1.3. The Management of the Adult Patient with Fatigue  
Epidemiological and clinical studies of fatigue have concluded that this symptom is often 
associated with significant morbidity 15. This makes the investigation and management of the 
fatigue presentation a particular challenge for primary care providers. Fatigue is known as a 
nonspecific symptom because it can be indicative of many underlying causes or related 
conditions, including physiological states (such as sleep deprivation or excessive activity), 
medical conditions (such as chronic inflammatory disease or blood conditions, viral infections or 
autoimmune illnesses), psychiatric disorders (such as depression, anxiety states or somatoform 
disorders), medication-related effects (such as from drugs prescribed for insomnia, 
antihistamines or chemotherapy drugs), and unhealthy lifestyles or stressors (such as disruptions 
in sleep cycles, excessive alcohol or caffeine intake, or the effects of traumatic events) 8, 16, 17. 
However, regardless of the cause, every patient suffering from fatigue merits the need for a 
careful assessment and evaluation.  
The first part of the assessment of a fatigue patient for a health care provider is listening 
to the patient's account of the symptoms, trying to understand their meaning for the patient, and 
determining possible cues of their cause through a comprehensive history taking and physical 
and psychological examination 16. More specifically, it is important for the primary care provider 
to explore what the patient means by the fatigue or tiredness, and if possible, whether their 
fatigue is associated with physical or psychological factors. Informed by the initial observations, 
the provider may proceed with further investigation, if deemed necessary. As stated by 
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McWhinney and Freeman (2009), clinical investigation over the course of one or two visits 
should help to inform a probable diagnosis or management plan for the large majority of   
patients 16. A battery of focused laboratory tests can be done to rule out common underlying 
conditions or causes (such as iron deficiency or pregnancy). Standard laboratory tests often 
include a complete blood count, the measurement of blood glucose levels, the measurement of 
specific enzymes, antibodies or proteins in the blood, and a urinalysis. Further directed tests 
(such as HIV antibody testing) or imaging tests (such as an ultrasound) may be indicated based 
on the patient’s history and physical findings. Specialist assessment of the patient may also be 
required if a co-occurring condition is more effectively managed or treated in a secondary or 
tertiary care setting (for example, referral to an allergist if the patient presents with severe 
seasonal allergies, in addition to the fatigue symptoms). Although focused investigations and 
referral to specialists can constitute reasonable management for some fatigue symptom patients, 
some patients may require ongoing in-office primary care visits, particularly if no medical 
explanation can be found, if the symptoms of fatigue persist or worsen, or if the associated 
morbidities worsen. When used properly, additional primary care visits allow for further 
investigation of the patient’s complaints, and they can also help to establish a stronger patient-
provider relationship, which is essential for providing support to the patient and for ensuring 
health care resources are used properly and efficiently 7.  
While symptoms of ill health are a common experience of everyday life for many 
individuals, symptoms of fatigue have been consistently demonstrated in previous research to be 
a significant burden for communities, primary care attenders and the health care system more 
broadly. Fatigue has been associated with high levels of morbidity and disability, and 
consequently, increased levels of health care utilization. Although few presenting complaints are 
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more challenging, a broad contextual approach involving communication with the patient and 
assessment of physical or psychological indicators is most effectively provided by a primary care 
provider 9. As stated by Lewis and Wessely (1992), “fatigue does not kill but it is common, 
disabling, and is regarded as a serious symptom by patients” 15. Therefore, evaluating fatigue 
symptom patients’ health care utilization, both in the context of other symptom patients and in 
the Canadian health care system, will be an important contribution to the existing literature and 
will be the focus of the thesis discussed herein.  
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CHAPTER TWO – LITERATURE REVIEW 
 This literature review was conducted in order to illustrate the problem of fatigue in 
multiple contexts and dimensions, to describe previous literature examining health care 
utilization among fatigue symptom patients, to identify a conceptual framework of health care 
utilization, to highlight notable gaps in the literature, and finally to determine possible 
contributions a study using electronic medical record (EMR) data could make to the existing 
literature. Consequently, this chapter will orient the reader to the current knowledge of fatigue 
symptom patients and its remaining limitations.  
 
Section One: Description of Fatigue Patients  
2.1. The Magnitude of Fatigue: The Prevalence of Fatigue and Its Associated Costs 
Fatigue consistently ranks among the most commonly presented complaints to 
physicians, regardless of practice setting or culture 9. The problem of excessive or unexplained 
fatigue has been common both in the primary care population and the community population for 
decades 18, 19. The prevalence of fatigue symptoms presented to family physicians has been found 
to range from 7% to 45%, depending upon the definition of fatigue, how the fatigue symptoms 
were identified and measured (for example, through primary care encounters, surveys or 
measurement scales), the population studied (for example, a primary care or community 
population), the inclusion and exclusion criteria applied (for example, requiring a minimum 
duration of fatigue symptoms), and the setting in which the study was conducted 3, 7, 15, 20-24.  
In the United States, it has been reported that fatigue was responsible for at least 10 
million office visits and up to $300 million in health costs each year 25. Furthermore, although 
chronic fatigue syndrome patients account for a small minority of fatigue sufferers 7, 8, the 
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estimated direct and indirect costs to the community for each individual suffering from CFS has 
been projected to be as high as $9,436 per patient annually 26. In a more recent study examining 
the effect of chronic fatigue syndrome in the United States, the annual direct costs from CFS 
were $3,286 per patient (mainly as a result of increased physician visits and prescription 
medication use) and the annual loss of household earnings due to CFS were $8,554 per patient, 
even after adjustment for confounding factors 27. A similar cost analysis determining the impact 
of fatigue patients or chronic fatigue syndrome patients on the Canadian health care system has 
not yet been completed, but it could be assured that a similar financial burden of fatigue is 
present within the Canadian context as well.  
 
2.2. The Problem of Fatigue: The Amorphous Symptom  
Fatigue has been particularly problematic for family physicians or primary care providers 
because of the fact that this symptom is often a nonspecific indicator of underlying medical 
pathology and psychological distress 7. Furthermore, many chronically fatigued patients have 
defied diagnostic categorization, including not meeting the clinical diagnosis of chronic fatigue 
syndrome 8, 9. In fact, the underlying cause cannot be identified in one-third of primary care 
patients presenting with fatigue, which has led to frustration for both the patient and the   
provider 17. Regardless of the cause, patients typically report having a lack of energy, being 
listless, and being too tired to participate in family, work, or leisure activities. The subjective 
feeling of fatigue is usually what individuals reported when seeking medical treatment 8, 10. 
However, this self-reported feeling of fatigue does not always correspond correctly with attempts 
to measure or quantify the patient’s fatigue experiences by the provider 10. This discrepancy 
between subjective presentation and attempts to objectively measure fatigue could have had an 
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influence on the predominant dismissal of fatigue symptoms in general practice, as well as the 
subsequent dissatisfaction patients felt with the care they had received 28, 29. Consequently, this 
common, yet amorphous symptom requires a committed, informed, organized, and efficient 
evaluation and assessment by health care providers in order to achieve positive outcomes 9.  
Symptom research is an important but difficult field of study within the broader context 
of health services research 30-32. Previous work by Kroenke identified three different methods for 
eliciting symptoms from a population: chart review; survey or questionnaire administration; and 
spontaneous reporting by the patient 31. Although subjectively described and voluntarily 
presented problems can be influenced by both personal and health system factors that can be 
difficult to account for, a comprehensive objective measure of the symptom of fatigue has been 
viewed as “an unattainable Holy Grail” 33. Again, this is because the unique experience of 
symptoms of illness does not easily translate into one comprehensive objective measure 1. Efforts 
to create a valid and reliable measurement tool for fatigue symptoms have produced scales such 
as the Fatigue Scale 34 and the Fatigue Severity Scale 35. However, there continues to be a lack of 
consistency within previous fatigue research in the way that “case” patients are identified and 
subsequently evaluated. As a result, symptom reporting by patients is considered to be the most
relevant method of case identification for clinical practice 31 and this method was utilized within
the present study. 
 
2.3. Characteristics of Patients with Fatigue: Demographics, Morbidity, and Duration  
Studies of fatigue patients have shown a bimodal distribution of patient age, with a peak 
in young adults aged 18 to 24 years and a second peak in older adults aged 60 years and over 9, 23, 
36, 37. Many studies have examined the role of gender in fatigue presentation. Some researchers 
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have found that women were more than twice as likely to seek medical help for their fatigue 
symptoms as compared to men 4, 11, 36, 38. Although this excess might have been explained 
exclusively by a higher incidence of fatigue in women as compared to men, it may have also 
been a result of a number of other underlying factors, including: that women were more frequent 
attenders to their family physician, giving them a greater opportunity to present symptoms; that 
women were more likely to express that they were feeling fatigued when visiting their family 
physician; or possibly that physicians were more sensitive to the ways in which women complain 
about fatigue symptoms 9. While many studies have found similar gender differences, with 
women being more likely to report both fatigue and chronic fatigue symptoms 3, 5, 28, 32, some 
primary care and hospital-based studies have found no statistically significant gender differences 
in fatigue presentation 25, 39. Furthermore, the relationship between patient ethnicity and fatigue 
presentation or prognosis has not been clearly defined in previous literature 40-42.  
Fatigue has been an important symptom in primary care practices due to its particularly 
high association with psychological and social problems. Reports using structured diagnostic 
assessments have revealed that between 50% and 80% of patients complaining of persistent and 
disabling fatigue in various clinical settings (including primary, secondary, and tertiary care 
clinics) met criteria for a psychiatric disorder, most commonly major depression, anxiety states, 
and somatization disorder 4, 8, 16, 43-45. The temporality of the fatigue presentation and the 
psychiatric disorder may be difficult to ascertain in individual cases 43. Studies have examined 
the timing of fatigue and psychiatric symptoms and have shown that the psychological or 
psychosocial symptoms frequently occurred either before or at the same time as the onset of the 
chronic fatigue, therefore indicating that the psychosocial symptoms were either a cause of or 
were co-occurring with the fatigue symptoms 3, 4, 46, 47.  
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Patients presenting with the symptom of fatigue have also been shown to experience high 
levels of co-occurring chronic morbidity 3, 8, 15, 43, 48. In a study by Kroenke et al. (1988), the 
prevalence of chronic morbidity was significantly higher among patients presenting with fatigue 
in comparison to other non-fatigued patients 3. In fact, fatigue symptom patients have been found 
to have an average co-morbidity count of 16.6 conditions over a four year period, which was 
significantly higher than the average co-morbidity count of 10.4 conditions experienced by the 
general patient population over the same four year period 23.  
Despite the recognition that fatigue symptoms can be an entangled and integrated 
component of chronic disease, its etiology in many chronic illnesses continues to not be well        
understood 8, 39, 48. Within this subset of fatigue symptom patients, the ability of health care 
providers to address a lengthy and broad differential diagnosis, while establishing the placement 
of the fatigue symptoms in the context of chronic and psychosocial morbidity, both in 
partnership with the patient and as efficiently as possible, was considered a significant task in 
primary care practice 9.    
When presented in primary care, providers tend to focus on co-occurring symptoms 
and to adhere to a wait-and-see policy for patients experiencing symptoms of fatigue 49. 
However, examining the duration and prognosis of the fatigue has been shown to better predict 
the course of fatigue and to more effectively manage future health care use 49, 50. A study 
conducted in the United States determined that of patients who reported fatigue as a major 
problem to their primary care providers, the mean duration of the fatigue was 3.3 years 3. In 
terms of prognosis, a systematic review conducted by Nijrolder et al. (2008) found that among 
previous studies conducted in the primary care setting, recovery or improvement in fatigue 
symptoms ranged from 22% to 97% of fatigue patients 49.  
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A Canadian study by Cathebras et al. (1992) examined 93 adult patients who attended 
their primary care provider through a self-initiated visit for a new symptom of fatigue and found 
that the outcome of fatigue was generally poor. This study estimated that between one half to 
two thirds of their fatigue patients continued to have fatigue complaints one year following the 
primary care visit; a longer duration of fatigue symptoms prior to the primary care visit predicted 
worse outcomes and longer times to recovery 39. A study conducted in the United States by 
Valdini et al. (1988) determined that 58% of family practice patients who presented with a chief 
complaint of fatigue were still fatigued one year after the initial visit 51. Ridsdale et al. (1993) 
identified 220 British patients who presented to their general practitioner with a chief complaint 
of fatigue 38. This study found that 59% of patients were still fatigued after 6 months. Patients 
with a previous diagnosis of anxiety or depression (OR=3.0, 95% CI=1.4 - 6.1) and those with 
fatigue symptom duration lasting more than three months prior to the visit (OR=2.1, 95% CI=1.1 
- 4.1) were more likely to remain fatigued at follow-up 38. These results were supported by an 
extensive international study involving fifteen primary care centers located in fourteen countries, 
in which both psychological morbidity and duration of fatigue symptoms predicted persistence of 
fatigue at follow-up 52.The previously noted study completed by Kroenke et al. (1988) 3 failed to 
demonstrate a similar effect of these variables on prognosis, while Taylor et al. (2002) 53 
concluded that the severity of fatigue at baseline was the most significant predictor of persistent 
fatigue symptoms at follow-up.   
 
2.4. Summary of Existing Literature on Fatigue Symptom Patients     
 In summary, the symptom of fatigue was highly prevalent in both community and 
primary care settings. With the exception of Cathebras et al.’s study conducted in 1992, the 
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majority of key findings regarding fatigue symptom patients have been derived from studies that 
have been based in the United States or in Europe. In general, these studies have found that the 
symptom of fatigue was experienced by a diverse demographic of primary care patients and that 
fatigue was often enmeshed in a complex of co-occurring symptoms and chronic morbidities. 
The presentation of fatigue by patients in primary care, as well as the duration and prognosis of 
this symptom, tended to be highly correlated with the presence of psychological and 
psychosocial morbidities. Although these studies have concluded that fatigue symptom patients 
represented a very complex and significant issue in primary care settings, a stronger 
understanding of the prevalence and level of morbidity of these patients within the Canadian 
primary care setting is still required.  
 
Section Two: Description of Health Care Utilization  
2.5. Theory of Health Care Utilization  
Many theories have been applied to health care seeking behaviours to explain why 
individuals and populations used health care services and health care resources. For example, 
attachment theory, which proposed that early childhood experiences with family caregivers 
shaped an individual’s behaviours within their interpersonal relationships, has been used to 
understand health service utilization 54. Specifically, individuals who have developed certain 
types of insecure attachment styles were more likely to report physical symptoms and to visit a 
primary care provider 54.  Alternatively, the social cognitive theory has been used to describe a 
multifaceted causal structure of an individual’s health care use involving self-efficacy, 
behavioural acquisition (through learning and reinforcements), outcome expectations, and 
perceived environmental or social impediments and facilitators 55, 56.  
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However, Andersen’s behavioural model of health services use 57-59, initially developed 
over 35 years ago, has been one of the most frequently used frameworks for conceptually 
organizing factors that might influence health care utilization behaviours. This conceptual 
framework worked to account for three main determinants of health service utilization: 1) 
individual behavior; 2) societal characteristics; and 3) health system factors. The individual 
behavior was composed of both predisposing and needs-based factors, which are described in 
more detail below. Societal characteristics were comprised mainly of the technology (for 
example, the development of immunizations and the use of anesthesia) developed and used in 
health care delivery and the associated societal norms of receiving this care 58. The health system 
factors represented determinants affecting the provision of formal health care goods and services 
in society. These factors involved the structural and resource-based elements of the health care 
system, including the organization of the system (for example, how medical personnel and 
facilities were coordinated and controlled) and the volume of services offered by this system (for 
example, the volume of services or resources offered in relation to the population being served 
and the geographical distribution of these services or resources) 58.  
Individual characteristics, such as age and sex, have been hypothesized to influence an 
individual’s predisposed nature or propensity to use health services more than other individuals, 
even though a direct causal relationship between these characteristics and subsequent health care 
use has not been established 57, 58. Instead, individuals in different age groups have been shown 
to experience varying levels and severities of illness and morbidity, and consequently different 
patterns of medical care. The tendency of an individual to seek care could also be impacted or 
influenced by the social status of the individual, which may subsequently influence an 
individual’s lifestyle patterns; the health of their surrounding environment (both social and 
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physical environments); and their attitudes or beliefs about health, medical care, and health care 
providers 57, 58. The social status of the individual also influences the availability of appropriate 
resources and associated enabling factors. These enabling factors include an individual’s 
income, the level of health insurance coverage (an issue for some countries more than others), 
and the accessibility to health care facilities and health care professionals 57, 58.  
Finally, the level of perceived (from the individual’s or patient’s perspective) and 
evaluated (from the health care provider’s perspective) illness influence an individual’s need to 
access health care services and how the provider facilitates the patient’s movement through the 
health system 57, 58. While the individual’s perceived illness results in the initial health care visit 
with a complaint or health issue; secondary use of health services is then controlled, to a large 
extent, by the health care provider who evaluates the illness and the need for further care.  This 
evaluated need may warrant the need for further investigation (such as through laboratory 
tests or imaging tests), referral to another physician or specialist, or a follow-up visit. Although 
these decisions for secondary care may be largely due to clinical judgment, the provider may 
also be influenced by a constellation of other factors, including health system factors (for 
example, the availability of investigative resources or the availability of specialists in the area) 
and pressures that are applied by the patient (for example, to provide further investigation or to 
reach a diagnosis).  
To summarize, regardless of the conceptual framework used (whether Andersen’s model 
or another), there are many factors that influence both the initial health care-seeking 
behaviours of individuals and the subsequent health care use following the assessment of the 
symptoms or complaints by the health care provider. Some of these factors may be captured and 
studied through secondary analyses of electronic medical record (EMR) data, whereas some may 
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only be adequately measured through primary data collection approaches. In order to develop a 
suitable conceptual framework for the current study, the Andersen model of health care 
utilization was adapted to structure the variables that were: 1) important factors or characteristics 
associated with health care utilization; and 2) accessible and available within the EMR database. 
This adapted conceptual framework is described further in Section 3.2. 
 
2.6. The Use of Health Care Services by Fatigue Symptom Patients    
Symptoms are the leading reason why patients seek medical care and often serve as a 
basis for establishing a preliminary diagnosis 2, 30, 60. Patients’ self-report of symptoms in primary 
care also help to guide management and treatment plans as they serve as an important indicator 
of the severity and complexity of the patient’s disability and morbidity 2, 61. Patients suffering 
from a complex of symptoms have been shown to be more frequent attenders of primary care 
practices, and have also been shown to experience high levels of secondary and tertiary health 
care use 21, 62, 63. In other words, symptom patients account for a major proportion of health 
resource utilization, regardless of the particular symptom or the medical setting 63-65. This effect 
has been shown to be exacerbated when the co-occurring morbidities were chronic or 
psychosocial in nature 62, 66.  
Fatigue patients have been shown to experience many of the characteristics that 
contribute to higher health care utilization patterns, including increased age 8, 43, being female 8, 
23, 28, 43, having high levels of disability and morbidity 24, 28, 39, 49, 67, and experiencing high levels 
of co-occurring psychosocial and chronic morbidity 4, 8, 39, 43. In fact, these characteristics have 
also contributed to poor prognosis among fatigue symptom patients, leading to further increase in 
the use of health care services. However, the degree to which a fatigue patients utilized health 
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care services was not positively related to their patient satisfaction level 29. Instead, a higher use 
of health care services, particularly in the absence of any final conclusions or clear management 
decisions, has led to frustration and discontent from the patient and the provider alike 29.  
In the Canadian study by Cathebras et al. (1992), fatigue symptom patients were found 
not to be significantly different in their amount of health care use in the year preceding or 
following the initial fatigue visit date, as compared to non-fatigued patients 39. More specifically, 
patients with complaints of fatigue did not differ from other clinic patients in the number of visits 
to the primary care clinic during the follow-up year, and were also no more likely to have been 
hospitalized 39. In the one year following the initial fatigue visit, the fatigue patients attended 
their primary care clinic an average of 3.4 times 39. In contrast, a study based in the United 
Kingdom by Ridsdale et al. (1994) found that patients who consulted to their primary care 
provider with a symptom of fatigue or tiredness (with a duration lasting for more than two 
weeks) visited their health care provider significantly more frequently in the six months before 
and the six months after the initial visit, as compared to the age-sex matched group of non-
fatigue patients 68. In the six month period following the initial encounter, patients with fatigue 
consulted to their primary care provider an average of 4.2 times (95% CI=3.7 - 4.6), as compared 
with an average of 1.6 visits (95% CI=1.3 - 1.9) made by the comparison group patients 68.  
In a study conducted by Kenter et al. (2003) 23 among Dutch primary care attenders, an 
episode of care was constructed for patients who presented to their primary care provider with 
the symptom of fatigue using the Reason for Encounter (RFE) and the International 
Classification of Primary Care (ICPC) system. While the majority (72%) of patients with an 
episode of care for fatigue required only one encounter with their family physician during an 
average episode length of approximately six months; it was noted that this did not imply that the 
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fatigue symptoms had disappeared, or even decreased 23. The main interventions administered to 
these patients during the episode of care were blood tests (75.7% of episodes), physical 
examinations (49.5% of episodes), advice or health education (34.2% of episodes), and a small 
number of referrals to specialists (3.3% of episodes) 23.  
A study conducted by Bombardier and Buchwald (1996) found that health care use 
among fatigue patients was “substantial” and that care was obtained from a wide range of allied 
and alternative health professionals 24. Among fatigue patients, the most common alternative 
health professionals seen were a psychiatrist, psychologist or counselor (50.9% of patients); a 
naturopath or homeopath (36.2% of patients); a chiropractor (22.7% of patients); and an 
acupuncturist (11.1% of patients) 24. In contrast to the findings of the Kenter et al. study, which 
found a small number of visits by fatigue patients, this sample of fatigue patients had an average 
of 21 health care visits during the previous year 24. Although these results were substantially 
different than the Kenter et al. study, the variation in health care use may have been largely due 
to the methodological differences between the two studies, which included differences in: 
settings (as the Kenter et al. study took place in a Dutch family practice and the Bombardier and 
Buchwald study took place in an American university-based chronic fatigue clinic); the case mix 
and inclusion criteria of the patients (as the Kenter et al. study included patients presenting to 
their primary care clinic with the symptom of fatigue and the Bombardier and Buchwald study 
included patients who were referred to the tertiary clinic for fatigue-specific problems); and the 
types of health care use that were included (as the Kenter et al. study had two broad categories of 
physician visits and “specialist referrals”, whereas the Bombardier and Buchwald study collected 
information on a wide range of visits to allopathic and “alternative” practitioners). Consequently, 
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the previous literature showed a considerable amount of variation and lack of consensus 
regarding the health care utilization patterns of fatigue symptom patients.  
 
2.7. Summary of Existing Literature on Fatigue Symptom Patients’ Health Care Utilization  
 In summary, the existing literature has been effective at exploring a variety of 
determinants that have influenced health care utilization by symptom patients, and more 
specifically, fatigue symptom patients. These studies were particularly focused on the 
predisposing (for example, the patient’s age and sex) and needs-based (for example, the patient’s 
level of morbidity) individual determinants, which are important components within 
Andersen’s behavioural model of health services use. These studies, which were primarily 
conducted in the United States and in Europe, tended to find that symptom patients (fatigue 
symptoms or otherwise) with a complex of chronic and psychosocial morbidities and who were 
more frequent attenders initially, experienced a higher level of subsequent health care use during 
a defined follow-up period. Furthermore, some studies demonstrated that fatigue symptom 
patients in particular experienced a higher level of health care use in comparison to the average 
or typical primary care population. However, a small number of these studies utilized EMR data 
to explore the relationships between symptom presentation and health care use 23, 68. Only one 
previous study was conducted in the Canadian primary care context, which found a considerable 
amount of health care use among fatigue patients; suggesting that further study of these patients 
would be important 39. As a result, a more detailed understanding of the various factors that 
influence health care use among fatigue symptom patients, both as compared to other symptom 
patients and in the context of the Canadian health care system, is required.  
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2.8. Existing Gaps in the Literature and the Proposed Contribution of the Current Study 
Symptoms of fatigue are widespread among both community and primary care 
populations. Although the amorphous and multidimensional nature of fatigue symptoms can 
make identification and definition of fatigue cases difficult, there is a need to more fully 
understand the current prevalence of this condition in patient populations and its impact on the 
health care system. Fatigue symptoms are in themselves an important cause of morbidity and 
may be the manifestation of underlying physical or psychosocial distress, but they have also been 
shown to create a significant financial burden on patients, communities, and on the health care 
system more broadly. Primary care providers are particularly well placed to effectively manage 
the primary and secondary complaints of fatigue symptom patients, in order to reduce potential 
negative health outcomes and potential inefficient use of health care resources. In fact, a primary 
care perspective has been highlighted as contributing important research regarding the nature, 
causes and consequences of fatigue 21. As an extension of this, electronic medical record 
databases have been recognized as representing a unique source of data for answering questions 
about primary health care delivery 69. Establishing a greater understanding of fatigue symptom 
patients in Canadian primary care settings will provide a necessary insight into these patients, an 
insight that is currently lacking in existing literature. Therefore, the current study aims to utilize 
a primary care EMR database to describe the characteristics of patients who present to their 
primary care provider with the symptom of fatigue, as well as their subsequent use of health care 
resources, all within a Canadian primary care context.  
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CHAPTER THREE – METHODOLOGY 
3.1. Research Objectives  
1) To describe the characteristics of patients who experience an index visit for a symptom of 
fatigue.  
Question 1: What are the age and sex characteristics of this symptom group?   
Question 2: What are the previous care-seeking frequencies prior to the index visit for 
this symptom group?  
Question 3: What are the mean number and most frequent types of previous and co-
occurring morbidities for this symptom group?  
Question 4: What is the mean number of subsequent visits experienced by this 
symptom group during a one year follow-up period?      
Question 5:  a) What is the mean number of referrals experienced by this symptom 
group during a one year follow-up period?               
b) What are the top five referrals made for this symptom group during a 
one year follow-up period?          
Question 6: What is the mean number of investigations experienced by this symptom 
group during a one year follow-up period?    
 
2) To analyze the relationship between factors (covariates such as age, sex, type of previous 
and co-occurring morbidity and previous care-seeking frequency) and the number of 
subsequent visits, the number of referrals received, and the number of investigations 
administered during a one year follow-up period. 
Hypothesis 1: Patients who present with a symptom of fatigue and who have multiple 
chronic or psychosocial previous and co-occurring conditions will 
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experience a higher rate of health care utilization compared to patients 
who present with a symptom of fatigue and who have fewer or no chronic 
or psychosocial previous and co-occurring conditions, adjusting for all 
other variables.  
Hypothesis 2: Patients who present with a symptom of fatigue and who have a higher  
previous care-seeking frequency will experience a higher rate of health 
care utilization compared to patients who present with a symptom of 
fatigue and who have a lower previous care-seeking, adjusting for all  
other variables.  
 
3) To analyze the differences in health care utilization patterns between patients who have 
an index visit for a symptom of fatigue compared to a matched comparison group of 
patients from the general patient population who have experienced an index visit for 
another symptom or complaint.  
Hypothesis 1: Patients who present with an index visit for fatigue will experience a 
higher level of health care utilization in comparison to their matched, non-
fatigue comparison patient who has experienced an index visit for another 
symptom.  
 
3.2. Thesis Framework  
Considering the potential determinants of health care use that have been identified in the 
previous literature, and considering what variables were accessible for the current study, an 
adapted Andersen behavioural model of health services use 57, 58 was created and can be found 
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in Figure 1. The patient-level variables were grouped into two categories: predisposing and need-
based determinants. Predisposing factors reflected a propensity toward use of health care 
services by the individual before the onset of the symptom or condition of interest; and need-
based factors reflect both the actual and the perceived level of illness. The patient-level 
predisposing factors included age and sex; while the need-based factors included the presence of 
a symptom, the number of previous or co-occurring morbidities and the number of previous 
visits experienced by the patient. Overarching context determinants were also included in the 
adapted model, in order to account for the provider- and practice-level characteristics that have 
been shown in the literature to influence health care utilization 70-72. Because examining the 
effects of these variables on health care utilization was not an objective of the current study, the 
provider number and practice number were captured using dummy variables and were controlled 
for in our analyses.  
The final component of the adapted Andersen model was the use of health services 
outcome variables. The three dependent variables that were derived to capture health care 
utilization were the number of subsequent visits experienced by the patient, the number and type 
of referrals requested, and the number of investigations ordered by the primary care provider, all 
in the structure of a one year follow-up period.  
The objective of this research was to explore multiple predictors of health care utilization 
among patients who have presented to their primary care provider with the symptom of fatigue, 
and to compare these health care utilization patterns with an “average” or “typical” symptom 
patient. Consequently, a case-comparison study was conducted, with the unit of analysis being 
the patient (both of these study design elements will be described in later sections).  
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Figure 1: Adapted Andersen’s Behavioural Model of Health Services Use*  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Adapted From: Andersen RM. Revisiting the behavioural model and access to medical care:  
Does it matter? Journal of Health and Social Behaviour 1995; 36: 1-10.  
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3.3. Data Sources 
 The data for the current study were derived from two main, interrelated sources: the 
Deliver Primary Health Care Information Project database and the embedded International 
Classification of Primary Care patient population.  
 
3.3.1. The Deliver Primary Health Care Information (DELPHI) Project 
The Deliver Primary Health Care Information (DELPHI) Project is an on-going and 
unique research database that was established in 2003 and is based at the Centre for Studies in 
Family Medicine at The University of Western Ontario. With funding from the Canada Foundation 
for Innovation and Ontario Primary Health Care Transition Fund grants, the DELPHI Project 
was developed to create a researchable database from the electronic medical records of primary 
care providers throughout Southwestern Ontario 69. This initiative recognized the potential of 
EMR technology as a tool for improving practice, policy and research in primary health care. 
The DELPHI Project subsequently had the central goals of facilitating the development of an 
EMR system in order to improve information-sharing in an interdisciplinary primary health care 
setting and to describe, assess and improve the quality of primary health care delivery 69. This 
project was supported by a number of key functioning partnerships, such as with the Institute for 
Clinical Evaluative Sciences (ICES), Healthscreen Solutions Inc. (the EMR software company) 
and the Department of Epidemiology and Biostatistics at The University of Western Ontario. 
Another key aspect of the successful execution and sustainability of this project was the 
implementation process, which progressed through four integral stages: provider recruitment; 
adequate EMR software uptake; well-designed database creation; and continuous data quality 
assessment 69.  
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Family physicians and other allied health professionals were recruited from ten family 
practices throughout Southwestern Ontario. The process of recruitment was done through 
complementary approaches, which included enlisting key community leaders in family medicine 
to identify a suitable EMR software, soliciting interest from the Family Medicine Education and 
Research Network e-mail discussion group, identifying providers who had expressed interest in 
integrating an EMR software into their practice, and ensuring that the principal investigator of 
the project personally visited these interested providers at their primary care practices to discuss 
the details and objectives of the DELPHI Project 69. Although this strategy did not result in a 
strict random sampling of primary care providers who practiced in Southwestern Ontario, the 
distribution of the family physicians covered a wide geographic area of Southwestern Ontario 
and was broadly representative by age and gender of Ontario family physicians. However, the 
DELPHI sample was less urban than the larger Ontario family physician population 69. Of the 
twenty-five family physicians that were recruited, sixteen were male and nine were female, with 
a mean estimated age of 52.5 years (calculated this proxy for age using the year of graduation 
and the assumption that most graduates would be on average 28 years old at the time of 
graduation).   
Once the DELPHI team obtained signed consent from the providers indicating their 
willingness to participate in the project, the patients of each recruited practice were informed of 
the project through prominently placed posters in the practices’ waiting and examining rooms 69. 
Patients who did not wish to participate were invited to discuss with their primary care provider 
directly or to contact the named project coordinator in order to be excluded from the data 
collection. Ethics review and approval was obtained from the Ethics Review Board of the 
University of Western Ontario (Study Number 11151E). As well, privacy concerns were actively 
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resolved in partnership with the Office of the Information and Privacy Commissioner of   
Ontario 69.  
The collaboration with the EMR software company, Healthscreen Solutions Inc., allowed 
the DELPHI database to accommodate research-oriented data input technologies and data 
extraction possibilities 69. In order to enhance correct use of the EMR, remote training was 
offered by the software vendor, supplemented by one-on-one intensive training sessions offered 
by the DELPHI staff. This included customized site-specific training and continuous trouble-
shooting throughout the implementation process 69. Not only was this approach important in 
developing a supportive relationship between the DELPHI team and the participants, but this 
training was also aimed to increase the validity of the data. As almost half of the participants 
were novice users of an EMR system at the time of implementation, a proactive and user-centred 
approach to ensuring data quality was important. The DELPHI team worked closely with the 
participants to provide additional training and support, as well as to emphasize the importance of 
consistent data entry. Furthermore, an ongoing quality monitoring system was developed to 
improve data completeness and standardization across the sites 69.  
The DELPHI Project for the current analysis consisted of twenty-four primary care 
physicians and four nurse practitioners from ten practices. About five years of patient data have 
been extracted since October 1, 2005, and the database contained records of approximately 
30,000 patients and more than 550,000 encounters. These records, extracted quarterly, include 
information such as billing codes, problem lists, medication lists, laboratory tests, procedures, 
investigations, immunizations, clinical notes, and referrals. All these data were extracted without 
any identifying information, such as provider name, patient name, health card number, full date 
of birth or full postal code; and each participating patient and provider was given a unique study 
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identifier 69. Furthermore, the pooled database was accessible only to DELPHI Project staff, who 
were required to sign strict confidentiality agreements.  
 
3.3.2. The International Classification of Primary Care (ICPC) 
One of the research-oriented data input technologies incorporated into the DELPHI 
database and the Healthscreen Solutions Inc. software was the International Classification of 
Primary Care, Revised Second Edition (ICPC-2-R) coding system 73, 74. The ICPC-2-R system, 
which is simply termed ICPC herein, was used by the DELPHI Project to allow for more 
detailed classification of patient encounters than is usually available in an EMR. The ICPC-
coded data captured important aspects of a primary care encounter, including reasons for 
encounter for each visit (recorded from the patient’s own words), the diagnoses for each visit 
(decided and recorded by the provider), and the tracking of diagnoses during a clinical episode of 
care 69. This system is structured into seventeen “chapters”, which represent systems of the 
human body. For example, chapter “D” corresponds to the digestive system and its related 
health conditions, whereas chapter “R” corresponds to the respiratory system and its related 
health conditions. To encourage ease of use, the coding of health conditions is as consistent as 
possible throughout each of the ICPC chapters. That is, a code of _28 designates “Limited 
function/disability” in each of the seventeen chapters.  
In order to facilitate the participating providers’ transition into this coding system, a 
gradual uptake was conducted, with two patients being randomly selected for ICPC coding each 
day from the provider’s list. The DELPHI team recognized that a “ramp-up” method of 
implementation would be the most ideal approach, as this method would not overwhelm the 
already busy providers who were just beginning to gain familiarity with a new coding system. 
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The participating health care providers were continuously trained on proper ICPC coding and a 
final random sample of approximately 10% of the total DELPHI patient population was 
achieved. To create a longitudinal record for each ICPC-selected patient, each subsequent in-
office visit by that patient was coded using ICPC. As of June 30, 2010, there were 3,341 ICPC 
patients contributing more than 50,000 ICPC-coded visits in the DELPHI database.  
The ICPC classification system is structured with two main foci of coding: Reason for 
Encounter and End of Visit codes, which work separately to represent the patient perspective and 
the provider perspective. The details of this ICPC structure can be seen in Figure 2. The RFE 
codes were recorded based on the patient’s perspective of why they came into the office for a 
visit with their primary care provider. These reasons may have involved symptoms or 
complaints, such as whether the patient was experiencing a headache or fatigue; they may have 
involved interventions or processes, such as whether a patient’s visit was for a diagnostic test or 
medication renewal; or the reason for the visit may have involved specific diagnoses, such as 
when a patient knew that the visit was specifically to address a previously diagnosed condition 
of, for example, pneumonia or multiple sclerosis. The other component of ICPC coding was the 
End of Visit codes, which were recorded by the provider themselves after the patient’s visit. 
Again, this coding could have involved a symptom code (for example, the headache may have 
simply remained as a headache at the end of the visit) or a diagnosis code for a condition that 
was diagnosed at this or a previous visit.  
Within this study, both the case and comparison patients were identified using the RFE 
symptom codes. The case patients were identified with the symptom RFE of A04, while the 
potential comparison patients were derived from one of the remaining 320 RFE symptom codes. 
The complete list of the 321 symptom RFE codes can be found in Appendix A. The symptom 
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and diagnosis End of Visit codes (recorded by the provider) were utilized to account for the 
number of previous and co-occurring morbidities experienced by each case and comparison 
patient. This distinction is displayed in Figure 2, and its purpose is discussed in further detail in 
Section 3.8.6.  
The ICPC system has notable advantages for its use in primary health care delivery. This 
system groups problems into chapters that are relevant to clinical medicine (similar to the 
ICD-10) 75. Its terms included undifferentiated problems (such as fatigue and “not otherwise 
specified/NOS” codes), which have been found to comprise 50% of a primary care provider’s 
workload 76-78. It also includes the RFE codes, which are based on information provided by the 
patients themselves. Additionally, ICPC has been translated into twenty languages, making it 
ideal for comparisons across countries and across populations 75, 79, 80.   
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1 2 
Figure 2: Structure of the ICPC-2-R* Coding System 
 
 
 
 
 
 
 
 
 
 
 
 
1Reason for Encounter codes utilized for case and comparison symptom group identification  
2End of Visit codes utilized for previous and co-occurring morbidity (chronic, psychosocial, 
other) identification  
 
*Adapted From: World Organization of National Colleges, Academies, and Academic 
Associations of General Practitioners/Family Physicians. ICPC-2-R: International Classification 
of Primary Care. 2nd ed. Oxford, New York: Oxford University Press, 2005.  
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3.4. Data Structure 
 Two main structural elements were imposed on the available EMR data: the definition 
and creation of an index visit for each included patient, and the creation of a case and 
comparison patient group for the subsequent analysis.  
 
3.4.1. Definition and Creation of an Index Visit  
In order to establish that the included patients were all experiencing incident symptoms, 
an index visit was defined for each patient. An eligible index visit for both the case and 
comparison patients required three components: 1) a complete one year run-in period of ICPC 
coding preceding the visit date; 2) a complete one year follow-up period of ICPC coding 
following the visit date; and 3) that at least one of the symptom RFEs presented at the visit date 
was not presented at any other in-office visits in the one year period preceding the visit date. If 
all three conditions were met, the patient was considered to have an eligible index visit. For the 
case patients, the symptom RFE that was presented at the index visit must have been an RFE of 
fatigue; while the comparison patients could have presented with an RFE of any of the remaining 
symptoms (non-fatigue RFEs). An eligible index visit was not excluded if the patient presented 
with the same symptom RFE during the following year. To reiterate, a case patient was allowed 
to have a subsequent visit for the symptom of fatigue during the following year.  
Imposing the structure of a run-in period created an incidence group of symptom patients, 
while the follow-up period structure was required to capture the dependent variables. Only one 
index visit was identified per patient, and each patient was included only once. Examples of 
eligible and ineligible index visits for both case and comparison patients can be found in Figure 
3. Patient A was excluded as he/she did not have sufficient ICPC coding for one year prior to the 
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visit date and therefore did not have a complete run-in period. Patient B was excluded due to the 
fact that he/she did not have a sufficient follow-up period. Patient C was excluded due to 
insufficient run-in and follow-up periods. Although Patient D did have a complete one year run-
in period and a complete one year follow-up period, such patients were ultimately excluded due 
to a previous in-office visit with the same symptom less than one year prior to the potential index 
visit date. In comparison, Patient E (representing a case patient) and Patient F (representing a 
comparison patient) were both included as they satisfied all three inclusion criteria, and remained 
eligible (as per our definition), even when a subsequent visit in the following year had the same 
symptom RFE presented.   
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Figure 3: Eligible and Ineligible Index Visits for Case and Comparison Patients 
Patient A: Excluded Due to Incomplete Run-In Period  
 
 
Patient B: Excluded Due to Incomplete Follow-Up Period 
 
 
Patient C: Excluded Due to Incomplete Run-In and Incomplete Follow-Up Periods 
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ICPC Coding 
Ends
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End of One 
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Up Period
Visit Date with 
RFE Symptom 
(A04 or Non-A04) 
Beginning of 
One Year Run-
In Period
End of One 
Year Follow-
Up Period
ICPC Coding 
Begins
ICPC Coding 
Ends
Visit Date with 
RFE Symptom 
(A04 or Non-A04) 
End of One 
Year Follow-
Up Period
ICPC Coding 
Begins
ICPC Coding 
Ends
Beginning of 
One Year Run-
In Period
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Patient D: Excluded Due to Ineligible Index Visit 
 
 
Patient E: Eligible Index Visit for Case Patients 
 
 
Patient F: Eligible Index Visit for Comparison Patients 
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3.4.2. Case-Comparison Study Design 
Previous research examining fatigue within populations has employed both     
quantitative 4, 23, 24, 28, 39, 67, 68 and qualitative 21, 29, 81, 82 methods. As the current study was utilizing 
a retrospective dataset, a selected number of research designs were possible. A recent study (in 
which a case-comparison study was not used) stated that the use of a control group from the 
general patient population would have been beneficial in making clear the degree to which the 
volume of health care use among the fatigue patient population was indeed much higher than that 
of the “normal” or “average” patients 83. Additionally, after applying the inclusion and exclusion 
criteria to the ICPC patients who had presented with the symptom of fatigue, the resulting 
sample size and power in determining significant differences within the analyses were      
reduced 84. Consequently, a comparative study was deemed suitable and beneficial in that it not 
only allowed for an increase in sample size and resulting study power 84, but it also allowed for 
the fatigue symptom patients and their resulting health care utilization patterns to be placed in 
context with a comparable group of primary care attenders.  
 
3.5. Study Populations 
Both the case and the comparison patient groups were drawn from the ICPC 
subpopulation of the DELPHI database. A complete flowchart of patient inclusion for the case 
and comparison patient groups can be found in Figure 4.  
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Figure 4: Flow Chart of Patient Inclusion for Case and Comparison Patient Groups 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients Excluded Due To Not 
Meeting Incident Fatigue Criteria 
n = 22 
Patients Excluded Due To Not 
Meeting Two Full Years (Run-In and 
Follow-Up) of ICPC Coding Criteria  
n = 1,525 
 
DELPHI Patient Population 
N = 29,303 
 
ICPC Patient Population 
n = 3,341 
Case Patients Comparison Patients 
Patients with > 1 Visit with an 
RFE of A04 
n = 274 
Patients Excluded Due To Not 
Meeting Incident Symptom Criteria  
n = 315 
Patients with > 1 Visit with a 
Symptom RFE (not A04) 
n = 3,064 
 
Patients Excluded Due To Not  
Meeting Two Full Years (Run-In and 
Follow-Up) of ICPC Coding Criteria 
n = 146 
Patients with Complete One Year Run-In 
Period and Complete One Year Follow-Up 
Period of ICPC Coding  
n = 128 
Patients with an Eligible Index 
Visit for Fatigue 
n = 106 
Patients Excluded Due To Not 
Meeting > 19 Years of Age Criteria 
n = 3  
Adult Patients with an Eligible Index 
Visit for Fatigue and Complete One 
Year Run-In and One Year Follow-Up 
Period of ICPC Coding 
n = 103 
Patients with Complete One Year Run-In 
Period and Complete One Year Follow-Up 
Period of ICPC Coding 
n = 1,557 
Patients with an Eligible Index 
Visit for Symptom 
n = 1,242 
 
Patients Excluded Due To Not 
Meeting Matching Criteria 
n = 387 
Eligible, Matched Comparison Patients  
n = 855 
Random Selection of Matched, 
Comparison Patients 
n = 103 
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3.5.1. Unit of Analysis  
 An important consideration in studying health care utilization was defining an 
appropriate unit of analysis. The choices of the unit of analysis were: the visit; the episode of 
care; or the patient 58. This selection was influenced by whether health services were assessed 
visit-by-visit during a given period of time or whether the purpose of the study was to assess the 
number of services received throughout the illness duration or the entire “episode of care” 58, 85. 
An episode of care approach attempts to delineate a particular illness experience and all of the 
associated medical care, which is beneficial when studying questions involving care associated 
with specific diagnoses, the continuity of care received, or the level of patient compliance 58, 85. 
In comparison, the current study examined the health care utilization patterns during a given 
period of time after an incident contact with a primary care provider, in which the characteristics 
of the patient were of primary importance in determining the overall volume of services 58. As 
having the visit as the unit of analysis results in counting a patient multiple times (for each of 
their visits during the data collection period), the objectives of the current study were tailored to 
having individual and independent patients followed over time, and having each patient included 
only once. There is a growing need to understand health service delivery on a longitudinal basis, 
which can be done by using the patient as the unit of analysis 86. Therefore, the unit of analysis 
for the current study was defined as the patient.  
 
3.5.2. Fatigue Symptom Patients  
 The case patients were identified as having presented to their primary care provider with 
an RFE of A04 at least one time during the data collection period: from March 1, 2006 to June 
30, 2010. The ICPC description for the A04 code was “Weakness/tiredness general”, which 
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included a spectrum of fatigue conditions: chronic fatigue syndrome, exhaustion, fatigue, 
lassitude, lethargy, and postviral fatigue 87. This definition of fatigue was validated and vetted by 
health professionals during the development of the ICPC 73, 74. The A04 code was simply 
referred to as “fatigue” herein. Within the current study, the period prevalence of the symptom of 
fatigue among ICPC-coded patients was found to be 8.2%, in that 8.2% of ICPC-coded patients 
had at least one in-office visit with an RFE of fatigue during the data collection period. The final 
number of eligible fatigue symptom or case patients was 103 patients. 
 
3.5.3. Comparison Patient Group  
The use of a comparison group can be a powerful quantitative research tool, with valid 
conclusions hinging on establishing an appropriate comparative sample 88. In recognition of this 
fact, careful consideration was used in determining the most suitable comparison group for the 
current study. Potential comparison groups and the sequence of decisions during this process are 
described in Appendix B. It was ultimately decided to compare the fatigue symptom patients, or 
the case patients, to average or typical symptom patients from the larger ICPC patient 
population. This final comparison group was structured as an incidence symptom group (the 
same structure as the fatigue symptom patients) and consisted of ICPC patients who had an index 
visit for any RFE-coded symptom, with the exception of the symptom of fatigue (RFE of A04). 
Only symptom RFE codes (ICPC codes _01 to _29) were of interest for identifying the 
comparison patients, and so the RFE codes from the rubrics: “Investigations and Processes” 
(ICPC codes _30 to _69), and “Diagnoses” (ICPC codes _70 to _99) were not eligible. These 
excluded RFE codes can be found in Appendix C. Described previously, the comparison 
patient’s index visit was structured in the same way as for the fatigue symptom patients, in that a 
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visit was only considered suitable if it had met the criteria of: a complete run-in period of ICPC 
coding; a complete follow-up period of ICPC coding; and that the symptom RFE presented at 
that visit date was not presented at a previous visit within the previous year. Suitable comparison 
patients were then evaluated based on the matching criteria (described in Section 3.5.4), and 
randomly selected without replacement.  
 
3.5.4. Matching Criteria for the Case and Comparison Patients  
 The purpose of a control group was to represent those patients who were at risk of 
becoming a case patient. Matching criteria were applied to ensure that this comparative study 
examining health care utilization patterns was not biased or influenced by differences in baseline 
characteristics between the two patient groups (or that these differences were reduced). As has 
been shown in previous literature and in a number of health care utilization theories, multiple 
factors influenced health resource use 57, 59, 89, 90 . As described in an earlier section (see Section 
3.2.), these factors can be needs-based, predisposing or contextual factors, at the practice-, 
provider-, and patient-level. Comparison patients with an acceptable index visit were matched to 
the case patients on five variables: patient sex, patient age (age window of ±5 years), practice 
number, provider number, and the quarter of the index date. As baseline differences between the 
case and comparison patients may have caused an effect on the observed differences in the 
dependent variables, it was important to ensure that the comparative groups did not differ 
significantly for these variables. However, it was also noted that once the patients were matched 
on these five predictive variables, their effects could no longer be analyzed. The final number of 
eligible comparison patients was 855 patients, from which one matched patient was randomly 
selected for each case patient (resulting in a 1:1 matching ratio). 
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The patient-level predisposing factors of sex and age have been shown to have a positive 
correlation with increasing health care utilization 58, 89, 91-93. As well, the time of year in which a 
patient attended their family physician may have influenced the degree of health care utilization. 
For example, seasonal illnesses, such as respiratory infections or influenzas, tended to be 
correlated with significant increases in health care utilization rates, producing an increased 
demand of health care personnel, acute care, and testing and treatment protocols 94, 95. The 
influence of practice-level factors can be the result of a number of factors, including: variation in 
geographic location (rural versus urban location); the social or economic status of the patient 
group being serviced by the practice; and the resources available to the practice (for example, 
proximity to a high density specialist population) 1, 89, 91-93. Finally, primary care physicians have 
traditionally been seen as the “gatekeeper” of health care, in that, particularly in the Canadian 
context, receiving a referral from the family physician was required for a patient to be seen or 
treated by a specialist 71, 72. It has been demonstrated that physician characteristics, including sex, 
age, areas of specialty and years of medical practice significantly influenced the rate of referral 
or investigations administered for their patients 71, 89, 91.  
 
3.6. Data Validity  
Quality of data was an important consideration when conducting secondary analyses of 
an existing database for research. Valid and accurate conclusions are essential in health care 
research, as findings can have implications for patient care, physician performance, and policy 
development 96. As EMRs are principally designed to support clinical care delivery, they are 
not structured in a way that easily facilitates use in research 97, 98. Routine EMR use by health 
care providers influences the usability and validity of the EMR-derived data. Characteristics of 
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provider use that negatively influence resulting data include: the lack of standardization of use 
among all providers or health care practices, which produces variability among providers and 
uniqueness of data entry; the preference for narrative entries over coding data with defined fields 
or structured medical lists; the lack of a standardized interpretation of clinical terms among 
providers; data recording in areas or fields that are not readily accessible for researchers (for 
example, free text entries); and that data not directly related to clinical care are often 
significantly under recorded 97. Each of these characteristics can produce variability and 
missingness in the data, which ultimately reduce the quality of the data. Within the EMR 
literature, the three main components of data quality include the concepts of completeness, 
correctness and comparability. These terms used within the EMR literature can be closely 
aligned to specific epidemiologic concepts. The relation between the EMR literature concepts 
and the associated epidemiologic concepts can be found in Figure 5.  
Completeness assesses whether an electronic medical record includes all relevant 
information for all possible patients. This concept can be associated with the epidemiological 
concept of sensitivity, in that it measures the proportion of observations that are actually 
recorded in the system 96. As the number of false negatives (patients that truly have a condition 
or symptom, but were not captured by the measure) increases, the sensitivity or completeness of 
the data subsequently decreases 84, 96. The completeness of the EMR data can also be influenced 
by the degree of missingness within the dataset. As mentioned previously, many characteristics 
of EMR use by health care providers can produce significant levels of missing or misclassified 
data. If a reasonable proportion of data are missing or misclassified due to differences in use 
among providers, various approaches to replacing this missing data with valid estimates are 
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possible (as will be discussed in Section 3.9.3.). Although it is an important area for future 
research, assessing the completeness of the data was beyond the scope of the current study.  
Correctness evaluates whether electronic data have been recorded appropriately and 
accurately, particularly as compared to a gold standard 99. Accuracy of data recording is 
dependent on whether the disease or condition identified is truly present in the patient, which is 
similar to the epidemiological concept of positive predictive value 84, 96. As stated by Neal et al. 
(1996), electronic records can be considered valid “when all those events that constitute a 
medical record are correctly recorded and all the entries in the record truly signify an event” 100. 
Similar to the structure of specificity, as the number of false positives (patients that are recorded 
as having a condition or symptom, but truly do not) increases, the positive predictive value or the 
correctness of the data decreases 84, 96. While the positive predictive value represents the 
proportion of observations that represents the true state of a patient, the accuracy of the EMR 
data describes the proportion of all recorded EMR data that are correct 84. Correctness is also 
related to the concept of content validity, which describes whether the EMR data measures and 
includes all of the dimensions of the construct it was intended to measure 84. Within the current 
study, the content of the ICPC coding system was validated and vetted by health professionals 
during the development of the ICPC 73, 74. Furthermore, an inclusion and exclusion criteria were 
provided by the World Organization of National Colleges, Academies and Academic 
Associations of General Practitioners/Family Physicians (WONCA) committee in order to 
promote correct and consistent coding of health conditions 73, 87. Finally, the use of a gold 
standard (such as an administrative database, disease registry or clinical values) as tool to 
determining the degree of correctness in an EMR database has been demonstrated in a number of 
previous studies 96, 98, 101, 102. Work has also been done to develop validated EMR definitions for 
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specific diseases or conditions, such as diabetes 103, 104. However, determining the correctness of 
the data recorded was out of the scope of the current study.   
Comparability of the EMR data constitutes whether the data produce similar 
demographic and disease prevalence profiles with that of an external population 98, 102. This is 
similar to the epidemiological concept of generalizability, which expresses the validity of 
assuming that patients in a specific sample population truly represents patients in the broader 
population 84, 105. Similar to generalizability, external validity is the degree to which the results 
from a dataset are applicable in other settings or to other patients 84. Furthermore, the 
comparability of EMR-derived data can be aligned with the epidemiological concept of 
reliability. The reliability of an effective measurement means that it will yield the same observed 
results when applied repeatedly 105. The comparability of the EMR-derived data was specifically 
assessed in the current study by evaluating the results from the analyses in the context of 
previous literature with comparable samples and settings. Additionally, the demographics of the 
DELPHI patient population, from which the sample was derived for this study, was compared to 
the Canadian Census Population in order to assess the appropriateness of generalizing the 
findings from this study to the larger Canadian population (as will be described in Section 
5.5.2.).  
Previous literature has recognized that EMR-derived data represented a significant source 
of information that was not readily captured through other data collection methods 97. As a result, 
research using this data source will provide important insight into primary health care delivery 
and health care utilization, when used appropriately and with great care 79. Although it was out of 
the scope of the current study, continuing work on assessing the validity and quality of EMR-
derived data for use in future research is essential. 
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Figure 5: Relation between EMR Literature Concepts and Epidemiologic Concepts  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EMR Literature Concept Epidemiologic Concept 
1.Completeness 
a) Sensitivity 
b) Missingness 
 
2. Correctness 
a) Positive Predictive Value 
b) Content Validity 
c) Gold Standard 
3. Comparability a) Generalizability/External Validity 
b) Reliability 
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3.7. Definition and Creation of Dependent Variables  
Three dependent variables were defined: the number of subsequent visits; the number and 
type of referrals; and the number of laboratory tests and investigations. These dependent 
variables were initially described in a descriptive manner to satisfy Objective One, and then were 
modeled as count variables for the multivariable models and to satisfy Objective Two and 
Objective Three. A summary of the dependent variables can be found in Table 1.  
 
3.7.1. Number of Subsequent Visits  
The number of subsequent visits variable was derived from the “Schedule” data file of 
the EMR software. This separate dataset included every in-office visit each patient had with their 
primary care provider, as well as the associated visit date. This dependent variable was defined 
as the number of in-office visits by a patient during the one year follow-up period for both the 
case and comparison patients. Consequently, all visits occurring after the index date (not 
including the index visit date itself) and during the one year follow-up period were included in 
the variable. Any visits occurring before the index date or after the follow-up period were not 
included. If a patient did not experience a visit throughout the follow-up period, the number of 
subsequent visits was equal to zero. For descriptive and analytic purposes, this variable was 
structured as an interval and count variable, respectively. Furthermore, this outcome variable was 
only able to capture health care visits to one source of health care services (primary care 
providers), and therefore could not account for other health care resources that may have been 
utilized by the patient following the index visit (such as hospital visits, allied health professionals 
at another location, complementary and alternative health care, and walk-in clinics).  
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3.7.2. Number and Type of Referral 
 The number and type of referrals variable was derived from the “Consultations” data file 
of the EMR software. This separate dataset included the referrals that occurred for each patient, 
the date the referral was initiated by the primary care provider, and the specialist service the 
patient was referred to. The referral variable was defined as the number and type of referrals 
made at the index visit date or during the one year follow-up period for both the case and 
comparison patients. Consequently, all referrals that were initiated on the index date or during 
the following year were included in the variable. Any referrals occurring after the follow-up 
period or anytime before the index date were excluded. Additionally, if a recorded referral was 
determined to be for a “Consult Report” or a “Read Report” (as noted in the referral description), 
it was subsequently excluded, to ensure a reasonable level of construct validity for this 
dependent variable and to avoid an overestimation of referrals for the two groups of patients. If a 
patient did not have a referral recorded throughout the follow-up period, the number of referrals 
was equal to zero. For descriptive and analytic purposes, this variable was structured as an 
interval and count variable, respectively.  
The type of referrals was also evaluated for descriptive purposes. The type of 
consultation specialty was re-coded to identify medical specialties recognized by the Ontario 
Health Insurance Plan (OHIP) and the Royal College of Physicians and Surgeons of Canada 106. 
The “Paediatrics” category from the OHIP specialty list was excluded as no patients under the 
age of nineteen years were included in the current study. Three additional referral type 
categories, not currently identified by OHIP, were also incorporated. A “General Practice” 
category was added to capture referrals that were made among general practitioners; a 
“Hospital/Specialty Clinic” category was added to capture referrals to settings with physicians 
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from multiple specialties or referrals to a specialty clinic (for example, pain clinics or sleep 
clinics); and an “Other Services/Unknown” category was added to capture referrals that were 
coded as “Other Services”, referrals that were non-medical specialty referrals (for example, a 
referral for optometry), and referrals that did not have any associated medical specialty type 
coded in the dataset, therefore the referral type was unknown. Accordingly, there were 35 
possible referral type categories and the complete list can be found in Appendix D.  
 
3.7.3. Number of Laboratory Tests and Investigations  
The number of laboratory tests and investigations variable was derived from the “Labs 
Ordered” and “Investigations” data files of the EMR software. These separate datasets included 
the tests and investigations that were ordered for each patient and the date the test or 
investigation was initiated by the primary care provider. These two datasets were mutually 
exclusive in that they represented two distinct uses of investigative health resources: examination 
of a sample (laboratory tests, derived from the “Labs Ordered” data) and examination of a person 
(imaging tests, derived from the “Investigations” data). Although this variable was a composite 
of two measures, this variable was simply termed as the number of investigations herein. The 
investigations variable was defined as the total number of clinical investigations (that is the sum 
of the number of laboratory tests and the number of investigations) that were ordered by the 
primary care provider at the index visit date or during the one year follow-up period for both the 
case and comparison patients. Consequently, all investigations that were initiated on the index 
date or during the following year were counted in the variable. Any investigations with an 
associated date occurring after the follow-up period or anytime before the index date were not 
included. If there were no associated investigations during the follow-up period, the number of 
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investigations was equal to zero. Examples of data entries that were included in this dependent 
variable can be found in Appendix E.  
To ensure that each data entry represented a singular test among the “Labs Ordered” data, 
a multiplicative factor was applied to data entries that were assumed to represent multiple tests. 
For example, based on information from the Laboratory Test Information Guide, a resource 
utilized by the London Laboratory Services Group for London Health Sciences Centre and St. 
Joseph’s Health Care London, a “CBC” was identified as generally producing three broad types 
of laboratory tests: cell count, hematocrit testing and hemoglobin testing 107. As a result, a factor 
of three was applied to each “CBC” data entry. A similar process was done for “Lipid 
Assessment” (multiplicative factor of three applied) and “Urinalysis” (multiplicative factor of 
two applied). However, this data coding issue was found not to be an issue for the investigations 
data. For descriptive and analytic purposes, the number of laboratory tests and investigations was 
structured as an interval and count variable, respectively. Furthermore, this outcome variable was 
only able to capture the laboratory tests and investigations that were ordered or initiated by the 
primary care provider; whether the patient actually received the test or investigation was not 
evaluated.  
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Table 1: Summary of Dependent Variables  
Dependent Variable Definition  
Descriptive  
Analysis Structure  
(Objective One) 
Multivariable  
Analysis Structure 
(Objective Two  
and Objective Three)  
Number of Subsequent  
  Visits  
Number of in-office 
provider visits during 
the one year follow-up 
period  
Interval Variable  Count Variable  
Number of Referrals  
Number of referrals 
during the one year 
follow-up period  
1. Interval Variable 
2. Type Categorization 
Count Variable  
Number of Laboratory  
  Tests and Investigations  
Number of laboratory 
tests and investigations 
during the one year 
follow-up period  
 
Interval Variable 
 
Count Variable  
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3.8. Definition and Creation of Independent Variables  
The main independent variable for this study was the classification of patients into the 
case or comparison patient groups. The other independent variables, to be described in 
subsequent sections, were classified into two strata: provider- or practice-level variables and 
patient-level variables. A summary of the dependent variables can be found in Table 2. 
 
3.8.1. Main Independent Variable: Case vs. Comparison Patient 
Identifying a patient as belonging to the case or comparison patient group created the 
main independent variable (described in detail in the previous Section 3.5.). Again, evaluating 
the differences in health care utilization between the case and comparison patients was one of the 
principal objectives of the current study. This status differentiated patients as having an incident 
symptom of fatigue (case group) or as having another, non-fatigue incident symptom 
(comparison group). Based on previous literature, it was hypothesized that fatigue symptom 
sufferers would experience different utilization patterns than patients suffering from the other, 
comparison symptoms. While this nominal variable was noted as the main independent variable; 
the remaining independent variables are described in the following sections.  
 
3.8.2. Provider-Level and Practice-Level Variables  
The provider- and practice-level variables were controlled for using the unique study 
identifier of both the primary care provider and the primary care practice. As was described 
previously in Section 3.5.4., the effects of these variables on resulting health care use were not of 
interest for the current study; instead, their potential effects were adjusted for through matching 
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and adjustment in the multivariable analyses. The remaining independent variables were all 
within the patient-level stratum. 
 
3.8.3. Patient-Level Variable: Age 
The age of each patient was calculated at the point each patient entered the study, which 
was one year prior to their individual index visit date. Patients who were under nineteen years of 
age were not included in this study. The decision to exclude child and adolescent patients who 
presented with the symptom of fatigue was based on previous literature that has concluded that 
both the presentation and the experience of symptoms of fatigue can be significantly different 
among children and adolescents as compared to adult patients 108-111. Similarly, comparison 
patients who were under the age of nineteen years were not included. In the final sample of case 
patients, only three patients were under nineteen years of age and were subsequently excluded 
(leaving a final sample size of 103 patients). For Objectives One and Two, age was modeled as a 
continuous variable. For Objective Three, the age of each patient was used as a matching 
criterion; therefore the influence of age on the resulting health care utilization patterns was no 
longer assessed.  
 
3.8.4. Patient-Level Variable: Sex 
The sex of each patient was modeled as a binary variable (male and female) for 
Objectives One and Objective Two. For Objective Three, the sex of each patient was used as a 
matching criterion; therefore the effect of patient sex on health care utilization patterns was no 
longer assessed.  
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3.8.5. Patient-Level Variable: Morbidity  
The level of previous and co-occurring morbidity was captured by creating three separate 
independent variables: previous and co-occurring chronic morbidities, previous and co-occurring 
psychosocial morbidities, and previous and co-occurring other morbidities. Each of these 
variables was a distinct and separate measure of morbidity, and were not categorized in a 
mutually exclusive or hierarchical manner. Each will therefore be described on its own. In 
reference to these variables, the terms “morbidity” and “condition” will be used interchangeably 
herein. The previous and co-occurring morbidities were counted using the symptom or diagnosis 
End of Visit codes that were recorded for each patient during the one year run-in period and/or at 
the index visit. In order to ensure a clear distinction between how these variables were counted 
and how the case and comparison patients were identified; separate parts of the ICPC system (the 
End of Visit codes and the RFE codes, respectively) were used (see Figure 2). This was done to 
avoid a tautology of the definition of these three independent variables and the definition of our 
case and comparison patients. 
 
3.8.5a. Previous and Co-Occurring Chronic Morbidities  
The criteria for identifying previous and co-occurring chronic conditions were derived 
from the published list by O’Halloran et al. in 2004 112. This list identified 126 ICPC-coded 
conditions that were both relevant to primary care and that met characteristics significant to 
defining a chronic morbidity. These conditions were had a duration that lasted, or was expected 
to last, at least 6 months; had a pattern of recurrence; had a poor prognosis or deterioration; and 
had physical or mental consequences or sequelae that impacted the patient’s quality of life 112. 
These criteria were then applied to each term within the ICPC and a final code set of 126 chronic 
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conditions was established, and can be found in Appendix F. More specifically, the 126 chronic 
morbidities were identified through the End of Visit symptom and diagnosis codes of the ICPC. 
Although this list was developed to identify chronic conditions managed in an Australian general 
practice setting, this list was considered suitable for identifying chronic conditions in a Canadian 
primary care setting. Consequently, this list was used to identify the number of previous and co-
occurring chronic morbidities of both the case and comparison patients. All chronic morbidities 
that were presented at the index visit or at in-office visits in the previous year were included. For 
descriptive purposes, the number of previous and co-occurring chronic morbidities was defined 
as a continuous variable. 
  
3.8.5b. Previous and Co-Occurring Psychosocial Morbidities 
The number of previous and co-occurring psychosocial conditions was identified using 
two ICPC-defined chapters, as well as individual “Fear and Concern” codes from each chapter. 
The two included chapters represented psychological conditions (any code from chapter “P”) and 
social problems (any code from chapter “Z”), while the remaining codes captured fear or concern 
issues relating to a specific body system (for example, a fear of cancer of the digestive system or 
a fear of skin disease). These psychosocial conditions were identified through the End of Visit 
symptom and diagnosis codes of the ICPC, similar to the identification of the previous and co-
occurring chronic morbidities. The validation of ensuring that these codes captured psychosocial 
conditions was previously completed by the international WONCA committee 73, 74. The final list 
included 42 psychological conditions, 26 social problems, and 43 fear and concern conditions. 
The final list of the 111 previous and co-occurring psychosocial morbidities can be found in 
Appendix G. All psychosocial morbidities that were presented at the index visit or at in-office 
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visits in the previous year were included. For descriptive purposes, the number of previous and 
co-occurring psychosocial morbidities was defined as a continuous variable.  
 
3.8.5c. Previous and Co-Occurring Other Morbidities  
The morbidities experienced by a patient that were not chronic or psychosocial in nature 
were captured by the number of previous and co-occurring other morbidities variable. These 
previous and co-occurring other morbidities included the non-chronic, non-psychosocial 
conditions experienced by the patient during the one year run-in period or at the index visit. Like 
the previous and co-occurring chronic and psychosocial conditions, these codes were identified 
through the End of Visit symptom and diagnosis codes of the ICPC. The codes A96 (“Death”), 
A97 (“No disease”), and A98 (“Health maintenance/preventive medicine”) were excluded as 
these codes did not represent diagnosable conditions.  The complete list of previous and co-
occurring other morbidities can be found in Appendix H. All other morbidities that were 
presented at the index visit or during the previous year were included. Although this variable’s 
impact on subsequent health care utilization patterns was not a main focus of the current study, it 
was important to capture the presence of other co-occurring conditions among the case and 
comparison patients. For descriptive purposes, the number of previous and co-occurring other 
morbidities was defined as a continuous variable. 
 
3.8.6. Patient-Level Variable: Previous Care-Seeking Frequency 
The previous care-seeking frequency variable was derived from the “Schedule” data file 
of the EMR software. Previous care-seeking frequency was defined as the number of in-office 
visits during the one year run-in period for both the case and comparison patients. Consequently, 
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all visits occurring before the index date (not including the index visit date itself) and during the 
one year run-in period were included in the variable. Any visits occurring after the index date or 
before the run-in period were not included. If a patient did not have an in-office visit in the year 
preceding the index visit, the patient’s previous care-seeking frequency was equal to zero. This 
variable was used to capture the frequency of primary health care use before the event of the 
index visit and to assess whether an increase in a patient’s “exposure” (that is, increased health 
service use prior to the index visit) was associated with an increase in health care use following 
the index visit. This variable was only able to capture health care visits to one source of health 
care services (primary care providers), and therefore could not account for other health care 
resources that may have been utilized by the patient prior to the index visit (such as hospital 
visits, allied health professionals, complementary and alternative health care, and walk-in 
clinics). For descriptive purposes, previous care-seeking frequency was defined as a continuous 
variable.  
 
 
 
 
 
 
 
 
 
 
 
 
56 
 
 
 
Table 2: Summary of Independent Variables  
Independent Variable Definition 
Variable Type 
Objective One 
Objective Two and 
Objective Three 
Case 
Classification of case and 
comparison patients  
  
Dichotomous 
  Case Patient 
  Comparison Patient  
Age Patient age in years Continuous    
Sex Sex of the patient  
Dichotomous 
  Male 
  Female  
  
Previous and Co- 
  Occurring Chronic    
  Morbidities  
Number of chronic 
conditions presented 
during the one year run-
in period and/or at the 
index visit date 
Continuous  Continuous  
Previous and Co- 
  Occurring Psychosocial  
  Morbidities  
Number of psychosocial 
conditions presented 
during the one year run-
in period and/or at the 
index visit date 
Continuous Continuous   
Previous and Co- 
  Occurring Other  
  Morbidities  
Number of other 
conditions presented 
during the one year run-
in period and/or at the 
index visit date  
Continuous  Continuous  
Previous Care-Seeking  
  Frequency 
Number of in-office 
visits during the one year 
run-in period  
Continuous  Continuous  
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3.9. Statistical Analysis  
 The data analyses for this study were carried out in two phases. The first phase involved 
describing the fatigue symptom patient population (descriptive analysis) and developing a model 
of covariates that might influence the health care utilization patterns of the fatigue symptom 
patients (multivariable analysis). This was done to address Objective One and Objective Two. 
The second phase involved comparing the utilization patterns of the fatigue symptom patients to 
those of the matched, comparison group (multivariable analysis). This was done to address 
Objective Three. All data analyses were conducted using the statistical software, Stata 10.0.  
 
3.9.1. Descriptive Analysis  
 The descriptive analyses were conducted on our fatigue symptom patient sample 
consisting of 103 patients. In order to satisfy Objective One of this study and to characterize a 
patient who presents to their primary care provider with a symptom of fatigue, the distributions 
of the independent and dependent variables were explored. As well, the most frequent types of 
previous and co-occurring chronic, psychosocial, and other morbidities were determined. The 
most frequent types of specialist referrals were also described.  
 
3.9.2. Multivariable Analysis  
 A series of analytic models were created in order to satisfy Objective Two and Objective 
Three of this study. These statistical analyses were conducted separately for each of the three 
dependent variables: the number of subsequent visits, the number of referrals, and the number of 
laboratory tests and investigations. The level of significance for these analyses was set at 0.05. 
The initial descriptive and bivariate analyses provided insight into the appropriate model 
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construction for each of the dependent variable models, which is detailed later in Section 3.9.7. 
and Section 3.9.8.  
 
3.9.3. Missing Data  
As was described earlier in Section 3.6., the completeness of data entry was an important 
factor in ensuring quality of EMR-derived data, and therefore valid results. In the following 
section, several aspects of missing data are described. Firstly, where possible, the level of 
completeness of the independent and dependent variables was assessed based on the work of 
previous EMR research. Secondly, missingness of data was an issue for one of the dependent 
variables and was subsequently addressed. Thirdly, although the remaining independent and 
dependent variable data were more complete; even a small amount of missing data could have 
potentially resulted in an underestimation of the prevalence of morbidity or the related health 
care resource utilization.  
Regarding the first point, previous research has demonstrated high rates of completeness 
for consultation or visit recording. In seven studies examining this variable, the extent of 
electronic consultation recording was consistently above 90% 98, 100, 113-117. For morbidity coding, 
previous research has demonstrated variability in the degree of completeness, ranging from 67% 
to 99% 113, 115-117. However, a higher degree of recording does not necessarily mean that all 
problems brought forward or addressed during the primary care encounter were fully recorded 99. 
General care providers suggested that mental and psychological problems were under-recorded 
due in part to difficulty in coding these issues 116. In comparison, conditions with clear diagnostic 
features, such as diabetes or high blood pressure, had higher quality of recording than conditions 
with more subjective criteria, such as asthma or depression 99.  
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Incomplete coding may have resulted in an underestimation of the number of previous 
and co-occurring morbidities experienced by patients within our sample; however, this was not 
seen as a significant issue in the identification of the case and comparison patients. This 
identification process was through the patient-provided Reason for Encounter codes, which were 
coded from the patient’s perspective. External health system factors may also have distorted 
coding practices over time, such as through incentive-based coding specifically targeting a 
certain diagnosis, intervention or investigation (for example, the Ontario provincial 
government’s incentive to track clinical markers for diabetes patients) 79, 99. It was assumed that 
the effects of these incentives were experienced consistently across the primary care practices. 
As well, no known Ontario provincial government targets were in place that were particularly 
relevant to the clinical conditions of interest for the current study.   
While completeness and correctness of data entry rely heavily on the enthusiasm and 
dedication of the practices and each participating health care provider, lack of consistent coding 
can also be attributed to unavailability of a computer (such as during a transition of care or 
during a home visit), or forgetfulness from the provider. Past research has demonstrated that 
simple requests or feedback to those who are providing coded data can significantly improve the 
consistency and completeness of the data 113, 114. As was stated in the previous section, the 
accuracy and completeness of the EMR data for the DELPHI Project was initially targeted and 
enhanced through site-specific training and a proactive, user-centred approach to encourage the 
participating providers to code correctly and reliably 69. An ongoing quality monitoring system 
has also been developed by the DELPHI team in order to maintain and improve that validity and 
standardization of the data that are populating the DELPHI database.  
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Regarding the second point, the completeness of one of the dependent variables, the 
number of laboratory tests and investigations, was compromised within the database due to 
missing data. This dependent variable was a composite of two distinct datasets within the EMR 
and one of the datasets contained incomplete data. This missing data was a result of the 
variability and uniqueness of how data were entered into the EMR by each practice. The “Labs 
Ordered” dataset did not contain any information for Practice 1, as this practice had recorded 
their laboratory test data in a different section of the EMR (a section that was not accessible to 
the DELPHI research team). It was determined that the missingness of the laboratory test data for 
the case and comparison patients from Practice 1 represented 7.9% of the total study sample 
(n=16 patients). However, this data was “Not Missing at Random” (NMAR), as it was 
systematically missing for patients coming from one specific practice 118-120. Although this 
situation was not ideal, as the missingness of the data was correlated to another variable within 
the study’s data matrix, the variability of the laboratory test data among the remaining practices 
was evaluated and a process of addressing this missing data was undertaken.  
Regarding the third point, there were a number of methods that could have been used for 
handling missing data, including case deletion, likelihood-based estimation, simple imputation, 
and multiple imputation 118, 119, 121. Each of these approaches had their benefits and limitations, 
which were evaluated in the context of the laboratory test missing data. It was ultimately decided 
to follow the simple imputation method of imputing unconditional means. As the mean number 
of laboratory tests per practice was fairly consistent (producing an average of 25.6 laboratory 
tests per practice during the one year follow-up period), it was concluded that the practices did 
not vary considerably in the number of laboratory tests that were recorded, despite the fact that 
they differed in how these data were recorded. This observation, combined with the fact that the 
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missing data represented <10% of the total sample, lead to the reasonable decision to impute the 
mean number of laboratory tests for the missing data. This procedure replaced the missing values 
for the 16 patients with plausible estimates, as imputing unconditional means replaced each 
missing item with the calculated mean from the observed values of laboratory tests during the 
one year follow-up 120. In this way, the mean of the variable was preserved, but the variance and 
covariance values were potentially biased. More specifically, as imputed data were not the true 
data, the variance estimates were potentially reduced 120. In particular, as we are imputing data 
for one of the dependent variables of the current study, the resulting findings must be interpreted 
with caution. However, this potential bias was deemed suitable and as with any inference made 
with missing data, the results were interpreted with caution. Additionally, the advantages of this 
imputation approach were that it maintained valuable data and a complete dataset, on which 
standard techniques and analyses were applied.  
 
3.9.4. Collinearity  
Potential collinearity among the independent variables was assessed through a correlation 
matrix. This was done to ensure that the regression coefficients were as precise as possible and 
that the final model was as parsimonious as possible. The inclusion of highly correlated variables 
(with a correlation coefficient of higher than 0.36) in a multivariate model could significantly 
alter the interpretation of the correlation coefficients 122.  However, it was determined that none 
of the covariates were highly correlated, and thus all covariates were subsequently considered for 
the final models.  
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3.9.5. Influential Points  
The presence of influential points for the continuous independent variables was assessed 
through the use of simple plots. The data were observed graphically to ensure that outlying 
points were not leading the relationship between the independent and dependent variables 122.   
 
3.9.6. Interactions 
Examining potential interactions between the independent variables was not an a priori 
objective of the current research study, as interactions among the variables in the current study 
have not been shown in previous literature. Interaction terms were consequently not incorporated 
into the final model as testing for all first-order interactions in a model consisting of multiple 
predictors for an outcome would lead to false-positives 122.  
 
3.9.7. Bivariate Analyses   
Bivariate analyses were conducted between the three dependent variables and each of the 
independent variables.  Two sample t-tests and Pearson correlation coefficients were done to 
detect significant relationships between the count dependent variables (number of subsequent 
visits, number of referrals, and number of investigations) and the independent variables. These 
exploratory analyses determined which independent variables were important for inclusion in the 
final multivariate regression models.  All variables with a p-value of 0.2 or less were included in 
the final analysis, as suggested by Vittinghoff et al. (2005) 122. Additionally, three of the 
independent variables (the number of previous and co-occurring chronic morbidities, the number 
of previous and co-occurring psychosocial conditions, and previous care-seeking frequency) 
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were forced into each of the three models in order to explicitly test the hypotheses of Objective 
Two, which were described earlier in the Methodology chapter.   
 
3.9.8. Negative Binomial Regression Model    
 A negative binomial regression (Stata command nbreg) was used to model the number of 
subsequent visits, the number of referrals and the number of investigations of the case and 
comparison patients during the one year follow-up period. Our dependent variable data were 
over-dispersed and it was determined that each had an unconditional mean that was much lower 
than the unconditional variance. Although a Poisson distribution can be utilized for count data, 
this distribution holds the strong assumption that the mean and variance are equal; consequently, 
this was not a suitable model for our data 123, 124. Instead, a negative binomial regression model 
was used for over-dispersed count data; with unequal mean and variance values. A zero-
truncated negative binomial regression model was not considered for any of the three dependent 
variables as it was possible for the data to generate one or more zero counts. Likewise, no 
negative counts were possible for any of the observed variables. A zero-inflated regression 
model was considered as a possible model structure for the dependent variables with a 
considerable number of zero counts in the entire sample. However, it was determined that there 
were not an excess of zeros (less than 50%) for each of the three outcome variables; 
consequently this extension was not necessary. A glm command was used to obtain the residuals 
to check other assumptions of the negative binomial regression model. When required, an age 
squared term was added to the model as age tends to have a non-linear relationship in regression 
analyses 125. Lastly, a likelihood ratio test was also conducted to test and confirm that a negative 
binomial regression model fit our data more suitably as compared to a Poisson distribution. 
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3.9.9. Run-In and Follow-Up Period Sensitivity Analysis  
A sensitivity analysis was conducted by altering the run-in and follow-up period length 
for the fatigue symptom patient group. These periods were reduced from one year to six months 
periods. The final multivariable models of each of the three dependent variables were replicated 
using bivariate analyses in order to screen variables for inclusion into the final regression model 
(p-value of 0.2 or less to meet the cut-off requirement for inclusion). This sensitivity analysis 
was done by adjusting the criteria imposed on the original sample of fatigue symptom patients, 
which subsequently increased the sample size of fatigue patients. The findings from these models 
were compared to the relationships found from the original negative binomial regression models.   
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CHAPTER FOUR – RESULTS 
4.1. Objective One: Description of the Fatigue Symptom Patient Sample 
 The final sample of fatigue symptom patients consisted of 103 patients from March 1, 
2006 to June 30, 2010. A description of the patient-level characteristics is provided in Table 3. 
The demographic characteristics include the mean age (in years) and sex distribution of the 
patients. As well, this table presents information regarding the distribution of the number of 
previous and co-occurring chronic, psychosocial, and other morbidities among the sample; as 
well as the five most frequent conditions presented by the fatigue patients during the one year 
run-in period and/or at the index visit. The distribution of the number of subsequent visits, the 
number of referrals, and the number of investigations experienced by these patients during the 
one year follow-up period are described. The five most frequent types of specialist referrals 
experienced by these patients during the follow-up period are also included. 
The age distribution of the fatigue symptom patients was approximately normal with a 
mean age of 63.1 years (SD=17.4) and range from 20 to 96 years. Sixty-eight percent of the 
sample was female; thirty-two percent of the sample was male. The average number of previous 
and co-occurring chronic morbidities among the fatigue symptom patients was 7.7 chronic 
morbidities (SD=7.8) with a range from 0 to 42 conditions. The average number of previous and 
co-occurring psychosocial morbidities among these patients was 2.9 psychosocial morbidities 
(SD=4.7) with a range from 0 to 23 conditions. The average number of previous and co-
occurring other morbidities was 10.5 morbidities (SD=10.4) with a range from 0 to 61 
conditions. The average number of visits during the one year run-in period was 12.1 visits 
(SD=11.6) and ranged from 0 to 69 visits. The majority (76.7%) of fatigue symptom patients had 
at least five previous visits during the one year run-in period. A similar number of visits were 
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experienced by these patients during the one year follow-up period, with a mean of 12.3 visits 
(SD=11.4) and a similar range of 0 to 69 visits. Again, the majority (82.5%) of fatigue symptom 
patients had at least one follow-up visit. The fatigue patients had an average of 2.3 referrals (SD= 
3.1) with a range from 0 to 16; and an average of 20.2 investigations (SD=22.7) with a broad 
range from 0 to 125 investigations. Approximately one third (35.9%) of the fatigue symptom 
patients received no referrals during the one year follow-up period, whereas two thirds (67.0%) 
of the sample experienced at least five investigations during the following year.  
 Previous and co-occurring chronic conditions were common among 88% of the fatigue 
symptom patients. “Hypertension uncomplicated” was the most commonly experienced chronic 
morbidity; while “Diabetes non-insulin dependent”, “Anxiety disorder/anxiety state”, “Ischaemic 
heart disease with angina”, and “Depressive disorder” were the next most prevalent chronic 
conditions. Previous and co-occurring psychosocial conditions were common among 
approximately 52% of the fatigue symptom patients. “Anxiety disorder/anxiety state” was the 
most prevalent psychosocial condition. As presented in Table 3, “Depressive disorder”, 
“Relationship problem with partner”, “Sleep disturbance”, and “Partner illness problem” were 
the next most frequent psychosocial conditions among the fatigue patients. Previous and co-
occurring other conditions were common among 91% of the fatigue symptom patients. “Allergic 
rhinitis” was the most frequently presented non-chronic, non-psychosocial (therefore other) 
morbidity, which was followed by the next most common conditions of: “Skin disease other”, 
“Shortness of breath/dyspnoea”, “Chest pain NOS”, and “Cough”. Finally, the most common 
referral types for the fatigue symptom patients during the one year follow-up period were: 
Dermatology, Internal Medicine, Neurology, Gastroenterology, and General Surgery.  
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Table 3: Objective One – Description of the Fatigue Symptom Patient Sample (N=103) 
          Characteristic   Description/Frequency (%) 
Age 
Mean 63.1 years (SD:17.4) 
Range 20 - 96 years 
Sex 
Male 33 (32.0%) 
Female 70 (68.0%) 
Previous and Co-Occurring  
  Chronic Morbidity  
Mean  7.7 conditions (SD:7.8) 
Range 0 - 42 conditions 
Distribution  
0 Conditions 12 (11.7%) 
1 Condition  7 (6.8%) 
2 Conditions 8 (7.8%) 
3 Conditions 14 (13.6%) 
4 Conditions  9 (8.7%) 
5 or more Conditions  53 (51.5%) 
Description1  
Hypertension uncomplicated 157 (19.7%) 
Diabetes non-insulin dependent 100 (12.6%) 
Anxiety disorder/anxiety state 85 (10.7%) 
Ischaemic heart disease with  
  angina 
47 (5.9%) 
Depressive disorder  33 (4.1%) 
Previous and Co-Occurring  
  Psychosocial Morbidity  
Mean  2.9 conditions (SD:4.7) 
Range 0 - 23 conditions 
Distribution  
0 Conditions 49 (47.6%) 
1 Condition  8 (7.8%) 
2 Conditions 12 (11.7%) 
3 Conditions 6 (5.8%) 
4 Conditions  2 (1.9%) 
5 or more Conditions  26 (25.2%) 
Description1  
Anxiety disorder/anxiety state 85 (28.1%) 
Depressive disorder  33 (10.9%) 
Relationship problem with    
  partner 
25 (8.3%) 
Sleep disturbance  22 (7.3%) 
Partner illness problem 19 (6.3%) 
1Percentage of ‘Description’ may not add up to 100% as more than one condition could have 
been presented by each patient  
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Table 3: Description of the Fatigue Symptom Patient Sample Continued (N=103)  
          Characteristic   Description/Frequency (%) 
Previous and Co-Occurring   
  Other Morbidity  
Mean 10.5 conditions (SD:10.4) 
Range 0 - 61 conditions 
Distribution  
0 Conditions 9 (8.7%) 
1 Condition  3 (2.9%) 
2 Conditions 4 (3.9%) 
3 Conditions 9 (8.7%) 
4 Conditions  11 (10.7%) 
5 or more Conditions  67 (65.0%) 
Description1  
Allergic rhinitis 83 (7.7%) 
Skin disease other  39 (3.6%) 
Shortness of breath/dyspnoea 36 (3.3%) 
Chest pain NOS 30 (2.8%) 
Cough  30 (2.8%) 
Previous Care-Seeking  
  Frequency 
Mean 12.1 visits (SD:11.6) 
Range 0 - 69 visits 
Distribution  
0 Visits 2 (1.9%) 
1 Visit 4 (3.9%) 
2 Visits  3 (2.9%) 
3 Visits  12 (11.7%) 
4 Visits  3 (2.9%) 
5 or more Visits  79 (76.7%) 
Number of Subsequent Visits  
Mean  12.3 visits (SD:11.4) 
Range 0 - 69 visits 
Distribution  
0 Visits 1 (1.0%) 
1 Visit 6 (5.8%) 
2 Visits  4 (3.9%) 
3 Visits  1 (1.0%) 
4 Visits  6 (5.8%) 
5 or more Visits  85 (82.5%) 
1Percentage of ‘Description’ may not add up to 100% as more than one condition could have 
been presented by each patient  
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Table 3: Description of the Fatigue Symptom Patient Sample Continued (N=103)  
          Characteristic   Description/Frequency (%) 
Number of Referrals 
Mean  2.3 referrals (SD:3.1) 
Range 0 - 16 referrals 
Distribution  
0 Referrals 37 (35.9%) 
1 Referral 16 (15.5%) 
2 Referrals 17 (16.5%) 
3 Referrals  11 (10.7%) 
4 Referrals  6 (5.8%) 
5 or more Referrals 16 (15.5%) 
Description2  
Dermatology 36 (15.1%) 
Internal Medicine 25 (10.5%) 
Neurology 22 (9.2%) 
Gastroenterology 18 (7.5%) 
General Surgery  17 (7.1%) 
Number of Laboratory Tests and  
  Investigations 
Mean  20.2 investigations (SD:22.7) 
Range 0 - 125 investigations 
Distribution  
0 Investigations 8 (7.8%) 
1 Investigation 10 (9.7%) 
2 Investigations 4 (3.9%) 
3 Investigations 6 (5.8%) 
4 Investigations 6 (5.8%) 
5 or more Investigations 69 (67.0%) 
2Percentage of referral ‘Description’ may not add up to 100% as more than one referral could 
have been experienced by each patient  
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4.2. Objective Two: Determinants of Number of Subsequent Visits 
4.2.1. Bivariate Analyses  
The bivariate analyses between the number of subsequent visits during the one year 
follow-up period and each of the independent variables for the fatigue symptom patients 
(N=103) is presented in Table 4. Statistically significant relationships were found between the 
number of subsequent visits and the number of previous and co-occurring other morbidities 
(r=0.43, p<0.001); as well as between the number of subsequent visits and previous care-seeking 
frequency (r=0.71, p<0.001). Statistically significant relationships were not found between the 
number of subsequent visits and patient sex (p=0.185), patient age (p=0.726), the number of 
previous and co-occurring chronic morbidities (p=0.104), and the number of previous and co-
occurring psychosocial morbidities (p=0.635). Correlation between the number of subsequent 
visits and the remaining dependent variables was also assessed, and although the relationship 
between the number of subsequent visits and the number of referrals was insignificant, the 
relationship between the number of subsequent visits and the number of investigations was found 
to be significant (p<0.001).  
 
4.2.2. Multivariable Analysis 
A negative binomial regression was used to model the number of subsequent visits. The 
clustering of patients within physician and practices was adjusted for with robust standard errors. 
Variables included in the final regression model were selected from the results of the bivariate 
analyses, as each variable with a test significance of 0.2 or less was included. This resulted in the 
exclusion of patient age (p=0.726). The number of previous and co-occurring psychosocial 
morbidities (p=0.635) was forced into the model, despite its large p-value, in order to test the 
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hypotheses presented in Objective Two. Table 5 presents the results of the final multivariable 
analysis, reporting the incidence rate ratio (IRR) for each independent variable in which all other 
variables in the model were held constant.  
Based on the results of the final model seen in Table 5, the number of subsequent visits 
did not differ significantly between male and female fatigue symptom patients (p=0.398). As 
well, the presence of previous and co-occurring morbidities of any type (chronic, psychosocial, 
and other) did not have a statistically significant influence on the number of subsequent visits 
experienced by the patients during the one year follow-up period (all p-values were >0.05). 
However, for each visit increase in the fatigue patient’s previous care-seeking frequency, the 
number of subsequent visits increased by 4% (IRR=1.04, p<0.001). For each increase in the 
number of investigations, the number of subsequent visits increased by 1% (IRR=1.01, p<0.001). 
Additionally, the significant result of the likelihood ratio test confirmed that the data were over-
dispersed and were therefore more appropriately described by a negative binomial regression 
distribution as compared to a Poisson distribution. 
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Table 4: Bivariate Analyses of Number of Subsequent Visits (N=103)  
          Characteristic    n Mean SD p-value1  
Sex Male 33 10.18 9.11 0.185 
  Female  70 13.37 12.20   
    r   p-value2 
Age   0.03  0.726 
Previous and Co-Occurring Chronic Morbidities   0.16  0.104 
Previous and Co-Occurring Psychosocial  
    Morbidities 
  0.05  0.635 
Previous and Co-Occurring Other Morbidities   0.43  <0.001 
Previous Care-Seeking Frequency     0.71   <0.001 
Number of Laboratory Tests and Investigations   0.36  <0.001 
1Results from two-sample t-tests 
2Results from correlation coefficients 
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Table 5: Multivariable Negative Binomial Regression Analyses of Number of Subsequent  
       Visits (N=103)  
          Characteristic    
Incidence Rate 
Ratio 
95% 
Confidence 
Interval 
p-value 
Sex  Male 1.00    
  Female  1.12 0.87 - 1.44 0.398 
Age1  - - - 
Previous and Co-Occurring  
   Chronic Morbidities2 
 1.01 1.00 - 1.03 0.182 
Previous and Co-Occurring  
   Psychosocial Morbidities3 
 1.01 0.98 - 1.03 0.656 
Previous and Co-Occurring  
   Other Morbidities4 
 1.00 0.98 - 1.01 0.739 
Previous Care-Seeking Frequency5   1.04 1.03 - 1.06 <0.001 
Number of Laboratory Tests and  
   Investigations6 
 1.01 1.00 - 1.01 <0.001 
Likelihood Ratio Test7             Chi-Squared = 202.16              p-value <0.001 
1IRR of a one-point increase in the age (in years) 
2IRR of a one-point increase in the number of previous and co-occurring chronic morbidities  
3IRR of a one-point increase in the number of previous and co-occurring psychosocial 
morbidities  
4IRR of a one-point increase in the number of previous and co-occurring other morbidities 
5IRR of a one-point increase in the previous care-seeking frequency (in visits)  
6IRR of a one-point increase in the number of laboratory tests and investigations  
7Likelihood Ratio Test denotes a significant over-dispersion of the data, indicating that the data 
are more adequately modeled using a negative binomial regression distribution as compared to a 
Poisson distribution  
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4.3. Objective Two: Determinants of Number of Referrals  
4.3.1. Bivariate Analyses  
The bivariate analyses between the number of referrals during the one year follow-up 
period and each of the independent variables for the fatigue symptom patients (N=103) is 
presented in Table 6. A statistically significant relationship between the number of referrals and 
patient sex was found, as male patients had a higher average number of referrals during the one 
year follow-up period compared to the female patients (average of 3.94 referrals compared to an 
average of 1.56 referrals, p<0.001). As well, a statistically significant relationship was found 
between the number of referrals and the number of previous and co-occurring chronic 
morbidities among the patients (r=0.30, p=0.003) and the previous care-seeking frequencies of 
the patients (r=-0.12, p=0.023). Statistically significant relationships were not found between the 
number of referrals and patient age (p=0.494), the number of previous and co-occurring 
psychosocial morbidities (p=0.166), and the number of previous and co-occurring other 
morbidities (p=0.062). Correlation between the number of referrals and the remaining dependent 
variables was also assessed, but the relationships were found to be highly insignificant.  
 
4.3.2. Multivariable Analysis 
A negative binomial regression was used to model the number of referrals. The clustering 
of patients within physician and practices was adjusted for with robust standard errors. Variables 
included in the final regression model were selected from the results of the bivariate analyses, 
with each variable having a test significance of 0.2 or less being included. Therefore, patient age 
(p=0.494) was excluded. Table 7 presents the results of the final multivariable analysis, reporting 
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the incidence rate ratio for each independent variable in which all other variables in the model 
were held constant.  
Based on the results of the final model seen in Table 7, the number of referrals differed 
significantly between male and female fatigue symptom patients, with females receiving 59% 
less referrals during the follow-up period as compared to male patients (IRR=0.41, p<0.001). 
The presence of previous and co-occurring chronic and psychosocial morbidities did not have a 
statistically significant influence on the number of subsequent referrals during the following 
year, with p-values equal to 0.327 and 0.484, respectively. However, it was found that the 
number of referrals increased by 5% with each additional non-chronic, non-psychosocial (other) 
condition experienced by these patients (IRR=1.05, p<0.001). A statistically significant 
relationship was also found between the previous care-seeking frequencies of the fatigue 
symptom patients and subsequent referral. For each increase in the number of previous visits, the 
patients were 4% less likely to receive a referral following the index visit (IRR=0.96, p=0.002). 
Additionally, the significant result of the likelihood ratio test confirmed that the data were over-
dispersed and were therefore more appropriately described by a negative binomial regression 
distribution as compared to a Poisson distribution. 
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Table 6: Bivariate Analyses of Number of Referrals (N=103)  
          Characteristic    n Mean SD p-value1  
Sex Male 33 3.94 4.24 <0.001 
  Female  70 1.56 2.10   
    r   p-value2 
Age   0.07  0.494 
Previous and Co-Occurring Chronic Morbidities   0.30  0.003 
Previous and Co-Occurring Psychosocial  
    Morbidities 
  0.14  0.166 
Previous and Co-Occurring Other Morbidities   0.18  0.062 
Previous Care-Seeking Frequency     -0.12   0.023 
1Results from two-sample t-tests 
2Results from correlation coefficients 
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Table 7: Multivariable Negative Binomial Regression Analyses of Number of Referrals  
               (N=103) 
          Characteristic    
Incidence Rate 
Ratio 
95% 
Confidence 
Interval 
p-value 
Sex  Male 1.00    
  Female  0.41 0.25 - 0.67 <0.001 
Age1  - - - 
Previous and Co-Occurring  
   Chronic Morbidities2 
 1.01 0.99 - 1.03 0.327 
Previous and Co-Occurring  
   Psychosocial Morbidities3 
 1.02 0.97 - 1.06 0.484 
Previous and Co-Occurring  
   Other Morbidities4 
 1.05 1.02 - 1.07 <0.001 
Previous Care-Seeking Frequency5   0.96 0.93 - 0.98 0.002 
Likelihood Ratio Test6             Chi-Squared = 59.77              p-value <0.001 
1IRR of a one-point increase in the age (in years) 
2IRR of a one-point increase in the number of previous and co-occurring chronic morbidities  
3IRR of a one-point increase in the number of previous and co-occurring psychosocial 
morbidities  
4IRR of a one-point increase in the number of previous and co-occurring other morbidities 
5IRR of a one-point increase in the previous care-seeking frequency (in visits)  
6Likelihood Ratio Test denotes a significant over-dispersion of the data, indicating that the data 
are more adequately modeled using a negative binomial regression distribution as compared to a 
Poisson distribution  
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4.4. Objective Two: Determinants of Number of Laboratory Tests and Investigations  
4.4.1. Bivariate Analyses 
The bivariate analyses between the number of laboratory tests and investigations during 
the one year follow-up period and each of the independent variables for the fatigue symptom 
patients (N=103) is presented in Table 8. To account for the statistically significant correlation 
between the number of investigations and the number of subsequent visits during the one year 
follow-up period, the number of subsequent visits was also included as a covariate in the 
multivariable regression model. A statistically significant relationship was found between the 
number of laboratory tests and investigations and the number of previous visits (r=0.11, 
p=0.081), as well as the number of subsequent visits (r=0.36, p<0.001). However, statistically 
significant relationships were not found between the number of investigations and the remaining 
variables: patient sex (p=0.604), patient age (p=0.525), the number of previous and co-occurring 
chronic morbidities (p=0.553), the number of previous and co-occurring psychosocial 
morbidities (p=0.391), and the number of previous and co-occurring other morbidities (p=0.313).  
 
4.4.2. Multivariable Analysis 
A negative binomial regression was used to model the number of laboratory tests and 
investigations. The clustering of patients within physician and practices was adjusted for with 
robust standard errors. Variables included in the final regression model were selected from the 
results of the bivariate analyses, as each variable having a test significance of 0.2 or less was 
included. Therefore, patient age (p=0.525), patient sex (p=0.604), and the number of previous 
and co-occurring other morbidities (p=0.313) were excluded. However, the number of previous 
and co-occurring chronic morbidities (p=0.553) and the number of previous and co-occurring 
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psychosocial morbidities (p=0.391) were forced into the model in order to test the hypotheses 
presented in Objective Two. Table 9 presents the results of the final multivariable analysis, 
reporting the incidence rate ratio for each variable in which all other variables in the model were 
held constant.  
Based on the results of the final model seen in Table 9, the number of laboratory tests and 
investigations remained statistically significantly related to the number of previous and 
subsequent visits made by the fatigue symptom patients. For each visit increase in the fatigue 
patient’s previous care-seeking frequency, the number of subsequent investigations decreased by 
4% (IRR=0.96, p=0.006). In contrast, each visit increase in the number of following visits 
produced a 5% increase in the number of subsequent investigations during the one year follow-
up period (IRR=1.05, p<0.001). However, the number of chronic or psychosocial conditions 
among the patients did not significantly influence the resulting number of laboratory tests and 
investigations administered during the follow-up period, with p-values of 0.964 and 0.197, 
respectively in the final model. Lastly, the significant result of the likelihood ratio test confirmed 
that the data were over-dispersed and were therefore more appropriately described by a negative 
binomial regression distribution as compared to a Poisson distribution. 
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Table 8: Bivariate Analyses of Number of Laboratory Tests and Investigations (N=103)  
          Characteristic    n Mean SD p-value1  
Sex Male 33 17.33 23.01 0.604 
  Female  70 19.83 22.60   
    r   p-value2 
Age   0.06  0.525 
Previous and Co-Occurring Chronic Morbidities   0.06  0.553 
Previous and Co-Occurring Psychosocial  
  Morbidities 
  0.09  0.391 
Previous and Co-Occurring Other Morbidities   -0.10  0.313 
Previous Care-Seeking Frequency     0.11   0.081 
Number of Subsequent Visits   0.36  <0.001 
1Results from two-sample t-tests 
2Results from correlation coefficients 
 
 
 
 
 
 
 
 
 
 
 
 
 
81 
 
 
 
Table 9: Multivariable Negative Binomial Regression Analyses of Number of Laboratory  
               Tests and Investigations (N=103)  
          Characteristic    
Incidence Rate 
Ratio 
95% 
Confidence 
Interval 
p-value 
Sex  
  
Male - - - 
Female  - - - 
Age1  - - - 
Previous and Co-Occurring  
  Chronic Morbidities2 
 1.01 0.97 - 1.04 0.964 
Previous and Co-Occurring  
  Psychosocial Morbidities3 
 1.04 0.98 - 1.09 0.197 
Previous and Co-Occurring  
  Other Morbidities4 
 - - - 
Previous Care-Seeking Frequency5   0.96 0.95 - 0.99 0.006 
Number of Subsequent Visits6  1.05 1.03 - 1.07 <0.001 
Likelihood Ratio Test7           Chi-Squared = 1490.56              p-value <0.001 
1IRR of a one-point increase in the age (in years) 
2IRR of a one-point increase in the number of previous and co-occurring chronic morbidities  
3IRR of a one-point increase in the number of previous and co-occurring psychosocial 
morbidities  
4IRR of a one-point increase in the number of previous and co-occurring other morbidities 
5IRR of a one-point increase in the previous care-seeking frequency (in visits)  
6IRR of a one-point increase in the number of subsequent visits  
7Likelihood Ratio Test denotes a significant over-dispersion of the data, indicating that the data 
are more adequately modeled using a negative binomial regression distribution as compared to a 
Poisson distribution  
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4.5. Overview of Findings from Multivariable Analyses 
 In order to provide a cohesive review of the findings from the three multivariable models, 
Table 10 details the significant relationships (both in the positive and negative directions) that 
were found between the model covariates and each of the dependent variables.  
 
4.6. Objective Three: Differences in Health Care Utilization between Comparative Groups 
4.6.1. Baseline Characteristics of Case and Comparison Patients 
The distributions of the baseline characteristics for both the case and comparison patient 
groups, as well as the distributions of these characteristics for the overall sample, are presented 
in Table 11. After the matching process was conducted, the fatigue symptom patients and the 
comparison patients were of similar age (mean of 63.1 years, median of 64.0 years) and sex 
composition (32.0% male and 68.0% female). The case and comparison patients were also 
similar in their baseline numbers of previous and co-occurring chronic and psychosocial 
morbidities. However, results from the two sample t-tests showed that the patient groups were 
significantly different in the number of previous and co-occurring non-chronic, non-psychosocial 
(other) morbidities (p=0.033) and in their previous care-seeking frequencies (p=0.032). The case 
patients had a higher baseline level of previous and co-occurring other morbidities (average of 
10.5 other morbidities for fatigue symptom patients as compared to the average of 7.7 other 
morbidities for the comparison patients). As well, the fatigue symptom patients had a 
significantly higher level of previous care-seeking than the comparison group (average of 12.1 
visits for the case patients as compared to the average of 9.2 visits for the comparison patients).  
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Table 10: Overview of Multivariable Regression Analyses Findings 
NOTE:  
+ Indicates a statistically significant positive relationship  
− Indicates a statistically significant negative relationship  
An empty box indicates no statistically significant relationship in the multivariable analysis or 
p>0.2 in the bivariate analysis 
 
 
 
 
 
Characteristic  
Dependent Variable  
Number of 
Subsequent Visits 
Number of 
Referrals 
Number of 
Laboratory Tests 
and Investigations 
Age       
Female   −   
Number of Previous and Co-      
  Occurring Chronic Morbidities       
Number of Previous and Co- 
  Occurring Psychosocial Morbidities      
Number of Previous and Co- 
  Occurring Other Morbidities   +   
Previous Care-Seeking Frequency +  − − 
Number of Subsequent Visits      + 
Number of Laboratory Tests and  
  Investigations +   
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Table 11: Baseline Characteristics of Comparative Patient Groups and Overall Sample 
  
Characteristic 
Fatigue Symptom 
Group (N=103) 
Comparison 
Group (N=103)  
All Patients 
(N=206)   
p-value1 Mean 
(SD) 
Median 
Mean 
(SD) 
Median 
Mean 
(SD) 
Median 
Age 
63.1 
(17.4) 
64.0 
64.0 
(17.2) 
65.0 
63.5 
(17.3) 
64.0 0.715 
Sex, n (%)         
  Female  70  (68.0%) 70  (68.0%) 140  (68.0%) 1.00 
  Male  33  (32.0%) 33  (32.0%) 66  (32.0%)  
Number of Previous and  
  Co-Occurring Chronic   
  Morbidities 
7.7 
(7.8) 
5.0 
6.0  
(8.8) 
3.0 
6.9 
(8.4)  
4.0 0.142 
Number of Previous and  
  Co-Occurring   
  Psychosocial  
  Morbidities 
2.9 
(4.7) 
1.0 
2.4  
(5.1) 
1.0 
2.7 
(4.9) 
1.0 0.417 
Number of Previous and  
  Co-Occurring Other  
  Morbidities 
10.5 
(10.4) 
7.0 
7.7  
(8.1) 
5.0 
9.1 
(9.4) 
6.0 0.033 
Previous Care-Seeking  
  Frequency  
12.1 
(11.6) 
9.0 
9.2  
(6.7) 
8.0 
10.7 
(9.6) 
8.0 0.032 
Number of Subsequent  
   Visits  
12.3 
(11.4) 
9.0 
8.6  
(6.9) 
7.0 
10.5 
(9.6) 
8.0  
Number of Referrals 
2.3 
(3.1) 
1.0 
2.1 
(2.9) 
1.0 
2.2 
(3.0) 
1.0  
Number of Laboratory  
  Tests and Investigations 
20.2 
(22.7) 
 12.0 
11.1 
(13.7) 
 5.0 
15.6 
(19.2) 
 8.0  
1Results comparing case group and comparison group baseline characteristics using two sample 
t-tests 
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4.6.2. Multivariable Analysis  
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Table 12: Multivariable Negative Binomial Regression Analyses for Case and Comparison  
                 Patients (N=206) 
Dependent Variable Regression Model 
Incidence Rate 
Ratio 
95% 
Confidence 
Interval 
p-value 
Number of Subsequent Visits 
Negative binomial 
regression model 1.191 1.01 - 1.41 0.038 
Number of Referrals 
Negative binomial 
regression model 0.972 0.71 - 1.32 0.845 
Number of Laboratory Tests 
and Investigations 
Negative binomial 
regression model 1.683 1.26 - 2.24 <0.001 
1IRR calculated by adjusting for matched variables (age, age2, sex, practice number, provider 
number and quarter of index visit) and the remaining independent variables (number of previous 
and co-occurring chronic morbidities, number of previous and co-occurring psychosocial 
morbidities, number of previous and co-occurring other morbidities and previous care-seeking 
frequency); and the number of laboratory tests and investigations  
2IRR calculated by adjusting for matched variables (age, age2, sex, practice number, provider 
number and quarter of index visit) and the remaining independent variables (number of previous 
and co-occurring chronic morbidities, number of previous and co-occurring psychosocial 
morbidities, number of previous and co-occurring other morbidities and previous care-seeking 
frequency)  
3IRR calculated by adjusting for matched variables (age, age2, sex, practice number, provider 
number and quarter of index visit); the remaining independent variables (number of previous and 
co-occurring chronic morbidities, number of previous and co-occurring psychosocial 
morbidities, number of previous and co-occurring other morbidities and previous care-seeking 
frequency); and the number of subsequent visits  
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4.7. Results of the Run-In and Follow-Up Period Sensitivity Analysis 
 The results of the sensitivity analysis for the Number of Subsequent Visits, the Number 
of Referrals, and Number of Laboratory Tests and Investigations dependent variables can be 
found in Appendix I, Appendix J, and Appendix K, respectively. In each table, the first column 
outlines the significant relationships between the model covariates and the dependent variable 
during a six month run-in and follow-up period. The second column represents the findings from 
our original multivariable analyses; in which a full twelve month run-in and follow-up period 
was used (this column was shaded to differentiate the findings). After reducing the required run-
in and follow-up periods to six months, the sample of patients who had presented with an index 
visit for the symptom of fatigue, and who had complete six month run-in and follow-up periods, 
became 167 patients. Despite this increase in sample size, the results were largely the same as the 
initial analysis done with our original fatigue symptom patient group consisting of 103 patients. 
All significant relationships (and the associated direction of the relationship) within each of the 
multivariable analyses were maintained. One additional finding from the sensitivity analyses was 
in the multivariable model for the number of laboratory tests and investigations. Originally, there 
was no significant relationship between the sex of the patient and the number of subsequent 
investigations. However, after conducting the sensitivity analysis, the sex of the patient was 
found to be significantly and positively related with the number of investigations administered in 
the following year. In contrast to the findings for the number of subsequent referrals (which 
found that female patients were significantly less likely to receive a referral in the following 
year), the female patients were found to experience 67% more investigations during the 
following year, as compared to the male patients (IRR=1.67, p=0.016). This is a marked 
difference as compared to our original findings, and demonstrates the need for examining the 
influence of gender on fatigue patient’s use of health services in future studies.  
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CHAPTER FIVE – DISCUSSION 
 The purpose of the last chapter of this thesis will be to compare our results to the existing 
literature; to present interpretations for our key findings; to highlight the strengths and 
limitations of the current study; to outline the implications of our findings and the directions of 
future research; and finally, to discuss the conclusions of this work. To provide a broad overview 
of the key results presented in the previous chapter, the fatigue symptom patients were found to 
have significant rates of referrals (within the group itself) and investigations (in comparison to 
other symptom patients) in the year following the index date; the sex of the fatigue symptom 
patients significantly influenced the frequency of referral; and the previous care-seeking 
frequency of the patients was significantly related to each of the dependent variables, but in 
varying directions.  
 
5.1. Objective One: Description of Fatigue Symptom Patients  
We found a period prevalence of 8.2% of fatigue symptom presentation among the entire 
ICPC patient population, during our data collection period between March 1, 2006 and June 30, 
2010. Although there has been a wide range of prevalence estimates of fatigue in primary care 
settings in previous literature, this period prevalence was comparable to two studies conducted in 
somewhat similar settings and among similar populations of patients. In the Netherlands, 
“fatigue” is recorded as the Reason for Encounter for 6.3% of the patients in general practice 126. 
This comparable finding was derived from a fairly similar setting of general practice clinics 
(although the study was conducted in the Netherlands) and had data derived from the same 
classification system of the ICPC. A Canadian study conducted by Cathebras et al. (1992) in 
Montreal, Quebec found that of 686 patients who presented to two family medicine clinics, 
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13.6% of these patients presented with a complaint of fatigue 39. Within this study, the presence 
of fatigue was self-reported by the patients and the primary care visits were self-initiated, which 
was similar to the current study. The Cathebras et al. study identified fatigue as a presenting 
complaint in two ways: 1) the patient mentioned “fatigue” or a closely related response (such as 
being “tired” or “drained”) when asked by the health care staff, “Why did you see the doctor 
today?” or 2) the patient stated to the physician directly that their presenting complaint was 
fatigue 39. Although the identification of patients was not as structured as the ICPC system, and 
despite the fact that this prevalence value was obtained twenty years ago, this study provided a 
valuable reference point of the estimated prevalence of fatigue symptoms in a Canadian primary 
care population.  
The majority (68%) of our fatigue patient sample were female, which was in agreement 
with many other studies that have shown the presentation of fatigue symptoms skewed towards 
women. Our proportion of females was slightly higher than the proportions found by Bensing et 
al. (1990) (37.8% female), but slightly less skewed towards females than the Ridsdale et al. 
(1994) study (75.5% female) 28, 68. However, our proportion of female patients was particularly 
similar to the Canadian study by Cathebras et al., in which 65.6% of patients presenting with a 
new symptom of fatigue to their primary care provider were women 39. The average age of our 
fatigue symptom patient sample was 63.1 years, which was an older patient sample compared to 
other studies. For example, the studies by Ridsdale et al. and Cathebras et al. each had a much 
younger population of patients who presented to their primary care clinic with the complaint of 
fatigue; with mean ages of 43 years and 43.2 years, respectively 28, 68. 
The average number of visits prior to the index visit was found to be 12.1 visits, and 
76.7% of the fatigue symptom patients had at least five previous visits during the one year run-in 
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period. This finding was markedly higher than the Ridsdale et al. study based in four primary 
care practices in England, which found an average of 6.2 visits by fatigue patients during the 
year before the fatigue-related visit 68. In comparison, an average of 17.1 medical visits per year 
by chronic fatigue patients was found in an American university-based chronic fatigue clinic 24. 
This count of medical visits included a wide range of health care professionals and captured 
health care use among a more severely fatigued patient population. However, the fact that our 
average number of previous medical visits is somewhat comparable to this study based in a 
tertiary care clinic is potentially important in that it signifies a level of health care use by our 
primary care patients that is comparable to fatigue patients requiring specialized care.  
While 64.1% of fatigue symptom patients received at least one referral from their 
provider following the index visit, 92.2% of the sample had at least one laboratory test or 
investigation in the following year. In a study of fatigue patients in a Dutch primary care 
population, only about 4.0% of the patients received a referral to another health care professional 
during the observation period (which was approximately four years); whereas the most frequent 
laboratory test and investigations administered to these patients were: blood tests (75.7% of 
patients), physical examinations (49.5% of patients), health education (34.2% of patients), urine 
testing (4.9% of patients), and imaging (2.4% of patients) 23. This study, conducted by Kenter et 
al. (2003) examined the clinical episode of care for fatigue, which differed from the current 
study’s structure. Kenter et al. found that over a four year period, 21% of patients (from a basic 
primary care population of 12,292 patients) started a new episode of care with the symptom of 
fatigue 23. This episode of care structure allowed for the measurement of health care utilization 
that resulted directly from or was clinically related to the fatigue presentation 23. In comparison, 
the current study examined associations between the fatigue presentation and resulting health 
91 
 
 
 
care utilization over a one year period, but did not specifically assess causal relationships. These 
differences, and differences in patterns of care in the Netherlands as compared to Canada, were 
likely the reason of the variation in the frequency of referrals and investigation in our group of 
fatigue symptom patients (high frequencies of referral and investigation) and the group of fatigue 
patients in the Kenter et al. study (low frequencies of referral and investigation).  
Considerably high numbers of previous and co-occurring morbidities were found among 
our fatigue symptom sample. Firstly, the average number of previous and co-occurring chronic 
conditions was as high as 7.7 conditions. In previous literature, patients with a chronic disease 
often reported symptoms of fatigue 15, and likewise, the prevalence of chronic disease was higher 
among patients presenting with fatigue than among other patients 3. An average of 2.9 
psychosocial conditions was also found among our fatigue patients. Since previous studies have 
demonstrated a strong association between the presentation of fatigue and significant 
psychological distress 4, 39, 68, this average of psychosocial morbidity was less than what was 
expected. Finally, the number of non-chronic, non-psychosocial conditions among these patients 
was found to be an average of 10.5 conditions. This large burden of “other” conditions was not 
found to be represented in previous fatigue literature, and therefore could be an important 
addition to the existing literature.  
When adding the average numbers of chronic (7.7), psychosocial (2.9), and other (10.5) 
morbidities together, the overall average of previous and co-occurring morbidity for our fatigue 
patients was approximately 21.1 conditions over a one year run-in period. In the study conducted 
by Kenter et al. (2003), fatigue symptom patients were found to have an average co-morbidity 
count of 16.6 conditions, which was slightly, but not markedly less than the level of morbidity in 
our fatigue patient sample 23. The evaluation of fatigue symptom patients demonstrates a 
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significant burden of complex morbidity, which may be an influential factor in their subsequent 
management and health care utilization.  
To summarize, comparable findings from the existing literature were present for the sex 
distributions (more specifically, the skewed representation of female patients in fatigue patients), 
as well as for the complex of co-occurring morbidity for our fatigue symptom patients. However, 
it was noted that the number of previous and co-occurring psychosocial conditions among our 
patients was less than what was expected, based on the existing literature which has consistently 
demonstrated high correlations between psychosocial morbidity and fatigue presentation. 
Conflicting results in the previous care-seeking frequency among fatigue patients was evident in 
the literature. Finally, non-comparable findings from the existing literature were present for the 
approximate age of an average fatigue patient (in that our fatigue patient population was 
markedly older than fatigue populations in previous studies) and the frequency of referrals and 
investigations experienced by these patients (as our patients experienced a decidedly higher 
number of referrals and investigations when compared to previous studies).  
 
5.2. Objective Two: Description of Health Care Utilization of Fatigue Symptom Patients  
 The second objective assessed the health care utilization patterns of fatigue symptom 
patients, and analyzed the relationship between the covariates (patient age, patient sex, number 
of previous and co-occurring morbidity, and previous care-seeking frequency) and each of the 
three outcome variables (number of subsequent visits, number of referrals, and number of 
laboratory tests and investigations). To examine these relationships more specifically, two 
hypotheses were tested.  
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Hypothesis 1: It was hypothesized that a fatigue symptom patient who presented with an 
increased number of chronic or psychosocial previous and co-occurring conditions would 
experience an increased level of health case use (that is an increased number of subsequent visits, 
referrals, and investigations during the one year follow-up period), adjusting for all other 
variables. This was hypothesized based on the conceptual framework stating a potential 
relationship between the disease burden experienced by these patients (therefore translated to an 
increased perceived or evaluated need) and subsequent health care use. However, this hypothesis 
was not reflected in the results of the three multivariable models for the fatigue symptom 
patients. In all three cases, when the number of chronic and psychosocial conditions were tested 
in the bivariate analyses and forced into the multivariable models, significant relationships 
between these independent variables and the dependent variables were not found.  
There have been few prior studies examining the relationship between symptom 
presentation, associated levels of morbidity, and resulting health care utilization. In fact, no 
previous studies have tested these relationships using each of the three dependent variables of the 
current study. A study conducted by Stoller (1988) reported that while the number of physical 
morbidities or symptoms was correlated with the number of prescribed medications, the level of 
morbidity was not associated with the number of physician visits 127. Our findings regarding the 
number of chronic and psychosocial morbidities would concur with Stoller’s observed 
association with the number of physician visits, but our findings regarding the remaining 
outcomes (referrals and investigations) are new to the literature. Further interpretation of these 
results will be presented later.  
  
Hypothesis 2: It was hypothesized that a fatigue symptom patient who had an increased 
previous care-seeking frequency would experience an increased level of health care use (that is 
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an increased number of subsequent visits, referrals, and investigations during the one year 
follow-up period), adjusting for all other variables. This was hypothesized based on previous 
literature, in which patients who were classified as “frequent attenders” experienced significantly 
higher rates of subsequent health care use 63-65. A systematic review of frequent attenders by 
Vedsted and Christensen (2005) concluded that one-third of frequent attenders continued to be 
high users of health care resources, such as through increased visits to clinics and increased 
hospitalizations during the following year 128. Our findings showed an inconsistent relationship 
between the previous care-seeking frequency of a patient and their subsequent health care use. 
While a positive relationship was found with the number of visits in the year following the index 
visit, adjusting for all other variables in the multivariable model (a 4% increase in the number of 
subsequent visits), decreases were found with the number of referrals and the number of 
laboratory tests and investigations (a 4% decrease for each outcome). Further interpretation of 
these results will be presented later.  
 
5.3. Objective Three: Differences in Health Care Utilization between Comparative Groups  
 The third objective assessed the differences in health care utilization patterns (that is the 
number of subsequent visits, number of referrals, and the number of laboratory tests and 
investigations) between the case patients and the comparison patients. The case and comparison 
patients were matched on a 1:1 ratio, and these two patient groups were not significantly 
different on the matched variables, including age and gender (as seen in Table 11). Furthermore, 
these two patient groups were not statistically different in the patients’ number of previous and 
co-occurring chronic and psychosocial morbidities (as seem in Table 11).  
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Hypothesis 3: It was hypothesized that the fatigue symptom patients would experience 
an increased number of subsequent visits, referrals, and investigations during the one year 
follow-up period, in comparison to their matched, non-fatigue comparison patients. The fatigue 
symptom patients were found to have 19% more subsequent in-office visits and 68% more 
laboratory tests and investigations during the one year follow-up period, as compared to the other 
symptom patients and adjusting for all other variables. However, there was no statistically 
significant difference found between these two patient groups in the number of referrals received 
during the following year.  
There are a number of potential reasons for these findings. Firstly, these findings could be 
true in that fatigue patients are significantly more likely to experience increased subsequent visits 
and increased investigations as compared to other symptom patients. Secondly, although the case 
and comparison patients were matched on a number of factors (age, sex, practice, provider, and 
quarter of index visit date); differences in subsequent health care use may have been the result of 
a variety of other factors, including variation in the burden of morbidity and differences in the 
previous care-seeking frequencies among the patients. As was described in Table 11, the fatigue 
symptom patients had significantly higher prevalence rates of previous and co-occurring non-
chronic, non-psychosocial conditions, as well as significantly higher care-seeking frequencies or 
visits during the preceding year leading to the index visit. However, even after adjusting for 
these characteristics, the fatigue symptom patients still experienced a significantly higher number 
of subsequent visits and subsequent laboratory tests and investigations. Thirdly, the case and 
comparison patients may have also differed in the number of subsequent visits or investigations 
because of differences in unmeasured factors influencing evaluated need by the providers (in that 
the health care provider may have asked the fatigue symptom patients to come back for more 
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follow-up visits or ordered more tests and investigations) or differences in perceived need among 
the case and comparison patients (in that fatigue symptom patients may have perceived 
themselves as having a greater burden of illness, and therefore came back for more follow-up 
visits or demanded more tests and investigations). Although, these unmeasured and potential 
factors did not seem to produce similar differences in the referral patterns between the fatigue 
and non-fatigue patients.  
Our results were not consistent with the Cathebras et al. study, which compared 93 
fatigue patients with patients in the remaining clinic sample 39. Despite higher levels of somatic 
and emotional distress among the fatigue patients, these patients were not significantly different 
in the number of visits to their primary care provider during the one year follow-up period, as 
compared to the other clinic patients. However, as the evaluation of health care use was done 
through a follow-up survey, the validity of these results may have been compromised by: 1) self-
report measures which may have been systematically answered differently by fatigue patients 
versus other patients; and/or 2) an attrition rate of 28% among the initial fatigue patient group (as 
compared to the attrition rate of 21% for the total clinic population). One strength of the current 
study was the use of an electronic medical record which consistently recorded each patient’s 
visits to the primary care provider, which eliminated the potential influence of recall bias or the 
underestimation of the number of visits by patients due to the bias of reporting socially 
acceptable answers, both of which are possible in self-reported measures.   
In the study conducted by Ridsdale et al. (1994), physicians recruited 220 patients (aged 
sixteen years and older) who had presented to their offices with fatigue over a one year period 68. 
These patients were then matched (by age, sex, physician, and practice) with a comparison group 
of patients. This study found that patients who had presented with self-reported fatigue attended 
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the primary care practice significantly more frequently than the comparison group in the six 
months after entry into the study. Patients with fatigue visited their primary care provider an 
average of 4.2 times (95% CI=3.7 - 4.6) compared with 1.6 visits (95% CI=1.3 - 1.9) for patients 
in the comparison group 68. These results were generally similar to the current study in that the 
fatigue patients had a significantly increased number of subsequent visits as compared to the 
comparison group (an average of 6.2 visits in a six month follow-up period and an average of 5.3 
visits in a six month follow-up period, respectively). Although our study found similar 
differences between patient groups, our patients’ number of subsequent visits was slightly higher 
with an average of 6.2 visits (as compared to an average of 4.2 visits) during a six month follow-
up period. Ridsdale et al. concluded that the frequency of subsequent visits in the fatigued patient 
group could not be related to the duration or severity of the fatigue symptoms alone, but that 
fatigue patients were more likely to attend more frequently when also reporting symptoms of 
psychological distress, a correlation that has been noted in a number of previous studies 68. 
However, this was not reflected in the current study as the case and comparison patients 
experienced similar levels of psychosocial morbidity at baseline. Previous studies examining 
differences in the number of investigations and referrals between fatigue and non-fatigued 
patient groups were not found in the literature for comparison, and consequently the current 
study will provide an important contribution in this area.  
 
5.4. Summary and Interpretation of Findings  
 Two elements of our findings were chosen for further interpretation. Some of these 
findings may provide contributions to the existing fatigue literature and therefore require further 
interpretation and assessment.  
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The first key finding was a result of our comparative study research design, and 
distinguished differences in health services use by fatigue symptom patients, when compared to 
other symptom patients. More specifically, the previously un-researched outcome of the number 
of laboratory tests and investigations was found to be a resource that fatigue symptom patients 
utilized 68% more frequently than the comparison patients, which designates a topic that is 
worthy of more attention. This finding may potentially highlight the reality that symptoms of 
fatigue, unlike other symptoms, are symptoms of ill health that both providers and patients want 
to explain and investigate, instead of using the “wait and see” approach. Additionally, as fatigue 
symptom patients experienced a higher frequency of subsequent visits, perhaps the need to 
explain and investigate the fatigue occurrence was increased or more substantiated. These 
statistically significant differences between our fatigue and non-fatigue symptom patients justify 
the current study and emphasize the importance of future research and clinical focus on this 
particular group of patients. 
The second key series of findings was a result of our examination of fatigue symptom 
patients’ health care use patterns. The fatigue symptom patients had substantial levels of 
referrals, with almost 65% of these patients experiencing at least one referral during the one year 
follow-up period. Possible reasons for these high rates of referrals may be because primary care 
providers do not feel comfortable dealing with patients presenting with fatigue (whether as a 
primary or secondary complaint) and the complex of associated conditions presented with the 
fatigue symptom; the providers may receive pressure from the patients to provide a referral; or 
the natural history of the patient’s health conditions required specialized care. Furthermore, male 
fatigue symptom patients were almost 60% more likely to receive a referral, as compared to 
female fatigue patients. This may have been because the female patient’s fatigue and associated 
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As well, fatigue symptom patients who were experiencing other previous and co-
occurring conditions (non-chronic and non-psychosocial) were significantly more likely to be 
referred for specialized care. However, similar significant relationships were not found for 
referrals of fatigue patients who were experiencing concomitant chronic or psychosocial 
conditions. These findings could indicate that fatigue presentation in a chronically ill patient may 
have been confidently handled by the primary care provider, but fatigue presentation 
accompanied by non-chronic conditions warranted a more concerted search for diagnosis 
through referral to a specialist, instead of management by the primary care provider.  
 Patients who were considered frequent attenders were less likely to be referred and also 
to receive laboratory tests and investigations. A possible interpretation of these findings may be 
that although frequent attenders to primary care providers remained frequent attenders in the 
following year, these patients were more likely to be cared for within the primary care office 
setting and not referred or sent for laboratory tests or investigations. This may be because the 
primary care providers were less likely to refer or investigate for patients who were deemed 
frequent attenders. On the other hand, the initiation of a referral or investigation was possibly 
more likely for patients who were previously low or infrequent care-seekers, and who were 
perhaps less well known by their provider and whose presentation of fatigue symptoms required 
more extensive exploration or investigation over the following year.  
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Due to the fact that these data were the first study in twenty years to examine the 
presence of fatigue in primary care in Canada, and given the various strengths of this research (as 
discussed in a following section), our overall findings highlight the need for further research and 
further understanding of these patients and their influence on the Canadian health care system. 
  
5.5. Generalizability of Results  
5.5.1. Comparison of Included and Excluded Fatigue Symptom Patients  
 Due to the inclusion criteria (of a sufficient one year run-in and follow-up period, as well 
as a suitable index visit), 177 or 64% of patients who had presented with the RFE of fatigue for 
at least one in-office visit during the data collection period were excluded from the analysis. 
However, there were no significant differences between the fatigue symptom patients who were 
included in the analysis and the fatigue symptom patients who were excluded. The mean age of 
the included patients was approximately 66.0 years, versus 63.3 years for excluded patients (not 
statistically significant, p=0.304). The proportion of male and female patients was also similar 
between the included and excluded groups, with proportion of female patients being 68.0% and 
63.3%, respectively (not statistically significant, p=0.430). A summary of these results can be 
found in Appendix L. 
 
5.5.2. Comparison of DELPHI ICPC Population and Canadian Census Population  
When compared to the 2011 Canadian census population, the DELPHI ICPC patient 
population was found to be older and with a higher proportion of females (as can be seen in 
Appendix M) 129. The median age of the DELPHI ICPC population was 56 years, while the 
median age of the 2011 Canadian census population was 40.6 years. Furthermore, 57% of the 
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ICPC population was female, compared to 51% of the census population. These differences do 
not indicate that the DELPHI ICPC population was different from the Canadian population, as 
the ICPC population represented a random sample of individuals who sought care from their 
primary care provider. Females and older individuals have been consistently shown in the 
literature to seek care more often 9, 62-65, 128, they would therefore have been more likely to be 
included in the overall DELPHI population, and subsequently in our case and comparison patient 
samples. Regardless, inferences made beyond the Southwestern Ontario population must be done 
carefully.  
 
5.6. Strengths of Research  
This study was the first in twenty years to describe the presence and characteristics of 
fatigue symptom patients within the context of the Canadian health care system. This study also 
made a valuable contribution to the limited body of research that has worked to characterize 
symptom patients and their subsequent health care use patterns using an electronic medical 
record, and more specifically the ICPC system. As electronic medical records become more 
ubiquitous in health care delivery, particularly in primary health care delivery, research using 
these rich sources of data will become increasingly important.  
The use of the ICPC system to identify fatigue symptom patients was a particularly 
unique facet of the current Canadian research. This allowed the identification of fatigue symptom 
patients recorded from the patient’s reason for the visit, which did not require a health care to 
discern the symptom, but only to record it. Moreover, the ICPC system enabled the 
characterization of the symptom patients’ level of co-occurring morbidity (by counting and 
categorizing the End of Visit codes over the one year run-in period); this created a more 
complete picture of a patient’s overall health and measured a potentially significant influence on 
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a patient’s level of health care use. Finally, this study included patients on the wide spectrum of 
fatigue, and was not focused only on chronic fatigue syndrome patients or severely fatigued 
patients, which has been identified as a weakness in past studies that have focused on these 
highly selected subgroups of fatigue sufferers 15.   
The current study also examined three dimensions of health care use: number of in-office 
visits, number of referrals to specialists, and number of investigations. Previous literature that 
has focused on fatigue patients and their health care resource use has had a limited measurement 
of usage; typically focusing on primary care visits, visits to alternative health care providers, and 
number of hospitalizations. Although this study was not able to capture visits to alternative 
health care providers or use of hospital services, it aimed to capture three dimensions of primary 
health care system use: visits to primary care providers, visits to secondary and tertiary care 
clinics, and use of investigative resources. The EMR also allowed for a longitudinal assessment 
of these variables during the one year follow-up period. In a recent systematic review of fatigue 
studies by Nijrolder et al. (2008), it was noted that most studies did have an approximate one 
year follow-up period; however only one measurement (such as a follow-up questionnaire or 
survey) was used to capture information after the baseline assessment 49.   
 
5.7. Limitations of Research  
 A potential limitation of the current study and its use of EMRs was that we were unable 
to measure the severity of symptoms when capturing a patient’s level of morbidity. Although 
including the level of severity of each condition would have given a more in-depth picture of the 
health of our case and comparison patients, this measurement was not available within our data 
source. Instead, a crude number of recorded morbidities were captured. However, as reported by 
Sha et al. (2005), the total symptom or morbidity count does, at minimum, provide an important 
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proxy for severity of illness and is still considered a valuable tool in measuring a patient’s level 
of health, particularly if scales of severity have not yet been incorporated into the EMR 2.  
 Another limitation of using an EMR is that we were unable to capture visits to alternative 
or allied health professionals. As has been shown in previous research, fatigue symptom patients 
tended to use a large amount of complementary and alternative therapies in order to manage or 
treat their symptoms 24. We were also unable to capture details of the socioeconomic status of 
each of the included patients, which would have provided more patient- or context-level 
variables and could have accounted for important contributing factors to the patients’ health and 
health care utilization patterns.  
 As was mentioned previously, assessing the validity and completeness of EMR-derived 
data can be challenging. Although evidence from previous research was used to broadly assess 
the completeness of the data used for this study, we were unable to differentiate between truly 
missing data (when a provider failed to record existing information into the EMR) and a zero 
count (when a patient did not have a co-occurring morbidity, subsequent referral or subsequent 
investigation). However, it was assumed that the missingness within the data source occurred at 
random, as we had no reason to believe that the participating providers preferentially recorded 
data based on the individual patient characteristics.  
In a similar sense, the dependent variables (measuring the number of referrals and the 
number of laboratory tests and investigations) could not capture whether the patient truly visited 
a specialist after being referred or had the laboratory test or investigation done after it was 
ordered by the provider. Instead, these variables only captured the referrals and investigations 
that were recorded in the EMR during the follow-up period. Although this may have resulted, in 
this case, in an overestimate of the actual health care use by our patient groups, a review of the 
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literature on the validity of EMR-derived data indicated that these variables were sufficient in 
meeting the objective of this research.  
 
5.8. Policy and Practice Implications  
Symptoms are the principal reason for clinic visits in approximately half of all outpatient 
encounters 31. Patients with complex and multiple concurrent problems are now the norm rather 
than the exception in primary care patients 130. In fact, work by Fortin et al. (2005) determined 
that approximately 90% of patients in Canadian family practices were suffering from more than 
one chronic condition and as many as 50% of patient had five or more concurrent chronic 
conditions 131. The present study also found high levels of co-occurring morbidities with 88.4%, 
52.4%, and 91.3% of fatigue symptom patients experiencing one or more chronic, psychosocial 
or non-chronic, non-psychosocial co-occurring conditions, respectively. Although the prevalence 
of multiple health conditions has been shown to increase with age in both men and women, 
multimorbidity can no longer be perceived as just an issue for older adults 132. Despite advances 
in medical care and public health initiatives, a growing proportion of individuals suffer from 
complex multimorbidity 133.  
Currently, health care providers have limited guidance or evidence as to how to approach 
care decisions for patients suffering from multidimensional conditions 132. Establishing a more 
comprehensive understanding of how best to deliver care and how best to design the health care 
system for these patients may lead to significant improvements in quality of life, utilization of 
health care, patient safety, patient satisfaction, morbidity, and mortality 130, 132, 134. A recent study 
by Glynn et al. (2011) found that health care utilization was significantly increased among 
patients with multimorbidity 134. Regarding practice implications, communicating the prevalence 
of the symptom of fatigue found by this study to clinicians would reinforce the fact that symptom  
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patients represent a significant population within their practice. Furthermore, the majority of the
fatigue patients were not just experiencing fatigue alone, but were suffering from multiple chronic, 
concomitant morbidities. Although this study evaluated only three dimensions of health services 
use, clinicians would be interested to note that fatigue patients had high levels of health care usage.   
A specific recommendation from the current study is to improve the development of 
clinical guidelines, particularly fatigue guidelines, in order to promote the provision of high 
quality care that meets the needs of patients suffering from multidimensional or multimorbid 
conditions. This could be done by encouraging providers to practice patient-centred care, which 
has been viewed as essential approach when dealing with patients with multimorbidity 130, 132. In 
a general sense, this patient-centred approach focuses on assessing the complex needs of the 
patients, as well as developing and strengthening the patient-provider relationship 132, 135. The 
understanding of a “typical” patient with the symptom of fatigue will help to reduce the amount 
of uncertainty among health professionals, and it will help to inform improved health policy and 
clinical guideline development into the future.  
 
5.9. Future Research  
Future research can continue to form an understanding of symptom patients in primary 
care through longer data collection periods. Electronic medical records are a valuable source of 
longitudinal data, in which multiple dimensions of health and health care use can be recorded 
into one comprehensive database. The present study was longer than many previous studies, with 
a one year run-in and a one year follow-up period. However, care over time is key in the 
management of patients in primary care. Including more years of observation would allow for 
the study of recurrent visits for the symptom of fatigue, with sufficient run-in and follow-up 
periods and adequate sample sizes. This would enable an extended exploration of the impact of 
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recurrent symptom presentation and the complex of patient morbidity on subsequent health care 
utilization.  
Future research could also incorporate more patient- and context-level characteristics as 
possible predictors of health care utilization. The current data that is available from EMR 
databases does not allow for the exploration of more comprehensive patient- or context-level 
details. This would require an addition of qualitative data, which could be collected and recorded 
from brief surveys or interviews conducted during the encounter. For example, these approaches 
could collect data on patient socioeconomic status, education level, employment status, ethnicity, 
and immigrant status, given our diverse and multiethnic population in Ontario and Canada. The 
outcomes that could be evaluated with these added characteristics could include the patient’s 
perception and satisfaction with care they have received or a patient narrative detailing their 
experiences of their constellation of morbidity and symptoms.  
Finally, future work assessing the validity and quality of EMR-derived data is essential. 
As growing volumes of data are routinely being recorded, ensuring consistent, complete and 
accurate data recording increases in importance. A greater focus on the effects of feedback, 
incentives and evidence-based guidelines in improving data recording by health care 
professionals, as well as the development of data validation measures in order to establish 
appropriate levels of data quality within an EMR database, are all areas of opportunity for future 
studies.  
 
5.10. Conclusion 
 Fatigue is a common issue in primary care and has been shown to pose a significant 
financial burden on the health care system and the broader community. This study provided a 
current characterization of fatigue symptom patients, and their subsequent health care use, in 
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comparison to patients who have presented to a primary care provider with other symptoms and 
in the context of the Canadian health care system. This was the first Canadian study to identify 
symptom patients and to capture their morbidity characteristics through an EMR database, and 
more specifically through the primary care-focused coding of the ICPC system. This study 
explored the determinants of health care use and found that fatigue symptom patients 
experienced higher subsequent visits and investigations over a one year follow-up period, when 
compared to other symptom patients.  
Based on the results of this study, primary care providers, specifically family physicians 
and nurse practitioners, as well as policy makers could dedicate more attention to the care of 
symptom patients.  For our fatigue symptom patients, the most important findings that were 
supported by previous literature were a consistently high proportion of female patients; a large 
number of co-occurring conditions; and a significant amount of overall health care use. New 
findings from the current study demonstrated that these patients had an older average age as 
compared to previous studies; that the level of chronic or psychosocial morbidity was in fact not 
significantly related to subsequent health care use; that the fatigue symptom patients experienced 
significant numbers of referrals, particularly males and patients with non-chronic conditions; and 
that fatigue symptom patients had more subsequent visits and laboratory tests and investigations, 
in comparison to other symptom patients. Managing non-specific symptoms will continue to 
present challenges for primary care providers, but particularly in the case of fatigue, a growing 
understanding of these patients will help to provide increased guidance for providers and 
improved management of symptom patients into the future.  
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APPENDICES 
Appendix A: RFE Symptom Codes Used to Identify Case and Comparison Patients 
ICPC Code            ICPC Code Description  
A01 Pain general/multiple sites 
A02 Chills 
A03 Fever 
A04 Weakness/tiredness general* 
A05 Feeling ill 
A06 Fainting/syncope 
A07 Coma 
A08 Swelling 
A09 Sweating problem 
A10 Bleeding/haemorrhage NOS 
A11 Chest pain NOS 
A13 Concern about/fear of medical treatment 
A16 Irritable infant 
A18 Concern about appearance 
A20 Euthanasia request/discussion 
A21 Risk factor for malignancy 
A23 Risk factor NOS 
A25 Fear of death/dying 
A26 Fear of cancer NOS 
A27 Fear of other disease NOS 
A28 Limited function/disability NOS 
A29 General symptom/complaint other 
B02 Lymph gland(s) enlarged/painful 
B04 Blood symptom/complaint 
B25 Fear of AIDS/HIV 
B26 Fear of cancer blood/lymph 
B27 Fear of blood/lymph disease other 
B28 Limited function/disability (B) 
B29 Lymph/immune mechanism symptom/complaint other 
D01 Abdominal pain/cramps general 
D02 Abdominal pain epigastric 
D03 Heartburn 
D04 Rectal/anal pain 
D05 Perianal itching 
D06 Abdominal pain localized other 
D07 Dyspepsia/indigestion 
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ICPC Code            ICPC Code Description  
D08 Flatulence/gas/belching 
D09 Nausea 
D10 Vomiting 
D11 Diarrhoea 
D12 Constipation 
D13 Jaundice 
D14 Haematemesis/vomiting blood 
D15 Melaena  
D16 Rectal bleeding 
D17 Incontinence of bowel 
D18 Change in faeces/bowel movements 
D19 Teeth/gum symptom/complaint 
D20 Mouth/tongue/lip symptom/complaint 
D21 Swallowing problem 
D23 Hepatomegaly 
D24 Abdominal mass NOS 
D25 Abdominal distension 
D26 Fear of cancer of digestive system 
D27 Fear of digestive disease other 
D28 Limited function/disability (D) 
D29 Digestive symptom/complaint other 
F01 Eye pain 
F02 Red eye 
F03 Eye discharge 
F04 Visual floaters/spots 
F05 Visual disturbance other 
F13 Eye sensation abnormal 
F14 Eye movements abnormal 
F15 Eye appearance abnormal 
F16 Eyelid symptom/complaint 
F17 Glasses symptom/complaint 
F18 Contact lens symptom/complaint 
F27 Fear of eye disease 
F28 Limited function/disability (F) 
F29 Eye symptom/complaint other 
H01 Ear pain/earache 
H02 Hearing complaint 
H03 Tinnitus, ringing/buzzing ear 
H04 Ear discharge 
H05 Bleeding ear 
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ICPC Code            ICPC Code Description  
H13 Plugged feeling ear 
H15 Concern with appearance of ears 
H27 Fear of ear disease 
H28 Limited function/disability (H) 
H29 Ear symptom/complaint other 
K01 Heart pain 
K02 Pressure/tightness of heart 
K03 Cardiovascular pain NOS 
K04 Palpitations/awareness of heart 
K05 Irregular heartbeat other 
K06 Prominent veins 
K07 Swollen ankles/oedema 
K22 Risk factor for cardiovascular disease  
K24 Fear of heart disease 
K25 Fear of hypertension 
K27 Fear of cardiovascular disease other 
K28 Limited function/disability (K) 
K29 Cardiovascular symptom/complaint other 
L01 Neck symptom/complaint 
L02 Back symptom/complaint 
L03 Low back symptom/complaint 
L04 Chest symptom/complaint 
L05 Flank/axilla symptom/complaint 
L07 Jaw symptom/complaint 
L08 Shoulder symptom/complaint 
L09 Arm symptom/complaint 
L10 Elbow symptom/complaint 
L11 Wrist symptom/complaint 
L12 Hand/finger symptom/complaint 
L13 Hip symptom/complaint 
L14 Leg/thigh symptom/complaint 
L15 Knee symptom/complaint 
L16 Ankle symptom/complaint 
L17 Foot/toe symptom/complaint 
L18 Muscle pain 
L19 Muscle symptom/complaint NOS 
L20 Joint symptom/complaint NOS 
L26 Fear of cancer musculoskeletal  
L27 Fear of musculoskeletal disease other 
L28 Limited function/disability (L) 
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ICPC Code            ICPC Code Description  
L29 Musculoskeletal symptom/complaint other 
N01 Headache 
N03 Pain face 
N04 Restless legs 
N05 Tingling fingers/feet/toes 
N06 Sensation disturbance other 
N07 Convulsion/seizure 
N08 Abnormal involuntary movements 
N16 Disturbance of smell/taste 
N17 Vertigo/dizziness 
N18 Paralysis/weakness 
N19 Speech disorder 
N26 Fear of cancer of neurological system 
N27 Fear of neurological disease other 
N28 Limited function/disability (N) 
N29 Neurological symptom/complaint other 
P01 Feeling anxious/nervous/tense 
P02 Acute stress reaction 
P03 Feeling depressed 
P04 Feeling/behaving irritable/angry 
P05 Senility, feeling/behaving old 
P06 Sleep disturbance 
P07 Sexual desire reduced 
P08 Sexual fulfillment reduced 
P09 Sexual preference concern 
P10 Stammering/stuttering/tic 
P11 Eating problem in child 
P12 Bedwetting/enuresis 
P13 Encopresis/bowel training problem 
P15 Chronic alcohol abuse 
P16 Acute alcohol abuse 
P17 Tobacco abuse 
P18 Medication abuse 
P19 Drug abuse 
P20 Memory disturbance 
P22 Child behaviour symptom/complaint 
P23 Adolescent behaviour symptom/complaint 
P24 Specific learning problem 
P25 Phase of life problem adult 
P27 Fear of mental disorder 
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ICPC Code            ICPC Code Description  
P28 Limited function/disability (P) 
P29 Psychological symptom/complaint other 
R01 Pain respiratory system 
R02 Shortness of breath/dyspnoea 
R03 Wheezing 
R04 Breathing problem other 
R05 Cough 
R06 Nose bleed/epistaxis 
R07 Sneezing/nasal congestion 
R08 Nose symptom/complaint other 
R09 Sinus symptom/complaint 
R21 Throat symptom/complaint 
R23 Voice symptom/complaint 
R24 Haemoptysis 
R25 Sputum/phlegm abnormal 
R26 Fear of cancer of respiratory system 
R27 Fear of respiratory disease other 
R28 Limited function/disability (R)  
R29 Respiratory symptom/complaint other 
S01 Pain/tenderness of skin 
S02 Pruritus 
S03 Warts 
S04 Lump/swelling localized 
S05 Lumps/swellings generalized 
S06 Rash localized 
S07 Rash generalized 
S08 Skin colour change 
S09 Infected finger/toe 
S10 Boil/carbuncle 
S11 Skin infection post-traumatic 
S12 Insect bite/sting 
S13 Animal/human bite 
S14 Burn/scald 
S15 Foreign body in skin 
S16 Bruise/contusion 
S17 Abrasion/scratch/blister 
S18 Laceration/cut 
S19 Skin injury other 
S20 Corn/callosity 
S21 Skin texture symptom/complaint 
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ICPC Code            ICPC Code Description  
S22 Nail symptom/complaint 
S23 Hair loss/baldness 
S24 Hair/scalp symptom/complaint other 
S26 Fear of cancer of skin 
S27 Fear of skin disease other 
S28 Limited function/disability (S) 
S29 Skin symptom/complaint other 
T01 Excessive thirst 
T02 Excessive appetite 
T03 Loss of appetite 
T04 Feeding problem of infant/child 
T05 Feeding problem of adult 
T07 Weight gain 
T08 Weight loss 
T10 Growth delay 
T11 Dehydration 
T26 Fear of cancer of endocrine system 
T27 Fear of endocrine/metabolic disease other 
T28 Limited function/disability (T) 
T29 Endocrine/metabolic/nutritional symptom/complaint other 
U01 Dysuria/painful urination 
U02 Urinary frequency/urgency 
U04 Incontinence urine 
U05 Urination problems other 
U06 Haematuria  
U07 Urine symptom/complaint other 
U08 Urinary retention 
U13 Bladder symptom/complaint other 
U14 Kidney symptom/complaint  
U26 Fear of cancer of urinary system 
U27 Fear of urinary disease other 
U28 Limited function/disability (U) 
U29 Urinary symptom/complaint other 
W01 Question of pregnancy 
W02 Fear of pregnancy 
W03 Antepartum bleeding 
W05 Pregnancy vomiting/nausea 
W10 Contraception postcoital 
W11 Contraception oral 
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ICPC Code            ICPC Code Description  
W12 Contraception intrauterine 
W13 Sterilization female 
W14 Contraception female other 
W15 Infertility/subfertility female 
W17 Post-partum bleeding 
W18 Post-partum symptom/complaint other 
W19 Breast/lactation symptom/complaint 
W21 Concern about body image related to pregnancy 
W27 Fear of complications of pregnancy 
W28 Limited function/disability (W) 
W29 Pregnancy symptom/complaint other 
X01 Genital pain female 
X02 Menstrual pain 
X03 Intermenstrual pain 
X04 Painful intercourse female 
X05 Menstruation absent/scanty 
X06 Menstruation excessive 
X07 Menstruation irregular/frequent 
X08 Intermenstrual bleeding 
X09 Premenstrual symptom/complaint 
X10 Postponement of menstruation 
X11 Menopausal symptom/complaint 
X12 Postmenopausal bleeding 
X13 Postcoital bleeding 
X14 Vaginal discharge 
X15 Vaginal symptom/complaint other 
X16 Vulval symptom/complaint 
X17 Pelvis symptom/complaint female 
X18 Breast pain female 
X19 Breast lump/mass female 
X20 Nipple symptom/complaint female 
X21 Breast symptom/complaint female other 
X22 Concern about breast appearance female 
X23 Fear of sexually transmitted disease female 
X24 Fear of sexual dysfunction female 
X25 Fear of genital cancer female 
X26 Fear of breast cancer female 
X27 Fear of genital/breast disease female other 
X28 Limited function/disability (X) 
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ICPC Code            ICPC Code Description  
X29 Genital symptom/complaint female other 
Y01 Pain in penis 
Y02 Pain in testis/scrotum 
Y03 Urethral discharge male 
Y04 Penis symptom/complaint other 
Y05 Scrotum/testis symptom/complaint other 
Y06 Prostate symptom/complaint 
Y07 Impotence NOS 
Y08 Sexual function symptom/complaint male 
Y10 Infertility/subfertility male 
Y13 Sterilization male 
Y14 Family planning male other 
Y16 Breast symptom/complaint male 
Y24 Fear of sexual dysfunction male 
Y25 Fear of sexually transmitted disease male 
Y26 Fear of genital cancer male 
Y27 Fear of genital disease male other 
Y28 Limited function/disability (Y) 
Y29 Genital symptom/complaint male other 
Z01 Poverty/financial problem 
Z02 Food/water problem 
Z03 Housing/neighbourhood problem 
Z04 Social cultural problem 
Z05 Work problem 
Z06 Unemployment problem 
Z07 Education problem 
Z08 Social welfare problem 
Z09 Legal problem 
Z10 Health care system problem 
Z11 Compliance/being ill problem 
Z12 Relationship problem with partner 
Z13 Partner behaviour problem 
Z14 Partner illness problem 
Z15 Loss/death of partner problem 
Z16 Relationship problem with child 
Z18 Illness problem with child 
Z19 Loss/death of child problem 
Z20 Relationship problem parent/family 
Z21 Behaviour problem parent/family 
Z22 Illness problem parent/family 
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ICPC Code            ICPC Code Description  
Z23 Loss/death of parent/family member problem 
Z24 Relationship problem friend 
Z25 Assault/harmful event problem 
Z27 Fear of social problem 
Z28 Limited function/disability (Z) 
Z29 Social problem NOS 
 
*Indicates symptom code used to identify case patients only  
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Appendix B: Choice of Comparison Group 
In determining the most suitable comparison group for this study, many options were 
considered and their advantages and disadvantages were evaluated.  This appendix describes the 
two main structural options that were considered (multiple comparison groups or multiple case 
groups) and the reasoning as to why they were considered and ultimately not chosen.  
Establishing an appropriate comparison group is essential in the validity of a case-
comparison study. It was determined early on that creating a similar structure around the date 
and “type” (incident) of visit for the comparison patients in relation to the case patients was 
important. Ensuring a sufficient one year run-in period and a sufficient one year follow-up period 
around the comparison patient’s index date was also essential, in order to measure independent 
and dependent variables consistently. Based on these basic decisions, two main structural options 
were examined.  
1a) The first option considered was organized into four comparison groups and one case 
group, with each comparison group being comprised of the most common symptom patients. 
This method of comparison selection was based on the goal of comparing health care utilization 
patterns of the fatigue symptom patients to other symptom patients in the database. As well, 
choosing the top four RFE symptom codes in the database was proposed in order to ensure 
sufficient sample size numbers, particularly for a matched analysis. To be specific, the first 
comparison group would consist of an equal mix of the four most common symptoms presented 
in the ICPC database: 25% cough symptom patients (RFE of R05), 25% back pain symptom 
patients (RFE of L02), 25% knee pain symptom patients (RFE of L15) and 25% shoulder pain 
symptom patients (RFE of L08); the second comparison group would consist of 100% cough 
patients (the most common symptom in the ICPC database); the third comparison group would 
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consist of 100% back pain patients (the second most common symptom in the ICPC database); 
and the fourth comparison group would consist of 100% knee pain patients (the third most 
common symptom in the ICPC database). Each of the comparison groups would be mutually 
exclusive, and each included comparison patient would be identified as having a visit for one of 
the four main comparison symptoms. However, the justification as to why it was important to 
compare the health care utilization patterns of fatigue symptom patients to each of the four 
symptom groups could not be substantiated nor was it the true objective of this study.  
1b) Building off of the first option, the next consideration was composed of two 
comparison groups and one case group. This method would aim to compare health care 
utilization patterns of the fatigue symptom patients to two significant symptom groups from the 
ICPC population: musculoskeletal symptom patients and psychological symptom patients. In this 
option, the first comparison group would consist of patients with musculoskeletal symptoms 
(symptom codes from chapter “L”), while the second comparison group would consist of patients 
with non-musculoskeletal symptoms (symptom codes from all other chapters). It was further 
proposed that the non-musculoskeletal symptom patient group should be replaced with a 
psychological symptom patient group (symptom codes from chapter “P”). However, 
musculoskeletal symptom and psychological symptom patients have not been previously 
established as high or low users of health care resources within this database, therefore the 
interpretation of any potential findings was not well supported within this proposed structure.  
2) The second option was composed of having three case groups in comparison to one 
large comparison group consisting of all other ICPC patients. This approach would aim to 
establish how fatigue symptom patients, musculoskeletal symptom patients, and psychological 
symptom patients compare to the typical patient population in terms of their health care 
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utilization. This method was seen as an opportunity to create a “theoretical yard stick” of health 
care utilization, in which different symptom groups could be ranked as “higher users” or “lower 
users” of health care resources in comparison to the “typical” or general patient population. This 
approach was deemed as ultimately too ambitious to complete in the thesis timeframe, as it 
would require not only literature reviews on the three symptom groups (fatigue, musculoskeletal, 
and psychological symptoms presented in primary care), but also separate descriptive and 
analytic analyses. Although this was considered a plausible and potentially meaningful approach, 
it was decided to be more realistic to focus on fatigue symptom patients for the current study, 
with one comparison group that consisted of all other symptom patients in the ICPC database.  
Consequently, the final proposed option consisted of one comparison group (composed of 
all remaining patients in the ICPC database, with an index visit for a non-fatigue symptom) and 
one case group (composed of all of the fatigue symptom patients with an index visit for fatigue).   
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Appendix C: List of Non-Symptom Codes Excluded in the Comparison Group  
ICPC Rubric            ICPC Rubric Description  
_30 Medical examination/health evaluation complete 
_31 Medical examination/health evaluation partial  
_32 Sensitivity test 
_33 Microbiological/immunological test 
_34 Blood test 
_35 Urine test 
_36 Faeces test 
_37 Histological/exfoliative cytology 
_38 Other laboratory test NEC 
_39 Physical function test 
_40 Diagnostic endoscopy 
_41 Diagnostic radiology/imaging 
_42 Electrical tracing 
_43 Other diagnostic procedure 
_44 Preventive immunization/medication 
_45 Observation/health education/advice/diet 
_46 Consultation with primary care provider 
_47 Consultation with specialist 
_48 Clarification/discussion of patient's RFE/demand 
_49 Other preventive procedure 
_50 Medication/prescription/renewal/injection 
_51 Incision/drainage/flushing/aspiration/removal body fluid 
_52 Excision/removal tissue/biopsy/destruction/debridement/cauterization 
_53 Instrumentation/catheterization/intubation/dilation 
_54 Repair/fixation-suture/cast/prosthetic device (apply/remove) 
_55 Local injection/infiltration 
_56 Dressing/pressure/compression/tamponade 
_57 Physical medicine/rehabilitation 
_58 Therapeutic counseling/listening 
_59 Other therapeutic procedure/minor surgery NEC 
_60 Result test/procedure 
_61 Result examination/test/record/letter from other provider 
_62 Administrative procedure 
_63 Follow-up encounter unspecified 
_64 Encounter/problem initiated by provider 
_65 Encounter/problem initiated by other than patient/provider 
_66 Referral to other provider/nurse/therapist/social worker 
_67 Referral to physician/specialist/clinic/hospital  
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ICPC Rubric            ICPC Rubric Description  
_68 Other referral NEC 
_69 Other reason for encounter NEC 
  
ICPC Code            ICPC Code Description  
A70 Tuberculosis  
A71 Measles 
A72 Chickenpox 
A73 Malaria 
A74 Rubella 
A75 Infectious mononucleosis 
A76 Viral exanthem other 
A77 Viral disease other/NOS 
A78 Infectious disease other/NOS 
A79 Malignancy NOS 
A80 Trauma/injury NOS 
A81 Multiple trauma/injuries 
A82 Secondary effect of trauma 
A84 Poisoning by medical agent 
A85 Adverse effect medical agent 
A86 Toxic effect non-medicinal substance 
A87 Complication of medical treatment 
A88 Adverse effect physical factor 
A89 Effect prosthetic device 
A90 Congenital anomaly NOS/multiple 
A91 Abnormal result investigation NOS 
A92 Allergy/allergic reaction NOS 
A93 Premature newborn 
A94 Perinatal morbidity other 
A95 Perinatal mortality 
A96 Death 
A97 No disease 
A98 Health maintenance/preventive medicine 
A99 Disease/condition of unspecified nature/site 
B70 Lymphadenitis acute 
B71 Lymphadenitis chronic/non-specific 
B72 Hodgkin's disease/lymphoma 
B73 Leukaemia  
B74 Malignant neoplasm blood other 
B75 Neoplasm blood benign/unspecified  
B76 Ruptured spleen traumatic 
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ICPC Code            ICPC Code Description  
B77 Injury blood/lymph/spleen other 
B78 Hereditary haemolytic anaemia 
B79 Congenital anomaly blood/lymph other 
B80 Iron deficiency anaemia  
B81 Anaemia vit B12/folate deficiency 
B82 Anaemia other/unspecified 
B83 Purpura/coagulation defect 
B84 Unexplained abnormal white cells 
B87 Splenomegaly 
B90 HIV-infection/AIDS 
B99 Blood/lymph/spleen disease other 
D70 Gastrointestinal infection 
D71 Mumps 
D72 Viral hepatitis 
D73 Gastroenteritis presumed infection 
D74 Malignant neoplasm stomach 
D75 Malignant neoplasm colon/rectum 
D76 Malignant neoplasm pancreas 
D77 Malignant digestive neoplasm other/NOS 
D78 Neoplasm digestive system benign/unspecified 
D79 Foreign body digestive system 
D80 Injury digestive system other 
D81 Congenital anomaly digestive system 
D82 Teeth/gum disease 
D83 Mouth/tongue/lip disease 
D84 Oesophagus disease 
D85 Duodenal ulcer 
D86 Peptic ulcer other 
D87 Stomach function disorder 
D88 Appendicitis 
D89 Inguinal hernia 
D90 Hiatus hernia 
D91 Abdominal hernia other 
D92 Diverticular disease  
D93 Irritable bowel syndrome 
D94 Chronic enteritis/ulcerative colitis  
D95 Anal fissure/perianal abscess 
D96 Worms/other parasites 
D97 Liver disease NOS 
D98 Cholecystitis/cholelithiasis 
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ICPC Code            ICPC Code Description  
D99 Disease digestive system other 
F70 Conjunctivitis infectious 
F71 Conjunctivitis allergic 
F72 Blepharitis/stye/chalazion 
F73 Eye infection/inflammation other 
F74 Neoplasm of eye/adnexa 
F75 Contusion/haemorrhage eye 
F76 Foreign body in eye 
F79 Injury eye other 
F80 Blocked lacrimal duct of infant 
F81 Congenital anomaly eye other 
F82 Detached retina 
F83 Retinopathy  
F84 Macular degeneration  
F85 Corneal ulcer 
F86 Trachoma  
F91 Refractive error 
F92 Cataract 
F93 Glaucoma  
F94 Blindness 
F95 Strabismus 
F99 Eye/adnexa disease other 
H70 Otitis externa  
H71 Acute otitis media/myringitis 
H72 Serous otitis media 
H73 Eustachian salpingitis 
H74 Chronic otitis media 
H75 Neoplasm of ear 
H76 Foreign body in ear 
H77 Perforation ear drum 
H78 Superficial injury of ear 
H79 Ear injury other 
H80 Congenital anomaly of ear 
H81 Excessive ear wax 
H82 Vertiginous syndrome 
H83 Otosclerosis  
H84 Presbyacusis  
H85 Acoustic trauma 
H86 Deafness 
H99 Ear/mastoid disease other 
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ICPC Code            ICPC Code Description  
K70 Infection of circulatory system 
K71 Rheumatic fever/heart disease 
K72 Neoplasm cardiovascular 
K73 Congenital anomaly cardiovascular 
K74 Ischaemic heart disease with angina 
K75 Acute myocardial infarction 
K76 Ischaemic heart disease without angina 
K77 Heart failure 
K78 Atrial fibrillation/flutter 
K79 Paroxysmal tachycardia  
K80 Cardiac arrhythmia NOS 
K81 Heart/arterial murmur NOS 
K82 Pulmonary heart disease 
K83 Heart valve disease NOS 
K84 Heart disease other 
K85 Elevated blood pressure 
K86 Hypertension uncomplicated 
K87 Hypertension complicated 
K88 Postural hypotension 
K89 Transient cerebral ischaemia  
K90 Stroke/cerebrovascular accident 
K91 Cerebrovascular disease 
K92 Atherosclerosis/peripheral vascular disease 
K93 Pulmonary embolism  
K94 Phlebitis/thrombophlebitis 
K95 Varicose veins of leg 
K96 Haemorrhoids 
K99 Cardiovascular disease other 
L70 Infection of musculoskeletal system 
L71 Malignant neoplasm musculoskeletal  
L72 Fracture: radius/ulna 
L73 Fracture: tibia/fibula 
L74 Fracture: hand/foot bone 
L75 Fracture: femur  
L76 Fracture: other 
L77 Sprain/strain of ankle 
L78 Sprain/strain of knee 
L79 Sprain/strain of joint NOS 
L80 Dislocation/subluxation 
L81 Injury musculoskeletal NOS 
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ICPC Code            ICPC Code Description  
L82 Congenital anomaly musculoskeletal 
L83 Neck syndrome 
L84 Back syndrome without radiating pain 
L85 Acquired deformity of spine 
L86 Back syndrome with radiating pain 
L87 Bursitis/tendinitis/synovitis NOS 
L88 Rheumatoid/seropositive arthritis 
L89 Osteoarthrosis of hip 
L90 Osteoarthrosis of knee 
L91 Osteoarthrosis other 
L92 Shoulder syndrome 
L93 Tennis elbow 
L94 Osteochondrosis 
L95 Osteoporosis 
L96 Acute internal damage knee 
L97 Neoplasm musculoskeletal benign/unspecified 
L98 Acquired deformity of limb 
L99 Musculoskeletal disease other 
N70 Poliomyelitis 
N71 Meningitis/encephalitis 
N72 Tetanus 
N73 Neurological infection other 
N74 Malignant neoplasm nervous system 
N75 Benign neoplasm nervous system 
N76 Neoplasm nervous system unspecified 
N79 Concussion 
N80 Head injury other 
N81 Injury nervous system other 
N85 Congenital anomaly neurological  
N86 Multiple sclerosis 
N87 Parkinsonism 
N88 Epilepsy 
N89 Migraine 
N90 Cluster headache 
N91 Facial paralysis/bell's palsy 
N92 Trigeminal neuralgia  
N93 Carpal tunnel syndrome 
N94 Peripheral neuritis/neuropathy  
N95 Tension headache 
N99 Neurological disease other 
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ICPC Code            ICPC Code Description  
P70 Dementia 
P71 Organic psychosis other 
P72 Schizophrenia 
P73 Affective psychosis  
P74 Anxiety disorder/anxiety state 
P75 Somatization disorder 
P76 Depressive disorder 
P77 Suicide/suicide attempt 
P78 Neuraesthenia/surmenage 
P79 Phobia/compulsive disorder 
P80 Personality disorder 
P81 Hyperkinetic disorder 
P82 Post-traumatic stress disorder 
P85 Mental retardation 
P86 Anorexia nervosa/bulimia 
P98 Psychosis NOS/other 
P99 Psychological disorders other 
R71 Whooping cough 
R72 Strep throat 
R73 Boil/abscess nose 
R74 Upper respiratory infection acute 
R75 Sinusitis acute/chronic 
R76 Tonsillitis acute 
R77 Laryngitis/tracheitis acute 
R78 Acute bronchitis/bronchiolitis 
R79 Chronic bronchitis 
R80 Influenza 
R81 Pneumonia 
R82 Pleurisy/pleural effusion 
R83 Respiratory infection other 
R84 Malignant neoplasm bronchus/lung 
R85 Malignant neoplasm respiratory other 
R86 Benign neoplasm respiratory 
R87 Foreign body nose/larynx/bronchus 
R88 Injury respiratory other 
R89 Congenital anomaly respiratory 
R90 Hypertrophy tonsils/adenoids 
R92 Neoplasm respiratory unspecified 
R95 Chronic obstructive pulmonary disease 
R96 Asthma 
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ICPC Code            ICPC Code Description  
R97 Allergic rhinitis 
R98 Hyperventilation syndrome 
R99 Respiratory disease other 
S70 Herpes zoster 
S71 Herpes simplex 
S72 Scabies/other acariasis 
S73 Pediculosis/skin infestation other 
S74 Dermatophytosis 
S75 Moniliasis/candidiasis skin 
S76 Skin infection other 
S77 Malignant neoplasm of skin 
S78 Lipoma 
S79 Neoplasm skin benign/unspecified 
S80 Solar keratosis/sunburn 
S81 Haemangioma/lymphangioma 
S82 Naevus/mole 
S83 Congenital skin anomaly other 
S84 Impetigo 
S85 Pilonidal cyst/fistula 
S86 Dermatitis seborrhoeic 
S87 Dermatitis/atopic eczema 
S88 Dermatitis contact/allergic 
S89 Diaper rash 
S90 Pityriasis rosea 
S91 Psoriasis 
S92 Sweat gland disease 
S93 Sebaceous cyst 
S94 Ingrown nail  
S95 Molluscum contagiosum 
S96 Acne 
S97 Chronic ulcer skin 
S98 Urticaria 
S99 Skin disease other 
T70 Endocrine infection 
T71 Malignant neoplasm thyroid 
T72 Benign neoplasm thyroid 
T73 Neoplasm endocrine other/unspecified 
T78 Thyroglossal duct/cyst 
T80 Congenital anomaly endocrine/metabolic 
T81 Goitre 
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ICPC Code            ICPC Code Description  
T82 Obesity  
T83 Overweight 
T85 Hyperthyroidism/thyrotoxicosis 
T86 Hypothyroidism/myxoedema 
T87 Hypoglycaemia 
T89 Diabetes insulin dependent 
T90 Diabetes non-insulin dependent  
T91 Vitamin/nutritional deficiency 
T92 Gout  
T93 Lipid disorder 
T99 Endocrine/metabolic/nutritional disease other 
U70 Pyelonephritis/pyelitis 
U71 Cystitis/urinary infection other 
U72 Urethritis 
U75 Malignant neoplasm of kidney 
U76 Malignant neoplasm of bladder 
U77 Malignant neoplasm urinary other 
U78 Benign neoplasm urinary tract 
U79 Neoplasm urinary tract unspecified 
U80 Injury urinary tract 
U85 Congenital anomaly urinary tract 
U88 Glomerulonephritis/nephrosis 
U90 Orthostatic albuminuria/proteinuria 
U95 Urinary calculus  
U98 Abnormal urine test NOS 
U99 Urinary disease other 
W70 Puerperal infection/sepsis 
W71 Other infection complicating pregnancy/puerperium 
W72 Malignant neoplasm related to pregnancy 
W73 Benign/unspecified neoplasm related to pregnancy 
W75 Injury complicating pregnancy 
W76 Congenital anomaly complicating pregnancy 
W78 Pregnancy 
W79 Unwanted pregnancy 
W80 Ectopic pregnancy 
W81 Toxaemia of pregnancy 
W82 Abortion spontaneous 
W83 Abortion induced 
W84 Pregnancy high risk 
W85 Gestational diabetes 
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ICPC Code            ICPC Code Description  
W90 Uncomplicated labour/delivery livebirth 
W91 Uncomplicated labour/delivery stillbirth 
W92 Complicated labour/delivery livebirth 
W93 Complicated labour/delivery stillbirth 
W94 Puerperal mastitis 
W95 Breast disorder in pregnancy/puerperium other 
W96 Complications of puerperium other 
W99 Disorder of pregnancy/delivery other 
X70 Syphilis female 
X71 Gonorrhoea female 
X72 Genital candidiasis female 
X73 Genital trichomoniasis female 
X74 Pelvic inflammatory disease 
X75 Malignant neoplasm cervix 
X76 Malignant neoplasm breast female 
X77 Malignant neoplasm genital female other 
X78 Fibromyoma uterus 
X79 Benign neoplasm breast female 
X80 Benign neoplasm female genital  
X81 Genital neoplasm female other/unspecified 
X82 Injury genital female 
X83 Congenital anomaly genital female 
X84 Vaginitis/vulvitis NOS 
X85 Cervical disease NOS 
X86 Abnormal cervix smear 
X87 Uterovaginal prolapse 
X88 Fibrocystic disease breast 
X89 Premenstrual tension syndrome 
X90 Genital herpes female 
X91 Condylomata acuminata female 
X92 Chlamydia infection genital female 
X99 Genital disease female other 
Y70 Syphilis male 
Y71 Gonorrhoea male 
Y72 Genital herpes male 
Y73 Prostatitis/seminal vesiculitis 
Y74 Orchitis/epididymitis  
Y75 Balanitis 
Y76 Condylomata acuminata male 
Y77 Malignant neoplasm prostate 
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ICPC Code            ICPC Code Description  
Y78 Malignant neoplasm male genital other 
Y79 Benign/unspecified neoplasm male genital  
Y80 Injury male genital  
Y81 Phimosis/redundant prepuce 
Y82 Hypospadias 
Y83 Undescended testicle 
Y84 Congenital genital anomaly male other 
Y85 Benign prostatic hypertrophy 
Y86 Hydrocoele 
Y99 Genital disease male other 
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Appendix D: Referral Categories (35 Categories) 
 
• Allergy  
• Anesthesiology 
• Cardiac Surgery 
• Cardiology 
• Cardiovascular and Thoracic Surgery 
• Dermatology 
• Emergency Medicine 
• Endocrinology 
• Otolaryngology 
• Gastroenterology 
• General Practice* 
• General Surgery 
• Genetics 
• Geriatrics 
• Haematology 
• Hospital/Specialty Clinic* 
• Internal Medicine 
• Microbiology/Infectious Diseases 
• Nephrology 
• Neurosurgery 
• Neurology 
• Nuclear Medicine 
• Obstetrics and Gynecology 
• Oncology 
• Ophthalmology 
• Orthopedic Surgery 
• Other Services/Unknown* 
• Physical Medicine and 
Rehabilitation  
• Plastic Surgery 
• Psychiatry 
• Radiation Oncology 
• Radiology 
• Respirology 
• Rheumatology 
• Urology 
 
*Indicates referral category not originally included in the OHIP medical specialty list 
Adapted From: Ontario Health Insurance Plan. Health care provider specialty codes. 
http://www.health.gov.on.ca/English/providers/pub/ohip/tech_specific/pdf/5_7.pdf. Accessed 
January 25, 2012.  
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Appendix E: Example Data Entries of the Laboratory Tests and Investigations Variable
Laboratory Tests Data Entries  Investigations Data Entries 
Alkaline Phosphatase  Abdomen  
Bilirubin  Ankle  
Blood Film Exam Barium Enema 
CBC*  Bone Density  
Chloride Bone Scan 
C-reactive protein  Breast 
Creatinine  Cervical Spine 
Fecal Occult Blood  Chest 
Ferritin CT Head 
Free T4 ECG 
Glucose Random EEG 
Glycosylated Hb (HbA1C) EKG 
HDL Electrocardiogram 
Hematocrit Exercise Stress Test 
Hemoglobin  Femur 
LDL Hand 
Lipid Assessment* Hip 
Mononucleosis Screen Kidney 
Platelets Knee 
Potassium  Lumbar Spine 
RBC count Mammogram 
Sedimentation Rate MRI 
Sodium Obstetrical 
Sputum  Pelvis 
Stool Culture Prostate 
Transferrin Saturation  Pulmonary Function Test 
Triglycerides Renal 
Uric Acid Shoulder 
Urinalysis* Sinuses 
Urinalysis (Chemical) Sleep Study 
Vitamin B12 Stress Test 
W.B.C. Count Thorax 
 Thyroid 
 UGI  
 Ultrasound 
*Indicates data entries that received a multiplicative factor  
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Appendix F: Previous and Co-Occurring Chronic Morbidities 
ICPC Code  ICPC Code Description  
A70 Tuberculosis  
A79 Malignancy NOS 
A90 Congenital anomaly NOS/multiple 
B72 Hodgkin's disease/lymphoma 
B73 Leukaemia 
B74 Malignant neoplasm blood other  
B78 Hereditary haemolytic anaemia  
B81 Anaemia vit B12/folate deficiency  
B82 Anaemia other/unspecified  
B83 Purpura/coagulation defect 
B90 HIV-infection/AIDS 
D74 Malignant neoplasm stomach 
D75 Malignant neoplasm colon/rectum 
D76 Malignant neoplasm pancreas 
D77 Malignant digestive neoplasm other/NOS 
D84 Oesophagus disease 
D85 Duodenal ulcer  
D86 Peptic ulcer other 
D92 Diverticular disease 
D93 Irritable bowel syndrome 
D94 Chronic enteritis/ulcerative colitis  
D97 Liver disease NOS 
D98 Cholecystitis/cholelithiasis  
F83 Retinopathy  
F84 Macular degeneration 
F92 Cataract 
F93 Glaucoma  
F94 Blindness 
H82 Vertiginous syndrome 
H84 Presbyacusis 
H86 Deafness 
K73 Congenital anomaly cardiovascular  
K74 Ischaemic heart disease with angina 
K75 Acute myocardial infarction 
K76 Ischaemic heart disease without angina 
K77 Heart failure 
K78 Atrial fibrillation/flutter 
K79 Paroxysmal tachycardia  
K80 Cardiac arrhythmia NOS 
K81 Heart/arterial murmur NOS 
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ICPC Code            ICPC Code Description  
K82 Pulmonary heart disease  
K83 Heart valve disease NOS 
K84 Heart disease other  
K86 Hypertension uncomplicated  
K87 Hypertension complicated 
K88 Postural hypotension 
K89 Transient cerebral ischaemia  
K90 Stroke/cerebrovascular accident 
K91 Cerebrovascular disease  
K92 Atherosclerosis/peripheral vascular disease 
K93 Pulmonary embolism 
K94 Phlebitis/thrombophlebitis 
K95 Varicose veins of leg 
L71 Malignant neoplasm musculoskeletal  
L83 Neck syndrome 
L84 Back syndrome without radiating pain 
L85 Acquired deformity of spine 
L86 Back syndrome with radiating pain 
L88 Rheumatoid/seropositive arthritis  
L89 Osteoarthritis of hip 
L90 Osteoarthritis of knee 
L91 Osteoarthritis other 
L92 Shoulder syndrome 
L93 Tennis elbow 
L95 Osteoporosis  
N73 Neurological infection other 
N74 Malignant neoplasm nervous system 
N75 Benign neoplasm nervous system 
N76 Neoplasm nervous system unspecified  
N85 Congenital anomaly neurological  
N86 Multiple sclerosis  
N87 Parkinsonism 
N88 Epilepsy 
N89 Migraine 
N90 Cluster headache  
N92 Trigeminal neuralgia  
N93 Carpal tunnel syndrome 
N94 Peripheral neuritis/neuropathy  
P15 Chronic alcohol abuse 
P70 Dementia 
P71 Organic psychosis other 
P72 Schizophrenia  
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ICPC Code            ICPC Code Description  
P73 Affective psychosis  
P74 Anxiety disorder/anxiety state 
P75 Somatization disorder 
P76 Depressive disorder 
P78 Neuraesthenia/surmenage 
P79 Phobia/compulsive disorder 
P80 Personality disorder 
P81 Hyperkinetic disorder 
P82 Post-traumatic stress disorder 
P85 Mental retardation 
P86 Anorexia nervosa/bulimia  
P98 Psychosis NOS/other 
R84 Malignant neoplasm bronchus/lung 
R85 Malignant neoplasm respiratory other 
R90 Hypertrophy tonsils/adenoids  
R95 Chronic obstructive pulmonary disease 
R96 Asthma 
S77 Malignant neoplasm of skin 
S86 Dermatitis seborrhoeic 
S87 Dermatitis/atopic eczema  
S91 Psoriasis  
T71 Malignant neoplasm thyroid 
T81 Goitre 
T82 Obesity 
T83 Overweight 
T85 Hyperthyroidism/thyrotoxicosis  
T86 Hypothyroidism/myxoedema  
T89 Diabetes insulin dependent  
T90 Diabetes non-insulin dependent 
T92 Gout 
T93 Lipid disorder 
U75 Malignant neoplasm of kidney 
U76 Malignant neoplasm of bladder 
U77 Malignant neoplasm urinary other 
U88 Glomerulonephritis/nephrosis  
W15 Infertility/subfertility female 
W72 Malignant neoplasm related to pregnancy   
X74 Pelvic inflammatory disease 
X75 Malignant neoplasm cervix  
X76 Malignant neoplasm breast female  
X77 Malignant neoplasm genital female other 
Y77 Malignant neoplasm prostate 
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ICPC Code            ICPC Code Description  
Y78 Malignant neoplasm male genital other 
Y85 Benign prostatic hypertrophy  
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Appendix G: Previous and Co-Occurring Psychosocial Morbidities 
ICPC Code  ICPC Code Description  
Psychological   
P01 Feeling anxious/nervous/tense 
P02 Acute stress reaction  
P03 Feeling depressed 
P04 Feeling/behaving irritable/angry 
P05 Senility, feeling/behaving old 
P06 Sleep disturbance 
P07 Sexual desire reduced  
P08 Sexual fulfillment reduced  
P09 Sexual preference concern  
P10 Stammering/stuttering/tic 
P11 Eating problem in child  
P12 Bedwetting/enuresis 
P13 Encopresis/bowel training problem 
P15 Chronic alcohol abuse  
P16 Acute alcohol abuse  
P17 Tobacco abuse  
P18 Medication abuse 
P19 Drug abuse 
P20 Memory disturbance  
P22 Child behaviour symptom/complaint 
P23 Adolescent behaviour symptom/complaint 
P24 Specific learning problem 
P25 Phase of life problem adult 
P28 Limited function/disability (P)  
P29 Psychological symptom/complaint other 
P70 Dementia  
P71 Organic psychosis other 
P72 Schizophrenia  
P73 Affective psychosis  
P74 Anxiety disorder/anxiety state 
P75 Somatization disorder 
P76 Depressive disorder 
P77 Suicide/suicide attempt  
P78 Neuraesthenia/surmenage  
P79 Phobia/compulsive disorder  
P80 Personality disorder  
P81 Hyperkinetic disorder 
P82 Post-traumatic stress disorder 
P85 Mental retardation  
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ICPC Code            ICPC Code Description  
P86 Anorexia nervosa/bulimia  
P98 Psychosis NOS/other 
P99 Psychological disorders other 
  
Social Problems  
Z01 Poverty/financial problem  
Z02 Food/water problem  
Z03 Housing/neighbourhood problem 
Z04 Social cultural problem 
Z05 Work problem 
Z06 Unemployment problem  
Z07 Education problem  
Z08 Social welfare problem  
Z09 Legal problem  
Z10 Health care system problem  
Z11 Compliance/being ill problem 
Z12 Relationship problem with partner 
Z13 Partner behaviour problem  
Z14 Partner illness problem 
Z15 Loss/death of partner problem 
Z16 Relationship problem with child  
Z18 Illness problem with child  
Z19 Loss/death of child problem 
Z20 Relationship problem parent/family 
Z21 Behaviour problem parent/family 
Z22 Illness problem parent/family  
Z23 Loss/death of parent/family member problem  
Z24 Relationship problem friend 
Z25 Assault/harmful event problem  
Z28 Limited function/disability (Z) 
Z29 Social problem NOS  
  
Fear and Concern  
A13 Concern about/fear of medical treatment  
A18 Concern about appearance 
A25 Fear of death/dying 
A26 Fear of cancer NOS  
A27 Fear of other disease NOS  
B25 Fear of AIDS/HIV 
B26 Fear of cancer blood/lymph 
B27 Fear of blood/lymph disease other 
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ICPC Code            ICPC Code Description  
D26 Fear of cancer of digestive system 
D27 Fear of digestive disease other 
F27 Fear of eye disease  
H15 Concern with appearance of ears  
H27 Fear of ear disease  
K24 Fear of heart disease  
K25 Fear of hypertension  
K27 Fear of cardiovascular disease  
L26 Fear of cancer musculoskeletal  
L27 Fear of musculoskeletal disease other 
N26 Fear of cancer of neurological system 
N27 Fear of neurological disease other 
P27 Fear of mental disorder 
R26 Fear of cancer of respiratory system 
R27 Fear of respiratory disease other 
S26 Fear of cancer of skin 
S27 Fear of skin disease other 
T26 Fear of cancer of endocrine system 
T27 Fear of endocrine/metabolic disease other 
U26 Fear of cancer of urinary system 
U27 Fear of urinary disease other 
W02 Fear of pregnancy 
W21 Concern about body image related to pregnancy  
W27 Fear of complications of pregnancy  
X22 Concern about breast appearance female  
X23 Fear of sexually transmitted disease female  
X24 Fear of sexual dysfunction female  
X25 Fear of genital cancer female 
X26 Fear of breast cancer female  
X27 Fear of genital/breast disease female other 
Y24 Fear of sexual dysfunction male  
Y25 Fear of sexually transmitted disease male  
Y26 Fear of genital cancer male  
Y27 Fear of genital disease male other 
Z27 Fear of social problem  
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Appendix H: Previous and Co-Occurring Other Morbidities 
ICPC Code  ICPC Code Description  
A01  Pain general/multiple sites 
A02 Chills 
A03 Fever 
A05 Feeling ill 
A06 Fainting/syncope 
A08 Swelling 
A09 Sweating problem 
A10 Bleeding/haemorrhage NOS 
A11 Chest pain NOS 
A16 Irritable infant  
A20 Euthanasia request/discussion 
A21 Risk factor for malignancy 
A23 Risk factor NOS 
A28 Limited function/disability NOS 
A29 General symptom/complaint other 
A71 Measles 
A72 Chickenpox 
A73 Malaria 
A74 Rubella 
A75 Infectious mononucleosis 
A76 Viral exanthem other 
A77 Viral disease other/NOS 
A78 Malignancy NOS 
A80 Trauma/injury NOS 
A81 Multiple trauma/injuries 
A82 Secondary effect of trauma 
A84 Poisoning by medical agent 
A85 Adverse effect medical agent 
A86 Toxic effect non-medicinal substance 
A87 Complication of medical treatment 
A88 Adverse effect physical factor 
A89 Effect prosthetic device 
A91 Abnormal result investigation NOS 
A92 Allergy/allergic reaction NOS 
A93 Premature newborn  
A94 Perinatal morbidity other 
A95 Perinatal mortality  
A99 Disease/condition of unspecified nature/site  
B02 Lymph gland(s) enlarged/painful 
B04 Blood symptom/complaint 
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ICPC Code            ICPC Code Description  
B28 Limited function/disability (B) 
B29 Lymph/immune mechanism symptom/complaint other 
B70 Lymphadenitis acute 
B71 Lymphadenitis chronic/non-specific 
B75 Neoplasm blood benign/unspecified 
B76 Ruptured spleen traumatic  
B77 Injury blood/lymph/spleen other 
B79 Congenital anomaly blood/lymph other 
B80 Iron deficiency anaemia  
B84 Unexplained abnormal white cells 
B87 Splenomegaly 
B99 Blood/lymph/spleen disease other 
D01 Abdominal pain/cramps general 
D02 Abdominal pain epigastric 
D03 Heartburn 
D04 Rectal/anal pain 
D05 Perianal itching 
D06 Abdominal pain localized other 
D07 Dyspepsia/indigestion 
D08 Flatulence/gas/belching 
D09 Nausea 
D10 Vomiting 
D11 Diarrhoea  
D12 Constipation 
D13 Jaundice 
D14 Haematemesis/vomiting blood 
D15 Melaena  
D16 Rectal bleeding 
D17 Incontinence of bowel 
D18 Change in faeces/bowel movements 
D19 Teeth/gum symptom/complaint 
D20 Mouth/tongue/lip symptom/complaint 
D21 Swallowing problem 
D23 Hepatomegaly  
D24 Abdominal mass NOS 
D25 Abdominal distension  
D28 Limited function/disability (D) 
D29 Digestive symptom/complaint other 
D70 Gastrointestinal infection 
D71 Mumps 
D72 Viral hepatitis  
D73 Gastroenteritis presumed infection 
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ICPC Code            ICPC Code Description  
D78 Neoplasm digestive system benign/unspecified 
D79 Foreign body digestive system 
D80 Injury digestive system other 
D81 Congenital anomaly digestive system 
D82 Teeth/gum disease 
D83 Mouth/tongue/lip disease 
D87 Stomach function disorder 
D88 Appendicitis 
D89 Inguinal hernia  
D90 Hiatus hernia  
D91 Abdominal hernia other 
D95 Anal fissure/perianal abscess 
D96 Worms/other parasites 
D99 Disease digestive system other 
F01 Eye pain 
F02 Red eye 
F03 Eye discharge 
F04 Visual floaters/spots 
F05 Visual disturbance other 
F13 Eye sensation abnormal 
F14 Eye movements abnormal 
F15 Eye appearance abnormal 
F16 Eyelid symptom/complaint 
F17 Glasses symptom/complaint 
F18 Contact lens symptom/complaint 
F28 Limited function/disability (F) 
F29 Eye symptom/complaint other 
F70 Conjunctivitis infectious  
F71 Conjunctivitis allergic 
F72 Blepharitis/stye/chalazion 
F73 Eye infection/inflammation other 
F74 Neoplasm of eye/adnexa 
F75 Contusion/haemorrhage eye 
F76 Foreign body in eye 
F79 Injury eye other 
F80 Blocked lacrimal duct of infant 
F81 Congenital anomaly eye other 
F82 Detached retina 
F85 Corneal ulcer 
F86 Trachoma  
F91 Refractive error 
F95 Strabismus  
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ICPC Code            ICPC Code Description  
F99 Eye/adnexa disease other 
H01 Ear pain/earache 
H02 Hearing complaint 
H03 Tinnitus, ringing/buzzing ear 
H04 Ear discharge 
H05 Bleeding ear 
H13 Plugged feeling ear 
H28 Limited function/disability (H) 
H29 Ear symptom/complaint other 
H70 Otitis externa 
H71 Acute otitis media/myringitis  
H72 Serous otitis media 
H73 Eustachian salpingitis  
H74 Chronic otitis media 
H75 Neoplasm of ear 
H76 Foreign body in ear 
H77 Perforation ear drum 
H78 Superficial injury of ear 
H79 Ear injury other 
H80 Congenital anomaly of ear  
H81 Excessive ear wax 
H83 Otosclerosis  
H85 Acoustic trauma 
H99 Ear/mastoid disease other 
K01 Heart pain 
K02 Pressure/tightness of heart 
K03 Cardiovascular pain NOS 
K04 Palpitations/awareness of heart  
K05 Irregular heartbeat other 
K06 Prominent veins 
K07 Swollen ankles/oedema  
K22 Risk factor for cardiovascular disease  
K28 Limited function/disability (K) 
K29 Cardiovascular symptom/complaint other 
K70 Infection of circulatory system 
K71 Rheumatic fever/heart disease 
K72 Neoplasm cardiovascular  
K85 Elevated blood pressure 
K96 Haemorrhoids  
K99 Cardiovascular disease other 
L01 Neck symptom/complaint 
L02 Back symptom/complaint  
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ICPC Code            ICPC Code Description  
L03 Low back symptom/complaint 
L04 Chest symptom/complaint 
L05 Flank/axilla symptom/complaint 
L07 Jaw symptom/complaint 
L08 Shoulder symptom/complaint 
L09 Arm symptom/complaint 
L10 Elbow symptom/complaint 
L11 Wrist symptom/complaint 
L12 Hand/finger symptom/complaint 
L13 Hip symptom/complaint 
L14 Leg/thigh symptom/complaint 
L15 Knee symptom/complaint 
L16 Ankle symptom/complaint 
L17 Foot/toe symptom/complaint 
L18 Muscle pain 
L19 Muscle symptom/complaint NOS 
L20 Joint symptom/complaint NOS 
L28 Limited function/disability (L) 
L29 Musculoskeletal symptom/complaint other 
L70 Infection of musculoskeletal system 
L72 Fracture: radius/ulna 
L73 Fracture: tibia/fibula 
L74 Fracture: hand/foot bone 
L75 Fracture: femur 
L76 Fracture: other 
L77 Sprain/strain of ankle 
L78 Sprain/strain of knee 
L79 Sprain/strain of joint NOS 
L80 Dislocation/subluxation  
L81 Injury musculoskeletal NOS 
L82 Congenital anomaly musculoskeletal  
L87 Bursitis/tendinitis/synovitis NOS 
L94 Osteochondrosis 
L96 Acute internal damage knee 
L97 Neoplasm musculoskeletal benign/unspecified 
L98 Acquired deformity of limb 
L99 Musculoskeletal disease other 
N01 Headache 
N03 Pain face 
N04 Restless legs 
N05 Tingling fingers/feet/toes 
N06 Sensation disturbance other 
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ICPC Code            ICPC Code Description  
N07 Convulsion/seizure 
N08 Abnormal involuntary movements 
N16 Disturbance of smell/taste 
N17 Vertigo/dizziness 
N18 Paralysis/weakness 
N19 Speech disorder 
N28 Limited function/disability (N) 
N29 Neurological symptom/complaint other 
N70 Poliomyelitis  
N71 Meningitis/encephalitis 
N72 Tetanus 
N79 Concussion 
N80 Head injury other 
N81 Injury nervous system other 
N91 Facial paralysis/bell's palsy 
N95 Tension headache 
N99 Neurological disease other 
R01 Pain respiratory system 
R02 Shortness of breath/dyspnoea 
R03 Wheezing 
R04 Breathing problem other 
R05 Cough  
R06 Nose bleed/epistaxis 
R07 Sneezing/nasal congestion 
R08 Nose symptom/complaint other 
R09 Sinus symptom/complaint 
R21 Throat symptom/complaint 
R23 Voice symptom/complaint 
R24 Haemoptysis  
R25 Sputum/phlegm abnormal 
R28 Limited function/disability (R ) 
R29 Respiratory symptom/complaint other 
R71 Whooping cough 
R72 Strep throat  
R73 Boil/abscess nose 
R74 Upper respiratory infection acute 
R75 Sinusitis acute/chronic 
R76 Tonsillitus acute 
R77 Laryngitis/tracheitis acute 
R78 Acute bronchitis/bronchiolitis  
R79 Chronic bronchitis 
R80 Influenza 
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ICPC Code            ICPC Code Description  
R81 Pneumonia  
R82 Pleurisy/pleural effusion 
R83 Respiratory infection other 
R86 Benign neoplasm respiratory 
R87 Foreign body nose/larynx/bronchus 
R88 Injury respiratory other 
R89 Congenital anomaly respiratory 
R92 Neoplasm respiratory unspecified 
R97 Allergic rhinitis  
R98 Hyperventilation syndrome 
R99 Respiratory disease other 
S01 Pain/tenderness of skin 
S02 Pruritus 
S03 Warts 
S04 Lump/swelling localized 
S05 Lumps/swellings generalized  
S06 Rash localized  
S07 Rash generalized  
S08 Skin colour change 
S09 Infected finger/toe 
S10 Boil/carbuncle 
S11 Skin infection post-traumatic  
S12 Insect bite/sting 
S13 Animal/human bite 
S14 Burn/scald 
S15 Foreign body in skin 
S16 Bruise/contusion 
S17 Abrasion/scratch/blister 
S18 Laceration/cut 
S19 Skin injury other 
S20 Corn/callosity 
S21 Skin texture symptom/complaint 
S22 Nail symptom/complaint 
S23 Hair loss/baldness 
S24 Hair/scalp symptom/complaint other 
S28 Limited function/disability (S) 
S29 Skin symptom/complaint other 
S70 Herpes zoster 
S71 Herpes simplex 
S72 Scabies/other acariasis 
S73 Pediculosis/skin infestation other 
S74 Dermatophytosis 
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ICPC Code            ICPC Code Description  
S75 Moniliasis/candidiasis skin 
S76 Skin infection other 
S78 Lipoma 
S79 Neoplasm skin benign/unspecified 
S80 Solar keratosis/sunburn 
S81 Haemangioma/lymphangioma 
S82 Naevus/mole 
S83 Congenital skin anomaly other 
S84 Impetigo 
S85 Pilonidal cyst/fistula 
S88 Dermatitis contact/allergic 
S89 Diaper rash 
S90 Pityriasis rosea 
S92 Sweat gland disease 
S93 Sebaceous cyst 
S94 Ingrown nail  
S95 Molluscum contagiosum 
S96 Acne 
S97 Chronic ulcer skin 
S98 Urticaria  
S99 Skin disease other 
T01 Excessive thirst 
T02 Excessive appetite 
T03 Loss of appetite 
T04 Feeding problem of infant/child 
T05 Feeding problem of adult 
T07 Weight gain 
T08 Weight loss 
T10 Growth delay 
T11 Dehydration 
T28 Limited function/disability (T) 
T29 Endocrine/metabolic/nutritional symptom/complaint other 
T70 Endocrine infection 
T72 Benign neoplasm thyroid 
T73 Neoplasm endocrine other/unspecified 
T78 Thyroglossal duct/cyst 
T80 Congenital anomaly endocrine/metabolic  
T87 Hypoglycaemia 
T91 Vitamin/nutritional deficiency 
T99 Endocrine/metabolic/nutritional disease other 
U01 Dysuria/painful urination 
U02 Urinary frequency/urgency 
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ICPC Code            ICPC Code Description  
U04 Incontinence urine 
U05 Urination problems other 
U06 Haematuria 
U07 Urine symptom/complaint other 
U08 Urinary retention 
U13 Bladder symptom/complaint other 
U14 Kidney symptom/complaint 
U28 Limited function/disability (U) 
U29 Urinary symptom/complaint other 
U70 Pyelonephritis/pyelitis 
U71 Cystitis/urinary infection other 
U72 Urethritis 
U78 Benign neoplasm urinary tract 
U79 Neoplasm urinary tract unspecified 
U80 Injury urinary tract 
U85 Congenital anomaly urinary tract 
U90 Orthostatic albuminuria/proteinuria  
U95 Urinary calculus  
U98 Abnormal urine test NOS 
U99 Urinary disease other 
W01 Question of pregnancy 
W03 Antepartum bleeding 
W05 Pregnancy vomiting/nausea 
W10 Contraception postcoital 
W11 Contraception oral 
W12 Contraception intrauterine 
W13 Sterilization female  
W14 Contraception female other 
W17 Post-partum bleeding 
W18 Post-partum symptom/complaint other 
W19 Breast/lactation symptom/complaint 
W28 Limited function/disability (W) 
W29 Pregnancy symptom/complaint other 
W70 Puerperal infection/sepsis  
W71 Other infection complicating pregnancy/puerperium 
W73 Benign/unspecified neoplasm related to pregnancy 
W75 Injury complicating pregnancy 
W76 Congenital anomaly complicating pregnancy 
W78 Pregnancy 
W79 Unwanted pregnancy 
W80 Ectopic pregnancy 
W81 Toxaemia of pregnancy 
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ICPC Code            ICPC Code Description  
W82 Abortion spontaneous 
W83 Abortion induced 
W84 Pregnancy high risk 
W85 Gestational diabetes 
W90 Uncomplicated labour/delivery livebirth 
W91 Uncomplicated labour/delivery stillbirth 
W92 Complicated labour/delivery livebirth 
W93 Complicated labour/delivery stillbirth 
W94 Puerperal mastitis 
W95 Breast disorder in pregnancy/puerperium other 
W96 Complications of puerperium other 
W99 Disorder of pregnancy/delivery other 
X01 Genital pain female 
X02 Menstrual pain 
X03 Intermenstrual pain 
X04 Painful intercourse female 
X05 Menstruation absent/scanty 
X06 Menstruation excessive 
X07 Menstruation irregular/frequent 
X08 Intermenstrual bleeding 
X09 Premenstrual symptom/complaint 
X10 Postponement of menstruation 
X11 Menopausal symptom/complaint 
X12 Postmenopausal bleeding 
X13 Postcoital bleeding 
X14 Vaginal discharge 
X15 Vaginal symptom/complaint other 
X16 Vulval symptom/complaint 
X17 Pelvis symptom/complaint female 
X18 Breast pain female 
X19 Breast lump/mass female 
X20 Nipple symptom/complaint female 
X21 Breast symptom/complaint female other 
X28 Limited function/disability (X) 
X29 Genital symptom/complaint female other 
X70 Syphilis female 
X71 Gonorrhoea female 
X72 Genital candidiasis female 
X73 Genital trichomoniasis female 
X78 Fibromyoma uterus 
X79 Benign neoplasm breast female 
X80 Benign neoplasm female genital  
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ICPC Code            ICPC Code Description  
X81 Genital neoplasm female other/unspecified 
X82 Injury genital female 
X83 Congenital anomaly genital female 
X84 Vaginitis/vulvitis NOS 
X85 Cervical disease NOS 
X86 Abnormal cervix smear 
X87 Uterovaginal prolapse  
X88 Fibrocystic disease breast 
X89 Premenstrual tension syndrome 
X90 Genital herpes female  
X91 Condylomata acuminata female  
X92 Chlamydia infection genital female 
X99 Genital disease female other 
Y01 Pain in penis 
Y02 Pain in testis/scrotum 
Y03 Urethral discharge male 
Y04 Penis symptom/complaint other 
Y05 Scrotum/testis symptom/complaint other 
Y06 Prostate symptom/complaint 
Y07 Impotence NOS 
Y08 Sexual function symptom/complaint male  
Y10 Infertility/subfertility male 
Y13 Sterilization male 
Y14 Family planning male other 
Y16 Breast symptom/complaint male  
Y28 Limited function/disability (Y)  
Y29 Genital symptom/complaint male other 
Y70 Syphilis male 
Y71 Gonorrhoea male 
Y72 Genital herpes male 
Y73 Prostatitis/seminal vesiculitis  
Y74 Orchitis/epididymitis 
Y75 Balanitis  
Y76 Condylomata acuminata male  
Y79 Benign/unspecified neoplasm male genital  
Y80 Injury male genital  
Y81 Phimosis/redundant prepuce 
Y82 Hypospadias  
Y83 Undescended testicle 
Y84 Congenital genital anomaly male other 
Y86 Hydrocoele  
Y99 Genital disease male other 
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Appendix I: Run-In and Follow-Up Period Sensitivity Analysis for Number of Subsequent   
         Visits  
NOTE:  
+ Indicates a statistically significant positive relationship  
− Indicates a statistically significant negative relationship  
An empty box indicates no statistically significant relationship in the multivariable analysis or 
p>0.2 in bivariate analysis 
 
 
 
 
 
 
 
 
Characteristic 
Length of Run-In and Follow-Up Period of 
ICPC Coding 
Six Month Run-In and 
Follow-Up Period of 
ICPC Coding (N=167) 
One Year Run-In and 
Follow-Up Period of 
ICPC Coding (N=103) 
Age     
Female     
Number of Previous and Co-Occurring   
  Chronic Morbidities     
Number of Previous and Co-Occurring  
  Psychosocial Morbidities 
    
Number of Previous and Co-Occurring  
  Other Morbidities   
 
Previous Care-Seeking Frequency + + 
Number of Laboratory Tests and  
  Investigations + + 
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Appendix J: Run-In and Follow-Up Period Sensitivity Analysis for Number of Referrals 
NOTE:  
+ Indicates a statistically significant positive relationship  
− Indicates a statistically significant negative relationship  
An empty box indicates no statistically significant relationship in the multivariable analysis or 
p>0.2 in bivariate analysis 
 
 
 
 
 
 
 
 
 
 
Characteristic 
Length of Run-In and Follow-Up Period of 
ICPC Coding 
Six Month Run-In and 
Follow-Up Period of 
ICPC Coding (N=167) 
One Year Run-In and 
Follow-Up Period of 
ICPC Coding (N=103) 
Age     
Female − − 
Number of Previous and Co-Occurring  
  Chronic Morbidities     
Number of Previous and Co-Occurring  
  Psychosocial Morbidities      
Number of Previous and Co-Occurring  
  Other Morbidities +  +  
Previous Care-Seeking Frequency − − 
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Appendix K: Run-In and Follow-Up Period Sensitivity Analysis for Number of Laboratory  
           Tests and Investigations 
NOTE:  
+ Indicates a statistically significant positive relationship  
− Indicates a statistically significant negative relationship  
An empty box indicates no statistically significant relationship in the multivariable analysis or 
p>0.2 in bivariate analysis 
 
 
 
 
 
 
 
 
 
Characteristic 
Length of Run-In and Follow-Up Period of 
ICPC Coding 
Six Month Run-In and 
Follow-Up Period of 
ICPC Coding (N=167) 
One Year Run-In and 
Follow-Up Period of 
ICPC Coding (N=103) 
Age     
Female  −   
Number of Previous and Co-Occurring 
Chronic Morbidities 
  
  
Number of Previous and Co-Occurring  
  Psychosocial Morbidities 
  
 
Number of Previous and Co-Occurring  
  Other Morbidities   
  
Previous Care-Seeking Frequency − − 
Number of Subsequent Visits + + 
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Appendix L: Comparison of Included and Excluded Fatigue Symptom Patients  
Characteristic 
Included Patients 
N=103 (37.6%) 
Excluded Patients 
N=171 (62.4%) 
p-value1 
Mean Age (years) 63.1 63.3 0.304 
Sex, n (%)    
Female  70 (68%) 112 (63%) 0.430 
Male  33 (32%) 65 (37%)  
    
1 Results from two-sample t-tests 
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Appendix M: Comparison of the DELPHI ICPC Patient Population (N=3,341) and the  
2011 Canadian Census Population (N=33,476,685) 
Characteristic 
Canadian Census Population 
N=33,476,6852 
DELPHI ICPC Population 
N=3,3411 
Age Distribution (years)   
     Median Age  39.5  56.0  
     Median Age of Males 38.6  57.0 
     Median Age of Females  40.4 55.0 
Sex Distribution    
     Males  49% 43% 
     Females 51% 57% 
Note:  
1Sample of patients coded using the International Classification of Primary Care (ICPC), derived 
from the Deliver Primary Health Care Information (DELPHI) Project.  
22011 Canadian Census Population data derived from: Statistics Canada. 2011 Census of 
Population. Statistics Canada Catalogue. Ottawa: Catalogue No.: 98-316-XWE. 
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